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ABSTRACT
The medicinal plant Madagascar periwinkle (Catharanthus roseus) produces over 130
monoterpene indole alkaloid (MIA) natural products. Many of these compounds have
pharmaceutical value, such as the anticancer agents vinblastine and vincristine. Unnatural
modifications can impart novel bioactivity to the parent natural product. Advances in
synthetic biology and microbial engineering have allowed overproduction of natural
products and their analogs in non-native organisms such as yeast and E. coli. However,
re-engineering of plant pathways to yield "novel" products has been limited, particularly
when compared to the successes achieved in prokaryotic systems. This thesis describes
several strategies to re-engineer MIA biosynthesis in periwinkle to produce novel
alkaloids. The first strategy involves the introduction of a biosynthetic enzyme with
redesigned substrate specificity into periwinkle. The resulting transgenic plant culture
produces a variety of unnatural alkaloid compounds when co-cultured with precursors
that the re-engineered enzyme has been designed to accept. The second strategy improves
upon this work by enabling periwinkle to autonomously synthesize precursor analogs in
situ. Specifically, the prokaryotic halogenation machinery was introduced into the
genome of periwinkle, which lacks the biosynthetic ability to produce halogenated
compounds. These halogenases function within the context of the plant cell to generate
halogenated precursor, which is then shuttled into MIA metabolism to yield halogenated
alkaloids. Altogether, a new functional group-an organohalide-was introduced into
plant secondary metabolism in a regioselective and predictable manner. The third strategy
involves RNAi-mediated suppression of MIA biosynthesis in periwinkle. Alkaloid
production was obliterated in the resulting transgenic plant culture. The silenced plant
culture produces a variety of fluorinated alkaloids when co-cultured with fluorinated
starting substrate. The yields of some unnatural alkaloids were improved since the natural
precursor was absent. Finally, the fourth strategy describes chemical functionalization of
halogenated MIAs. Postbiosynthetic chemical derivatizations of halogenated MIAs using
palladium-catalyzed Suzuki-Miyaura cross-coupling reactions robustly afforded aryl and
heteroaryl analogs of MIAs. Altogether, the work described in this thesis demonstrates
the versatility of medicinal plants in the generation of unnatural alkaloids. Thus, despite
their genetic complexity, plants are a viable platform for synthetic biology efforts.
Thesis Supervisor: Sarah E. O'Connor
Title: Associate Professor of Chemistry
Acknowledgements
This thesis would not have been possible without the support and guidance of these
several individuals:
First and foremost, my advisor, Professor Sarah O'Connor, for your endless
encouragement, insightful guidance and inexhaustible enthusiasm. It has truly been an
honor working in your lab. You have shown me how exciting and impactful science can
be. You have given me the freedom to explore unconventional ideas that have proven to
be rewarding. I will always be eternally grateful to you.
Professor Catherine Drennan and Professor Gerald Fink, my thesis committee members,
for your support and suggestions on my research and my graduate/postgraduate career.
Professor Barbara Imperiali and Professor Kristala Jones Prather also for your steadfast
encouragement and helpful advice.
Members of the O'Connor lab, for the most amazing time one could ever ask for. Special
thanks to Peter Bernhardt, for letting me work on your re-engineered strictosidine
synthase and for your support throughout my graduate career; Justin Maresh and Xudong
Qu, for your vision and the hard work that you contributed in our collaborations; Nancy
Yerkes, for giving me a crash course in plant molecular biology, and for always making
the lab a fun environment to work in; Lesley-Ann Giddings, Dave Liscombe, Aimee
Usera and Zeke Nims, for your encouragement and advice both in science and in life;
Weslee Glenn for carrying on with the halogenase work and for your unfailing patience
and understanding; Bettina Ruff and John Cheng, for your friendship and kindness. It is
in large part because of you all that I am motivated and happy to spend countless hours in
lab.
Professor Stuart Schreiber, Professor Yongyuth Yuthavong, Dr. Sumalee
Kamchonwongpaisan, Ajarn Anchalee, P'Ked (Sirinya Matchacheep) and P'Nok
(Supanee Taweechai), for your guidance and for inspiring me to become a scientist.
My friends in Boston and elsewhere in the US, for helping me feel at home. I am most
grateful for Prae, Gob, Aam, Fang, 0, P'Tape, Yui, Kob, Tao, P'Joe, Mike, Amp and
Sam for being patient with me and for making me sane in trying times. Special thanks to
Effendi Leonard and Jill Hagel for our fruitful collaborations and for your helpful advice.
Thanks also to the Liu family, Jonathan, Chiu-Hui, Ken, Lucy, Kenneth and Omi for your
support and advice, as well as for helping me maintain a good balance in life.
Most importantly, my family-especially my mother, father and grandmother-for the
sacrifices that you have made to ensure my success and happiness in life, and for
instilling into me the importance of knowledge. I am so proud to have you in my life.
Although I only get to see you once a year, you give me enough love and warmth to last
me the entire lifetime. Thanks also to Chris and P'Nammon, my American family, for
loving me for who I am and for always being there for me.
Weerawat (Ricky) Runguphan
Table of Contents
List of Figures.....................................................................................................................7
List of Tables .................................................................................................................... 14
Conventions and Abbreviations .................................................................................. 15
Chapter 1. Background and Significance .................................................................. 18
1.1 Significance and Biosynthesis of Alkaloid Natural Products ............................ 19
1.2 Halogenated natural products ........................................................................... 22
1.3 Monoterpene Indole Alkaloids from Catharanthus roseus ............... 27
1.4 Precursor-Directed Biosynthesis of Monoterpene Indole Alkaloids and Re-
Engineering of Strictosidine Synthase ............................................................. 33
1.5 Plant Cell and Tissue Cultures ........................................................................... 35
1.6 Elicitation of Monoterpene Indole Alkaloid Biosynthesis and Metabolic
Engineering in C . roseus.................................................................................... 39
1.7 Reconstitution of Alkaloid Biosynthetic Pathways in Microbial Hosts ........... 43
1.8 Chemical Derivatizations of Monoterpene Indole Alkaloids ............................ 48
1.9 Research Goals and Thesis Overview................................................................51
1.10 R eferences..............................................................................................................53
Chapter 2. Overexpressing an Engineered Gene in C. roseus Cell Culture ........... 62
2 .1 Introduction ...................................................................................................... . 63
2.2 Results and Discussion ...................................................................................... 66
2 .3 C onclusions...................................................................................................... . 98
2.4 Experimental Methods ...................................................................................... 99
2.5 A cknow ledgem ents..............................................................................................112
2 .6 R eferences ............................................................................................................ 113
Chapter 3. Introducing Prokaryotic Halogenases into C. roseus Cell Culture ........ 115
3 .1 Introduction .......................................................................................................... 116
3.2 R esults and D iscussion ........................................................................................ 118
3 .3 C onclusions .......................................................................................................... 147
3.4 Experim ental M ethods ......................................................................................... 149
3.5 A cknow ledgem ents..............................................................................................170
3 .6 R eferences............................................................................................................170
Chapter 4. Silencing Tryptamine Biosynthesis in C. roseus Cell Culture ................ 173
4.1 Introduction .......................................................................................................... 174
4.2 Results and D iscussion ........................................................................................ 177
4.3 Conclusions..........................................................................................................206
4.4 Experim ental M ethods ......................................................................................... 206
4.5 A cknow ledgem ents..............................................................................................211
4.6 References ............................................................................................................ 211
Chapter 5. Chemogenetic Approaches to Further Derivatize Halogenated
A lkaloids ............................................................................................................. 214
5.1 Introduction..........................................................................................................215
5.2 Results and D iscussion ........................................................................................ 219
5.3 Conclusions..........................................................................................................247
5.4 Experim ental M ethods ......................................................................................... 247
5.5 A cknow ledgem ents..............................................................................................253
5.6 References ............................................................................................................ 253
Chapter 6. Conclusions and Future Directions...........................................................255
6.1 Conclusions .......................................................................................................... 256
6.2 Future D irections ................................................................................................. 260
6.3 References ............................................................................................................ 273
C hapter 2 - A ppendix A ................................................................................................ 276
C hapter 3 - A ppendix B ................................................................................................. 293
C hapter 5 - A ppendix C ................................................................................................ 324
Appendix D: Re-engineering Dioxygenases in Morphine Biosynthetic Pathway ....331
D .1 Introduction..........................................................................................................332
D .2 Results and D iscussion ........................................................................................ 335
D .3 Conclusions .......................................................................................................... 346
D .4 Experim ental M ethods ......................................................................................... 346
D .5 References ............................................................................................................ 350
CV............................................................................................. 351
List of Figures
Chapter 1
1.1 Examples of plant alkaloids and their sources .................................................. 20
1.2 Examples of halogenated natural products ...................................................... 23
1.3 Enzymatic chlorination of tryptophan ............................................................... 25
1.4 Proposed mechanism for the enzymatic chlorination of tryptophan by RebH and
P rn A ....................................................................................................................... 2 7
1.5 The early steps of MIA biosynthesis in C. roseus ............................................. 29
1.6 Biosynthesis of catharanthine, tabersonine and dihydroakuammicine in
C . roseus ................................................................................................................ 30
1.7 The late steps of MIA biosynthesis in C roseus ............................................... 32
1.8 Re-engineering of strictosidine synthase (STR) ............................................... 34
1.9 C. roseus whole plants, tissue and cell cultures................................................36
1.10 Procedure to generate transgenic C. roseus hairy root cultures ......................... 38
1.11 Summary of metabolic engineering efforts of monoterpene indole alkaloids in C.
ro seus ..................................................................................................................... 4 1
1.12 Reconstitution of benzylisoquinoline alkaloid pathway in microorganisms ......... 46
1.13 Exam ples of vinblastine analogs....................................................................... 49
1.14 Synthetic diversification of MIAs via palladium-catalyzed cross-coupling
reactio n s ................................................................................................................. 5 0
Chapter 2
2.1 Biosynthesis of monoterpene indole alkaloids in C. roseus .............................. 64
2.2 Schematic diagram of strictosidine synthase mutant constitutive expression
system and inducible expression system constructs ........................................ 68
2.3 1% agarose gel of PCR amplification of hairy root genomic DNA ................. 69
2.4 Unnatural alkaloid production in C. roseus hairy root culture expressing
re-engineered strictosidine synthase V214M (I) ................................................... 72
2.5 Unnatural alkaloid production in C. roseus hairy root culture expressing
re-engineered strictosidine synthase V214M (II) ................................................. 73
2.6 Unnatural alkaloid production in C. roseus hairy root culture expressing
re-engineered strictosidine synthase V214M (III) ................................................ 74
2.7 Unnatural alkaloid production in C. roseus hairy root culture expressing
re-engineered strictosidine synthase V214M (IV) ................................................ 75
2.8 Unnatural alkaloid production in C. roseus hairy root culture expressing
re-engineered strictosidine synthase V214M (V) ................................................. 76
2.9 UV spectra of alkaloid standards and isolated alkaloids from pCAMV214M hairy
root fed with 5-chlorotryptamine ..................................................................... 78
2.10 UV spectra of isolated alkaloids from pCAMV214M hairy root fed with 5-
m ethyltryptam ine .............................................................................................. 79
2.11 Aromatic region of 'H NMR and 'H- C HSQC spectra of chlorinated
ajm alicin e ............................................................................................................... 8 1
2.12 Aromatic region of 'H NMR and 'H-"C HSQC spectra of methylated
tabersonine ...................................................................................................... . . 8 1
2.13 LC-MS trace of catharanthine production in transgenic hairy roots.................83
2.14 Real-time RT-PCR analysis of transgenic hairy roots ...................................... 84
2.15 LC-MS traces of an in vitro enzymatic assay of pCAMV214M hairy root
ly sates (I)................................................................................................................87
2.16 LC-MS traces of an in vitro enzymatic assay of pCAMV214M hairy root
ly sates (II) .............................................................................................................. 8 8
2.17 LC-MS traces of an in vitro enzymatic assay of pCAMWT hairy root
ly sates (I) ............................................................................................................... 9 0
2.18 LC-MS traces of an in vitro enzymatic assay of pCAMWT hairy root
ly sates (II) ............................................................................................................. 9 2
2.19 LC-MS traces of the in vitro enzymatic assay of wild-type hairy root lysates
'spiked' with recombinant wild-type strictosidine synthase..............................95
2.20 Regeneration of C. roseus plants from root culture transformed with the V214M
m utant of strictosidine synthase......................................................................... 97
2.21 Accumulations of alkaloids in both wild type leaves from a plant grown from
seed, and in leaves derived from the regenerated plant .................................... 98
2.22 Schematic diagrams of strictosidine synthase mutant inducible expression system
and constitutive expression system constructs.....................................................100
2.23 HPLC trace of alkaloids from pCAMV214M hairy root fed with
5-chlorotryptam ine...............................................................................................106
2.24 HPLC trace of alkaloids from pCAMV214M hairy root fed with
5-m ethyltryptam ine .............................................................................................. 108
Chapter 3
3.1 RebH and PyrH, along with a partner reductase, halogenate the indole ring of
tryptophan to yield chloro-tryptophan ................................................................. 117
3.2 SDS-PAGE of C. roseus tryptophan decarboxylase purification ........................ 119
3.3 Steady state kinetic data for C. roseus tryptophan decarboxylase (TDC)...........120
3.4 Schematic diagram of prokaryotic halogenase plant expression plamids
pCAMRebHRebF and pCAMPyrHRebF ............................................................ 124
3.5 1% agarose gel of PCR amplification of RebF/H and wild-type hairy root
genom ic D N A ...................................................................................................... 125
3.6 1% agarose gel of PCR amplification of PyrH/RebF/STRvm and wild-type hairy
root genom ic D N A ............................................................................................... 126
3.7 Chlorinated alkaloids in C. roseus RebF/H hairy root culture.............................129
3.8 'H NMR and 'H-13C HSQC spectra of 12-chloro-19,20-dihydroakuammicine and
12-bromo- 19,20-dihydroakuammicine ................................................................ 130
3.9 Chlorinated alkaloids in C. roseus PyrH/RebF/STRvm hairy root culture ......... 131
3.10 Tabulated amounts of chlorinated alkaloid production in RebF/H hairy roots after
subsequent subcultures.........................................................................................135
3.11 Chlorinated alkaloid production in wild type line incubated with
7-chlorotryptam ine...............................................................................................136
3.12 Tabulated amounts of chlorinated alkaloid production in PyrH/RebF/STRvm
hairy roots after subsequent subcultures .............................................................. 137
3.13 Tabulated amounts of chlorinated alkaloid, 7-chlorotryptophan and 7-
chlorotryptamine in response to increasing KCl concentration ........................... 138
3.14 Extracted LC-MS chromatograms showing the presence of 12-bromo-19,20-
dihydroakuammicine in RebF/H hairy roots........................................................140
3.15 Brominated alkaloid production levels in selected RebF/H and wild type hairy
roots growing on solid media that have been supplemented with KBr ............... 141
3.16 Brominated and chlorinated alkaloids production levels in selected RebF/H hairy
roots growing on solid media that have been supplemented with KBr ............... 141
3.17 Extracted LC-MS traces showing the absence of iodinated alkaloids in selected
RebF/H and wild type hairy roots growing on solid media that have been
supplem ented w ith K I .......................................................................................... 142
3.18 Expression levels of RebH and RebF in 5 different RebF/H lines measured by
R T -P C R ............................................................................................................... 14 4
3.19 Expression levels of PyrH, RebF and STRvm in 4 different PyrH/RebF/ STRvm
lines m easured by RT-PC R .................................................................................. 145
3.20 Morphology of RebF/H, PyrH/RebF/STRvm and wild type hairy roots.............148
3.21 Construction of pCAMPyrHRebF and pCAMRebHRebF plasmids ................... 155
3.22 HPLC trace of alkaloids from TDCi hairy root fed with 7-chlorotryptamine ..... 164
3.23 HPLC traces of alkaloids from TDCi hairy root fed with 7-bromotryptamine ... 165
Chapter 4
4.1 Monoterpene indole alkaloid biosynthesis in C. roseus ...................................... 175
4.2 Silencing of tryptamine biosynthesis in C. roseus...............................................176
4.3 Schematic diagram of tryptophan decarboxylase silencing construct ................. 178
4.4 1% agarose gel of PCR amplification of TDCi and wild-type hairy root genomic
D N A ..................................................................................................................... 17 9
4.5 Extracted LC-MS chromatograms showing the absence of alkaloids in TDCi hairy
ro o ts......................................................................................................................18 0
4.6 Metabolite production in TDCi hairy roots after 1, 3, 5 and 7 subcultures ......... 182
4.7 Real-time RT-PCR analysis of TDCi hairy roots ................................................ 184
4.8 Extracted LC-MS chromatograms showing the presence of alkaloids................186
4.9 Extracted LC-MS chromatograms showing the presence of deuterated
alk alo id s ............................................................................................................... 187
4.10 Levels of alkaloid production in a representative silenced line supplemented with
tryptam ine in the culture m edia ........................................................................... 190
4.11 Extracted LC-MS chromatograms showing the presence of fluorinated
alk alo id s ............................................................................................................... 19 2
4.12 UV spectra of alkaloid standards and selected unnatural alkaloids from TDCi
hairy root fed with 5-fluorotryptam ine ................................................................ 193
4.13 MS/MS analysis for alkaloid standards and selected unnatural alkaloids TDCi
hairy root fed with 5-fluorotryptam ine ................................................................ 195
4.14 Metabolite production in wild type and TDCi line as evidenced by HPLC
an aly sis ................................................................................................................ 19 8
4.15 Quantification of unnatural alkaloid production in a suppressed and wild type line
fed w ith 5-fluorotryptam ine ................................................................................. 199
4.16 Quantification of unnatural alkaloid production in wild type line fed with
5-fluorotryptam ine ............................................................................................... 200
4.17 Secologanin production in wild type and TDCi lines .......................................... 202
4.18 Expression levels of SLS and GIH in 7 different TDCi lines measured by
R T -P C R ............................................................................................................... 20 3
4.19 Two-week-old wild type and TDCi hairy roots in solid Gamborg's B5 media...205
4.20 Regeneration of alkaloid deficient C. roseus plants from TDCi root culture ...... 205
Chapter 5
5.1 Biosynthesis of monoterpene indole alkaloids in C. roseus ................................ 215
5.2 Approaches to generate halogenated MIA analogs at the 4 possible positions of
the indole ring ...................................................................................................... 2 17
5.3 Strategy for synthetic diversification of MIAs using palladium-catalyzed Suzuki-
M iyaura coupling reaction ................................................................................... 217
5.4 Strategy for synthetic diversification of MIAs at the 7-position of the indole ring
using palladium-catalyzed Suzuki-Miyaura coupling reaction (I) ...................... 220
5.5 Strategy for synthetic diversification of MIAs at the 7-position of the indole ring
using palladium-catalyzed Suzuki-Miyaura coupling reaction (II) .................... 220
5.6 Extracted LC-MS chromatograms showing 12-chloro-19,20-dihydroakuammicine
p ro duction ........................................................................................................... 22 1
5.7 Extracted LC-MS chromatograms showing 12-chloro-19,20-dihydroakuammicine
and 12-bromo-19,20-dihydroakuammicine production ....................................... 221
5.8 Strategy for synthetic diversification of monoterpene indole alkaloids at the 6-
position of the indole ring using palladium-catalyzed Suzuki-Miyaura coupling
reactio n ................................................................................................................. 2 2 2
5.9 Extracted LC-MS chromatograms showing 1 1-chloroakuammicine, 1 1-chloro-
19,20-dihydroakuammicine and 11-chlorotabersonine production ..................... 223
5.10 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of TDCi hairy root extracts (I)..............................................................226
5.11 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of TDCi hairy root extracts (II) ............................................................ 227
5.12 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of TDCi hairy root extracts (III)...........................................................228
5.13 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of TDCi hairy root extracts (IV)...........................................................229
5.14 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of RebH/F hairy root extracts ............................................................... 230
5.15 MS/MS analysis for 19,20-dihydroakuammicine analogs (analogs with substituent
at the 7-position of the indole ring)......................................................................233
5.16 UV spectra of 19,20-dihydroakuammicine analogs (analogs with substituent at the
7-position of the indole ring) ............................................................................... 234
5.17 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 1 1-chloroakuam m icine (I)................................................................235
5.18 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 1 1-chloroakuam m icine (II) .............................................................. 236
5.19 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 11 -chloro- 19,20-dihydroakuammicine (I)........................................237
5.20 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 1 1-chloro-19,20-dihydroakuammicine (II)......................................238
5.21 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 1 1-chlorotabersonine (I)...................................................................239
5.22 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of l l-chlorotabersonine (II) ................................................................. 240
5.23 MS/MS analysis for akuammicine analogs (analogs with substituent at the 6-
position of the indole ring)...................................................................................244
5.24 MS/MS analysis for 19,20-dihydroakuammicine analogs (analogs with substituent
at the 6-position of the indole ring)......................................................................245
5.25 MS/MS analysis for tabersonine analogs (analogs with substituent at the 6-
position of the indole ring)...................................................................................246
Chapter 6
6.1 Overexpression of an engineered gene in C. roseus cell culture ......................... 256
6.2 Introduction of prokaryotic halogenases into C. roseus cell culture ................... 257
6.3 Mutasynthesis of tryptamine-derived alkaloids in C. roseus cell culture ............ 258
6.4 Chemogenetic approaches to derivatize halogenated alkaloids...........................259
6.5 Re-engineering of Papaver somniferum codeine O-demethylase in morphinan
alkaloid biosynthetic pathw ay..............................................................................260
6.6 Strategies to overcome the bottleneck in halogenated alkaloid biosynthesis in
R ebF/H hairy root cultures...................................................................................262
6.7 Generation of transgenic plant cultures capable of producing chlorinated and
brom inated alkaloids ............................................................................................ 266
6.8 Metabolic reprogramming of alkaloid biosynthesis in MIA-producing plant cell
cu ltures ................................................................................................................. 2 67
Appendix A
2A.1 LC-MS traces of selected alkaloid analogs formed by feeding 5-chlorotryptamine
to pCA M V 214M hairy roots................................................................................277
2A.2 LC-MS traces of selected alkaloid analogs formed by feeding 5-chlorotryptamine
to pCAMV214M hairy roots showing characteristic isotopic signature of
ch lo rin e ................................................................................................................ 2 80
2A.3 LC-MS traces of selected alkaloid analogs formed by feeding 5-bromotryptamine
to pCA M V 214M hairy roots................................................................................281
2A.4 LC-MS traces of selected alkaloid analogs formed by feeding 5-bromotryptamine
to pCAMV214M hairy roots showing characteristic isotopic signature of
b rom ine ................................................................................................................ 2 83
2A.5 LC-MS traces of selected alkaloid analogs formed by feeding 5-methyltryptamine
to pCA M V 214M hairy roots................................................................................284
2A.6 LC-MS traces of selected alkaloid analogs formed by feeding either 5-
chlorotryptamine or 5-methyltryptamine to pCAMV214M hairy roots showing
relative production levels of natural alkaloids compared to unnatural
chlorinated/m ethylated alkaloids. ........................................................................ 287
2A.7 'H NMR spectrum of 10-chloroajmalicine .......................................................... 288
2A.8 'C-'H HSQC spectrum of 10-chloroajmalicine .................................................. 289
2A.9 'H NMR spectrum of 10-methyltabersonine ....................................................... 290
2A.10 3C-1H HSQC spectrum of 10-methyltabersonine................................................291
2A.1 1 3C-1H HMBC spectrum of 10-methyltabersonine .............................................. 292
Appendix B
3B.1 Extracted LC-MS chromatograms showing the presence of 7-chlorotryptophan in
several R ebF/H hairy roots .................................................................................. 294
3B.2 Extracted LC-MS chromatograms showing the presence of 7-chlorotryptamine in
several RebF/H hairy roots .................................................................................. 297
3B.3 Extracted LC-MS chromatograms showing the presence of 12-chloro-19,20-
dihydroakuammicine in selected RebF/H hairy roots..........................................300
3B.4 Extracted LC-MS traces showing the isotopic distribution expected for a
chlorinated com pound .......................................................................................... 303
3B.5 Extracted LC-MS traces showing the production of chlorinated alkaloids along
with the traces showing production of the parent natural alkaloids from the same
cultu res ................................................................................................................. 30 5
3B.6 Chlorinated alkaloid production in PyrH/RebF/STRvm hairy roots (line 7).......307
3B.7 Chlorinated alkaloid production in RebF/H hairy roots after 1, 2, 6,7, 11 and 13
subcultures ........................................................................................................... 30 8
3B.8 Chlorinated alkaloid production in PyrH/RebF/STRvm hairy roots after 2, 3 and 4
subcultures ........................................................................................................... 3 10
3B.9 Levels of chlorinated alkaloid and 7-chlorotryptophan in response to increasing
K C l concentration ................................................................................................ 3 12
3B.10 Extracted LC-MS traces comparing the production of chlorinated and brominated
alkaloids in selected RebF/H hairy roots growing on solid media that have been
supplem ented w ith K B r ....................................................................................... 314
3B.1 1 Accumulation of the major natural alkaloids that are produced in wild type hairy
ro o ts......................................................................................................................3 15
3B.12 'H NMR spectrum of 12-chloro-19,20-dihydroakuammicine ............................. 316
3B.13 13C NMR spectrum of 12-chloro-19,20-dihydroakuammicine ............................ 317
3B.14 '3C-'H HSQC spectra of 12-chloro- 19,20-dihydroakuammicine.........................318
3B.15 'H NMR spectrum of 12-bromo-19,20-dihydroakuammicine ............................. 319
3B.16 13C NMR spectrum of 12-bromo-19,20-dihydroakuammicine ............................ 320
3B.17 '3C-'H HSQC spectrum of 12-bromo-19,20-dihydroakuammicine ..................... 321
3B.18 UV spectra of chlorinated and brominated alkaloids...........................................322
3B.19 MS/MS analysis for 12-chloro- 19,20-dihydroakuammicine and 12-bromo- 19,20-
dihydroakuam m icine............................................................................................323
Appendix C
5C.1 'H NMR spectrum of 12-phenyl-19,20-dihydroakuammicine ............................ 325
5C.2 13C NMR spectrum of 12-phenyl-19,20-dihydroakuammicine ........................... 326
5C.3 'H NMR spectrum of 12-(4-fluorophenyl)-19,20-dihydroakuammicine.............327
5C.4 3C NMR spectrum of 12-(4-fluorophenyl)-19,20-dihydroakuammicine............328
5C.5 'H NMR spectrum of 12-furanyl-19,20-dihydroakuammicine ............................ 329
5C.6 13C NMR spectrum of 12-furanyl-19,20-dihydroakuammicine ........................... 330
Appendix D
D.1 Biosynthesis of benzylisoquinoline alkaloids in Papaver somniferum ............... 333
D.2 Homology models of PsT60DM and PsCODM based on the crystal structure of
A tA N S .................................................................................................................. 3 37
D.3 Sequence alignment of PsDIOX1 (PsT60DM), PsDIOX2 and PsDIOX3
(P sC O D M )...........................................................................................................338
D.4 SDS-PAGE of purified wild type and mutant PsCODM enzymes.........340
D.5 LC-MS traces of an in vitro enzymatic assay of wild type and mutant PsCODM
enzym es w ith codeine .......................................................................................... 34 1
D.6 LC-MS traces of an in vitro enzymatic assay of wild type and mutant PsCODM
enzym es w ith thebaine ......................................................................................... 342
D.7 LC-MS traces of an in vitro enzymatic assay of wild type and mutant PsCODM
enzym es with thebaine and codeine.....................................................................344
D.8 LC-MS traces of an in vitro enzymatic assay of wild type and mutant PsCODM
enzym es w ith hydrocodone..................................................................................345
List of Tables
Chapter 1
1.1 Examples of medicinally important alkaloids.................................................. 21
Chapter 2
2.1 Tabulated high-resolution mass spectral data of the major unnatural alkaloid ..... 77
2.2 Hairy roots selection and adaptation processes ................................................... 101
Chapter 3
3.1 Kinetic constants for C. roseus tryptophan decarboxylase and tryptamine
su b strates .............................................................................................................. 1 19
3.2 High-resolution MS data for alkaloids observed in RebF/H hairy root
ex tracts ................................................................................................................. 13 3
3.3 High-resolution MS data for alkaloids observed in PyrH/RebF/STRv214m
hairy root extracts ................................................................................................ 133
3.4 Hairy root selection and adaptation processes ..................................................... 157
Chapter 4
4.1 High-resolution MS data for alkaloids observed in hairy root extracts .............. 189
Chapter 5
5.1 Suzuki-Miyaura cross-coupling reactions of 12-chloro-19,20-
dihydroakuammicine with aryl and heteroaryl boronic acids..............................231
5.2 High-resolution MS data for 19,20-dihydroakuammicine analogs (analogs with
substituent at the 7-position of the indole ring) ................................................... 232
5.3 High-resolution MS data for akuammicine analogs (analogs with substituent at
the 6-position of the indole ring) ..... ....................... ..... 241
5.4 High-resolution MS data for 19,20-dihydroakuammicine analogs (analogs
substituent at the 6-position of the indole ring) ................................................... 242
5.5 High-resolution MS data for analogs of tabersonine with substituent at the 6-
position of the indole ring .................................................................................... 243
Appendix D
D.1 PsCODM mutants that were constructed in this study ................. 336
D.2 Primers and templates for site-directed mutagenesis .......................................... 347
Conventions and Abbreviations
Compounds that are illustrated in Figures and Tables are numbered consecutively,
starting from 1 in each chapter; NMR data are presented by the chemical shift (8) in
parts-per-million (ppm), multiplicity (singlet, s; doublet, d; triplet, t; etc.), and J-coupling
constant in Hertz (Hz); NMR spectra are referenced to the NMR-solvents' residual proton
(for 1H NMR), most intense carbon (for 13C NMR) or fluorine (for 19F NMR) isotope
signal.
160MT 16-hydroxytabersonine 16-0-methyltransferase
4'-OMT 3'-hydroxy-N-methylcoclaurine-4'-O-methyltransferase
4HPAA 4-hydroxyphenylacetaldehyde
60MT norcoclaurine 6-0-methyltransferase
AVLBS a-3',4'-anhydrovinblastine synthase
AS anthranilate synthase
AtANS Arabidopsis thaliana anthocyanidine synthase
BBE berberine bridge enzyme
BIA benzylisoquinoline alkaloid
*C temperature in the Celsius scale
cDNA complementary deoxyribonucleic acid
CNMT coclaurine-N-methyltransferase
CODM codeine O-demethylase
COR codeinone reductase
CrSTR Catharanthus roseus strictosidine synthase
D4H desacetoxyvindoline 4-hydroxylase
DAT deacetylvindoline 0-acetyltransferase
DMAPP dimethyl allyl pyrophosphate
DMSO dimethylsulfoxide
DNA deoxyribonucleic acid
dNTP deoxyribonucleotide triphosphate
DRR 1,2-dehydroreticulene reductase
DRS 1,2- dehydroreticuline synthase
DTT dithiothreitol
DXPS 1-deoxy-D-xylulose synthase
EDTA ethylenediaminetetraacetic acid
ESI-MS electrospray ionization mass spectrometry
EtOAc ethyl acetate
FAD flavin adenine dinucleotide
G1OH geraniol 10-hydroxylase
GI GenBank index number
Glc glucose
HMBC heteronuclear multiple bond coherence
HPLC high-performance liquid chromatography
HPT hygromycin phosphotransferase
HRMS high-resolution mass spectrometry
HSQC heteronuclear single quantum coherence
Hz
IPP
IPTG
KBr
KCl
KI
Km
kDa
K3P0 4
LB
LC
LC-MS
LOMT
MAO
MAT
Me
MeCN
MeOD
MeOH
MEP
MIA
mRNA
MS
NAA
NADPH
NCS
NH 40H
NMR
NMT
NPTII
NSCLC
ODn
OpSTR
ORCA3
PCR
PDA
PDK
Pd(OAc) 2
PsCODM
PsT60DM
ppm
PVP
RNA
RNAi
rpm
Hertz (s-1)
isopentenyl pyrophosphate
isopropyl p-D-1-thiogalactopyranoside
potassium bromide
potassium chloride
potassium iodide
Michaelis constant; the substrate concentration at a half of the maximal
reaction velocity (Vmax)
kilo Dalton (one thousand Dalton)
potassium phosphate
Luria-Bertani media
liquid chromatography
liquid chromatography coupled to mass spectrometry
loganic acid methyltransferase
monoamine oxidase
minovincinine 19-0-acetyltransferase
methyl
acetonitrile
tetradeuterated (d4) methanol
methanol
methyl erythritol pathway
monoterpene indole alkaloid
messenger RNA
mass spectrometry
naphthyl acetic acid
reduced nicotinamide adenine dinucleotide phosphate (hydride)
norcoclaurine synthase
ammonium hydroxide
nuclear magnetic resonance
16- methoxy-2,3-dihydro-3-hydroxytabersonine N-methyltransferase
neomycin phosphotransferase II
non small-cell lung cancer
optical density at n nm
Ophiorrhiza pumila strictosidine synthase
jasmonate-responsive APETALA2 (AP2)-domain transcription factor
polymerase chain reaction
photodiode array (detector)
pyruvate dehydrogenase kinase
palladium acetate
Papaver somniferum codeine O-demethylase
Papaver somniferum thebaine 6-0-demethylase
parts per million
Polyvinylpyrrolidone
ribonucleic acid
RNA interference
revolutions per minute
RsSTR
rt
SAR
SDM
SDS-PAGE
SGS
SLS
SMT
SPhos
STR
STRvm
T16H
T60DM
TDC
TFA
THFE
TLC
TOF
UPLC
UV
UV-vis
Vmax
Rauvolfia serpentina strictosidine synthase
retention time
structure-activity relationship
site-directed mutagenesis
sodium dodecyl sulfate polyacrylamide gel electro
strictosidine glucosidase
secologanin synthase
scoulerine 9-0-methyltransferase
2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl
strictosidine synthase
strictosidine synthase V214M mutant (STRv214m
tabersonine 16-hydroxylase
thebaine 6-0-demethylase
tryptophan decarboxylase
trifluoroacetic acid
tetrahydrofuran
thin-layer chromatography
time-of-flight
ultra-performance liquid chromatography
ultraviolet light
ultraviolet and visible spectroscopy
maximum reaction velocity as [S] approaches o
phoresis
)
CHAPTER 1
BACKGROUND AND SIGNIFICANCE
Part of this chapter is published as a perspective in
Nature Chemical Biology 2009, 5, 292-300
1.1 Significance and Biosynthesis of Alkaloid Natural Products
Medicinal chemists are continually inspired by Nature, whose repertoire of biologically
active compounds is a proven and rich source of disease-fighting drugs". In fact, a report
in 2007 estimated that about one-third of new pharmaceuticals from 1981-2006
originated from, or were inspired by, natural products4 . Plant alkaloids are a structurally
diverse class of nitrogen-containing secondary metabolites with over 10,000 structurally
characterized members5' 6, many of which exhibit biological activities. While the
physiological role of alkaloids in plants has not been fully elucidated, current evidence
suggests that alkaloids are primarily involved in plant defense against pathogens, insects,
and herbivores 7. For example, the indolizidine, indolizine, and s-carbolines alkaloid
backbone structures exhibit up to 25 biological properties, including dopamine reuptake
inhibitor, glucosidase inhibitor and sodium channel blocker8 .Throughout history, the
bioactivities of plant alkaloids have been recognized and exploited: Socrates' death in
399 B.C. from consuming Conium maculatum (hemlock) extract containing the
neurotoxin alkaloid coniine 1; Cleopatra's use of Hyoscyamus muticus (Egyptian
henbane) extract containing atropine 2 to make her eyes more alluring; and the more
common use of caffeine 3 in coffee and tea as a mild stimulant (Figure 1.1)'. Modern
examples of medicinally important alkaloids are shown in Table 1.110.
Despite their medicinal properties and commercial potential, the exploration of alkaloids
as drug candidates remains a slow process, largely because of the inefficiency and high
expense of their extraction and purification. To screen a particular alkaloid for biological
activities, the compound must first be isolated and purified from crude plant extracts
often containing hundreds of contaminating metabolites. Extensive structural
characterizations are also required to ensure the identity and purity of the compound. All
of these steps-isolation, purification, and structural characterization-are time-
consuming and expensive. Low accumulation levels of bioactive alkaloids and
inconsistent yields, which depend heavily on the source organisms as well as
geographical and climate conditions, also complicate. For example, the anticancer agent
vincristine 5 (Figure 1.1), is isolated from Catharanthus roseus at concentrations that
reach only 0.0003% by dry weight".
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Table 1.1. Examples of medicinally important alkaloids. *Yield represents % dry weight.
MIA: monoterpene indole alkaloid; BIA benzylisoquinoline alkaloid. (Adapted from
Nature Chemical Biology 2009, 5, 292-300)
Alkaloid Type Approximate Source plant Pharmaceutical
yield* (organ) applications
Ajmaline MIA 1 (root) Rauwolfia Antiarrhythmic
sellowii
Berberine BIA 1 (root) Berberis Antimicrobial
vulgaris
Caffeine 3 Purine 1 (bean) Coffea Stimulant
arabica
Camptothecin MIA 0.05 (bark) Camptotheca Chemotherapeutics
acuminata
Cocaine Tropane 0.8 (leave) Erythroxylon Stimulant
coca
Codeine BIA 0.5 (seed Papaver Antitussive, analgesic
capsule) somniferum
Hyoscyamine Tropane 0.4 (leave) Hyoscyamus Anticholinergic,
muticus antimuscarinic
Morphine 45 BIA 10 (seed capsule) Papaver Analgesic
somniverum
Nicotine Tropane 3 (leave) Nicotiana Stimulant
tabacum
Noscapine BIA 2 (seed capsule) Papaver Analgesic, antitussive
somniverum
Papaverine BIA 1 (seed capsule) Papaver Vasodilator
somniverum
Quinidine MIA 0.2 (bark) Cinchona Antiarrhythmic
ledgeriana
Quinine MIA 6 (bark) Cinchona Antimalarial,
ledgeriana analgesic
Reserpine MIA 0.03 (root) Rauwolfia Antihypertensive
nitida
Sanguinarine BIA 0.001 (root) Sanguinaria Antibacterial (in
canadiensis dental products)
Scopolamine Tropane 0.1 (leave) Hyoscyamus Anticholinergic,
muticus antimuscarinic
Strychnine MIA 2 (root) Strychnos Stimulant, pesticide
nux-vomica
Vinblastine 4 MIA 0.0001 (whole Catharanthus Chemotherapeutics
plant) roseus
Vincristine 5 MIA 0.0003(whole Catharanthus Chemotherapeutics
plant) roseus
Yohimbine MIA 1 (bark) Pausinystalia Erectile dysfunction
yohimbe treatment
Advances in the field of organic synthesis over the last century have produced various
methodologies suitable for constructing complex natural products with multiple
stereocenters and functional groups' 14. Nevertheless, total or semi-synthesis of alkaloids
remains a daunting task and is impractical at the industrial level. For example, the total
synthesis of vinblastine 4 (Figure 1.1) from simple starting materials involves 44 steps,
with an overall yield of less than 1%14.
1.2 Halogenated Natural Products
Though once considered a rare occurrence in nature, halogenation has been observed in
many natural products 5 .Approximately 4000 halogenated compounds have been
identified from natural sources including marine organisms, bacteria, fungi, plants,
insects and higher animals (Figure 1.2)16. Chlorination and bromination predominate,
while iodination and fluorination are relatively rare. Many halogenated natural products
have biological activities, and in many cases, the presence of the halogen groups has been
demonstrated to play a vital role in establishing the bioactivity of a compound. For
example, salinosporamide A 6, a proteosome inhibitor currently in clinical trials for
multiple myeloma treatment, contains a chlorine group that is required for bioactivity. A
high-resolution crystal structure of the 20S proteosome bound to salinosporamide A 6
reveals that the hydroxyl group of the active site threonine opens up the s-lactone of 6
upon binding, which, consequently, releases a free hydroxyl group17'18 .This hydroxyl
group then performs an irreversible intramolecular displacement of the primary chlorine
substituent to form a tetrahydrofuran ring. Unsurprisingly, analogs of salinosporamide A
6 devoid of this chlorine group exhibit significantly lower proteosome inhibitory activity.
Similarly, rebeccamycin 7, an antitumor antibiotic isolated from the soil bacterium
Lechevalieria aerocolonigenes, also requires the presence of the two chlorine substituents
for its biological activity. The deschloro analog of rebeccamycin 7 exhibits more than
ten-fold lower cytotoxic activity against melanoma and leukemia cell lines19 . The
decrease in antitumor activity of the deschloro analog is proposed to be a result of the
lack of cell membrane permeability in the absence of the chlorine moieties. Likewise, the
non-halogenated analog of the antitumor sesterpenes neomangicol A 8 and B 9 also
exhibits lower cytotoxic activity against breast and colon tumor cell lines20 .
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Figure 1.2. Examples of halogenated natural products. Salinosporamide A 6, a
proteosome inhibitor, is isolated from the marine bacterium Salinospora tropica;
rebeccamycin 7, an antitumor antibiotic, is isolated from the soil bacterium Lechevalieria
aerocolonigenes; neomangicol A 8 and B 9, antitumor agents, are isolated from the
marine fungi Fusarium sp. strain CNC-477; cryptophycin A 10, a cytotoxin, is found in
cultures of the blue-green algae Nostoc linckia; the bromo-phenyl amide is found in the
Thai plant Arundo donax.
Since the presence of a halogen moiety often has a profound impact on the biological
activity of a compound, enzymatic halogenation has been studied in extensive detail over
the past four decades 5 ,2 1. The current understanding of halogenating enzymes and their
mechanisms of action suggest that halogenases can be divided into three groups2 '. The
first group is the molecular oxygen (0 2)-dependent halogenases, which are further
divided into flavin-dependent halogenases and non-heme iron-dependent halogenases.
The second group is the hydrogen peroxide (H20 2)-dependent haloperoxidases, which are
also divided into heme-dependent haloperoxidases and vanadium-dependent
haloperoxidases. Finally, the last group is the nucleophilic halogenases.
The main focus of our studies is the flavin-dependent halogenases (Figure 1.3). Several
members of this class of halogenases are well characterized and have been shown to carry
out enzymatic halogenation using flavin as the redox cofactor and molecular oxygen as
the oxidant21 . Flavin-dependent halogenases can catalyze regioselective chlorination of
free substrates (i.e. tryptophan 11 by PyrH, Thal, RebH or PrnA enzymes) as well as
substrates that are covalently attached to a thiolation domain in a nonribosomal
polypeptide synthetase (i.e. pyrrolyl-S-PltL by PltA enzyme) (Figure 1.3)21. Examples of
known flavin-dependent halogenases are the following: PyrH, which converts free
tryptophan 11 to 5-chlorotryptophan 11a in pyrroindomycin biosynthesis22 ; Thal, which
converts free tryptophan 11 to 6-chlorotryptophan 1lb, an intermediate in thienodolin
biosynthesis23 ,224; and finally, PrnA and RebH, both of which convert free tryptophan 11
to 7-chlorotryptophan ic during the biosynthesis of pyrrolnitrin and rebeccamycin26,
respectively.
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Figure 1.3. Enzymatic chlorination of tryptophan 11. PyrH chlorinates tryptophan 11 at
the 5-position; Thal chlorinates tryptophan at the 6-position; and RebH chlorinates
tryptophan at the 7-position. All reactions require molecular oxygen, reduced flavin
cofactor and chloride ion. The reduced flavin cofactor is reduced in situ, and therefore,
PyrH, Thal and RebH also require an NAD(P)H-dependent partner reductase to
regenerate the reduced flavin cofactor. Adapted from Chem. Biol. 2008, 15, 99-109.
Out of all known flavin-dependent halogenases, only PrnA and RebH have been
structurally characterized by X-ray crystallography 2 7 ,2s. The crystal structures of both
enzymes revealed a binding module that is consistent with those in known flavin
monooxygenases. Therefore, it was proposed that the reduced flavin would react with
molecular oxygen (02) to form FAD-C4a-OOH in a similar manner to that of known
flavin monooxygenases (step 1, Figure 1.4)29. This proposed first step is also supported
11b
11c
1
by spectroscopic and kinetics studies, which indicate that the flavin redox chemistry
could occur without tryptophan 11 present in the active site3 .After the initial FAD-C4a
OOH formation step, it is mechanistically plausible that the chloride ion could attack the
proximal oxygen of FAD-C4aOOH to form FAD-C4aOCl, which would then function as
the direct halogenating agent of tryptophan 11. However, the crystal structures of PrnA
and RebH showed that the tryptophan binding pocket and the flavin binding pocket are
separated by over 10 angstroms 27,28 . Moreover, the channel that connects the two binding
pockets is too narrow to allow direct interaction between the tryptophan substrate and the
oxidized flavin cofactor. Therefore, instead of forming FAD-C4 a-OCl, the next step is
proposed to be an attack of the chloride ion on the distal oxygen of FAD-C4a-OOH to
yield the reactive oxidant hypochlorous acid (HOCI) (step 2, Figure 1.4)30. HOCl is a
strong oxidant that is known to react indiscriminately with many biological molecules,
including the side chains of many amino acids31.Therefore, the enzyme must come up
with a strategy to ensure selective chlorination of tryptophan 11. The crystal structures of
both RebH and PrnA revealed a lysine residue (Lys79) in the channel that connects the
tryptophan and flavin binding pockets17 ,21. Moreover, Walsh and coworkers' 3 6Cl
radiolabeling studies indicated that chlorine forms a covalent adduct with the enzyme
prior to incorporation in the product 28 . By evaluating these data in light of the known
reactivity of lysine residues 31, Walsh and coworkers proposed that the trapped HOCl
reacts with Lys79 to form Lys- ENH-Cl (step 3, Figure 1.4). While less reactive than
HOC, this lysine chloramine species is highly stable (t,,2= 28 h at 25 'C and 63 h at 4 C)
and more discriminant towards the tryptophan 11 substrate. Therefore, in the final step of
enzymatic chlorination tryptophan by RebH and PrnA, the lysine chloramine species is
proposed to deliver a Cl* equivalent for electrophilic aromatic substitution of tryptophan
11 at the 7-position to form 7-chlorotryptophan 11c.
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Figure 1.4. Proposed mechanism for the enzymatic chlorination of tryptophan by RebH
and PrnA. Adapted from Acc. Chem. Res. 2009, 42, 147-155.
1.3 Monoterpene Indole Alkaloids from Catharanthus roseus
Monoterpene indole alkaloids (MIAs) comprise a structurally diverse class of natural
products with over 2000 members32 . The tropical flowering plant Madagascar periwinkle
(Catharanthus roseus) produces over 130 MIA natural products, including the anticancer
agents vinblastine 4 and vincristine 5 (Figure 1.1), all of which are derived from
tryptophan 11"-". MIA biosynthesis begins with the stereo-selective Pictet-Spengler
reaction of tryptamine 12 (derived from the decarboxylation of tryptophan 1133-35) and
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secologanin 13 (derived from terpene biosynthesis 36-38 ) to form strictosidine 15 (Figure
1.5). This reaction is catalyzed by the enzyme strictosidine synthase (STR) and represents
the first committed step of MIA biosynthesis 39 44. Following the strictosidine glucosidase
(SGD)-catalyzed deglucosylation of strictosidine, equilibrium of the unstable aglycon
intermediates leads to the formation of 4, 21-dehydrogeissoschizine 16, the branch-point
precursor of MIAs, and cathenamine 17 (Figure 1.5)45-49. Two distinct NADPH-
dependent reductases catalyze reduction of 4, 21-dehydrogeissoschizine 16 and
cathenamine 17 to produce geissoschizine 18 and ajmalicine 19, respectively 5-53
The proposed biosynthetic pathways for catharanthine 22, tabersonine 23 and
dihydroakuammicine 25 begin with geissoschizine 18 (Figure 1.6)54. None of the
enzymes responsible for the production of 22, 23 and 25 has been cloned, and the
proposed pathways are based mainly on studies that involve feeding isotopically labeled
substrates to C. roseus seedlings5 5 -64. Preakuammicine 19 is the common precursor to
catharanthine 22, tabersonine 23 and dihydroakuammicine 2560'65. The actual mechanism
for the formation of preakuammicine 19 from geissoschizine 18 remains unclear.
Elimination of one molecule of formaldehyde followed by reduction yields
dihydroakuammicine 25 from preakuammicine 19. Alternatively, reduction of the
iminium of preakuammicine 19 leads to stemmadenine 20, which rearranges to form the
ester dehydrosecodine 2166,67. While it may be possible that both catharanthine 22 and
tabersonine 23 are formed via a Diels-Alder cycloaddition from dehydrosecodine 21,
there is no precedent for this type of reaction in plant metabolismo.
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Figure 1.5. The early steps of MIA biosynthesis in C. roseus. TDC: tryptophan decarboxylase; STR: strictosidine synthase; SGS:
strictosidine glucosidase; spont.: spontaneuous. Green circle designates the location where the enzymatic transformation has occurred.
? indicates that the biosynthetic enzyme has not been identified.
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Figure 1.6. Biosynthesis of catharanthine 22, tabersonine 23 and dihydroakuammicine 25 in C. roseus. Green circle designates the
location where the enzymatic transformation has occurred. ? indicates that the biosynthetic enzyme has not been identified.
MeO-
The six steps from tabersonine 23 to vindoline 31 have been fully elucidated at the
genetic level, with the exception of the hydration step (Figure 1.7)69'70. This pathway
begins with the hydroxylation of tabersonine 23 by a cytochrome P450 monooxygenase
(tabersonine 16-hydroxylase (T16H)) to form 16-hydroxytabersonine 2671. The
hydroxyl group is subsequently methylated by a SAM-dependent 0-methyltransferase
(16-hydroxytabersonine 16-0-methyltransferase (160MT)) to yield 16-
methoxytabersonine 277. Following this step, a double bond in 16-methoxytabersonine
27 is hydrated by an uncharacterized enzyme to yield 16-methoxy-2,3-dihydro-3-
hydroxytabersonine 28. The recently discovered SAM-dependent N-methyltransferase
then methylates the indole nitrogen of methoxy-2,3-dihydro-3-hydroxytabersonine 28 to
form desacetoxyvindoline 2974. The penultimate step in this sequence, the hydroxylation
of desacetoxyvindoline 29, is carried out by the 2-oxoglutarate-dependent dioxygenase
desacetoxyvindoline 4-hydroxylase (D4H) to form deacetylvindoline 307. Finally,
deacetylvindoline 30 is acetylated by deacetylvindoline 0-acetyltransferase (DAT) to
form vindoline 3176. Notably, the enzymes that catalyze the last three steps of this
sequence, namely NMT, D4H and DAT, are only present in the aerial parts of the plants
and are absent altogether from plant cell cultures 74 76. The dimerization of catharanthine
22 and vindoline 31 is proposed to proceed via an iminium intermediate, which is
subsequently reduced to form anhydrovinblastine 77. A peroxidase (AVLBS, c-3',4'-
anhydrovinblastine synthase) has been cloned from C. roseus leaves and shows robust
activity in the dimerization of catharanthine 22 and vindoline 31 to anhydrovinblastine7 8
79. Hydroxylation of anhydrovinblastine yields vinblastine 4. Subsequent oxidation of the
N-methyl group of vinblastine 4 yields vincristine 5.
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Figure 1.7. The late steps of MIA biosynthesis in C roseus. T16H: tabersonine 16-hydroxylase; 160MT: 16-hydroxytabersonine 16-
0-methyltransferase; NMT: 16- methoxy-2,3-dihydro-3-hydroxytabersonine N-methyltransferase; D4H: desacetoxyvindoline 4-
hydroxylase; DAT: deacetylvindoline 0-acetyltransferase; and AVLBS: a-3',4'-anhydrovinblastine synthase. Green circle designates
the location where the enzymatic transformation has occurred. ? indicates that the biosynthetic enzyme has not been identified.
1.4 Precursor-Directed Biosynthesis of Monoterpene Indole Alkaloids and Re-
Engineering of Strictosidine Synthase
Modification of natural alkaloids can lead to the generation of compounds with improved
or altered biological properties. For example, vinflunine 51, a fluorinated analog of
vinblastine, is currently in phase III clinical trials for treatment of bladder cancer80"'. The
current supply of novel alkaloids, often generated through semi-synthesis, is limited
because the requisite precursors are typically produced in low levels. Recently, however,
precursor-directed biosynthesis has emerged as a powerful strategy to produce alkaloid
derivatives8 2. It was discovered that supplementing Datura stramonium root cultures with
fluorinated analogs of the phenyllactic acid substrate yielded several fluorinated tropane
alkaloids83 . In a similar effort, a wide variety of tryptamine 12 and secologanin 13
substrate analogs were fed into C. roseus root cultures and seedlings, affording many
unnatural MIAs"4' 85. Notably, this study also identified the stringent substrate specificity
of strictosidine synthase (STR) as a major bottleneck in precursor-directed biosynthesis
efforts. The apparent flexibility of downstream alkaloid pathways suggested that STR
could be reengineered to yield variants with improved or novel selectivity towards
unnatural substrate analogs. The structural elucidation of Rauvolfia serpentina STR 6 has
led to the development of several re-engineered STR variants with altered substrate
specificity (Figure 1.8). The earliest re-engineering attempt of STR yielded a mutant
(D177A) that was able to accept a secologanin analog harboring a pentynyl group87 . In
order to explore a larger mutational space, a medium-throughput colorimetric assay was
developed to identify functional STR mutants that can accept tryptamine analogs not
accepted by the wild type enzyme "8. The assay relied on the formation of products
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Figure 1.8. Re-engineering of strictosidine synthase (STR) to accept tryptamine 12 and
secologanin 13 analogs not accepted by the wild type enzyme.
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downstream of STR that can be visualized when metabolized by strictosidine glucosidase
(SGD), the next enzyme in the biosynthetic pathway. By using saturation mutagenesis on
several key residues that comprise the tryptamine binding pocket, two STR mutants that
could turnover unnatural tryptamine compounds were identified "8. Specifically, the
V214M mutant was able to turn over 5-chloro-, 5-bromo- and 5-methyltryptamine
analogs (12a-c), while the F232L mutant was able to turn over (R)-tryptaphanol 12d. In a
separate study, another STR mutant (V214A) was identified that is capable of turning
over 5-methyl- and 5'methoxytryptamine (12c, e)"9.
1.5 Plant Cell and Tissue Cultures
In light of the difficulties involved in the total syntheses, semi-syntheses and isolation of
many medicinally important alkaloids, tissue and cell cultures have been considered as
alternative production platforms (Figure 1.9). The discovery in the 1950s9 that
undifferentiated plant cells have the necessary biosynthetic machinery to produce many
of the same secondary metabolites as whole plants has led to the commercial use of plant
tissue cultures for production of several important pharmaceuticals. For example, taxol, a
widely used anticancer drug whose global sales have reached over one billion dollars
annually, has been a subject of intense yield optimization research. After decades of
studies involving various elicitation conditions and growth media formulations,
concentrations of taxol as high as 0.5% of dry weight have been achieved in plant cell
culture with methyl jasmonate elicitation91 . This is a dramatic increase from levels
observed in Pacific yew trees, which accumulate taxol at only 0.01 % of the dry weight 92 .
More recently, cultures of undifferentiated meristematic cells from Taxus cuspidata have
been shown to be an environmentally friendly and cost-effective source for sustainable
production of taxo 93. Another example of a natural product that has been obtained from
plant cell culture at commercial scales is shikonin, a naphthoquinone pigment. The
compound has been successfully derived from Lithospermum erythrorhizon cell
suspension cultures for use in the cosmetic industry4.
seedlings hairy root on solid media
mature plant callus on solid media
hairy root in liquid media
cell suspension
Figure 1.9. C. roseus whole plants, tissue and cell cultures.
The use of cell and hairy root cultures of C. roseus as a source for pharmaceutically
important alkaloids began in the early 1960s9 5 . Cell cultures can be generated by growing
C. roseus stem explants in the presence of c-napthaleneacetic acid (an auxin) and kinetin
(a cytokinin). Cultivation of C. roseus cell suspension cultures for alkaloid production is
not feasible on an industrial scale because alkaloid levels are normally low and unstable.
Extensive efforts have focused on optimizing undifferentiated plant cell suspension
cultures to obtain better yield, controllability and reproducibility of several
pharmaceutically important alkaloids96. However, because alkaloid biosynthesis appears
to be tissue/organ specific and varies according to the developmental stages97,
differentiated plant tissue cultures have also been utilized as production platforms instead
of cell suspension cultures98. Notably, C. roseus hairy root cultures offer more stable
alkaloid profiles and yields, owing in part to their higher genetic and biochemical
stability compared to cell suspension cultures 5. Hairy root cultures can be obtained by
infection of C. roseus stems with Agrobacterium rhizogenes (Figure 1.10)989 ". While
hairy root cultures of C. roseus have been studied extensively for their production of
medicinal alkaloids, like cell suspension cultures, their commercial use has not been
widespread. A key limitation of tissue cultures is that they do not make the bisindole
alkaloids, vinblastine 4 and vincristine 5, which only accumulate in the aerial parts of the
plants, or the direct precursor vindoline 315, '0.
plant expression
0
plasmid
transform infi
Agrobacterium
rhizogenes
6 weeks later
liquid culture
transformed
C. roseus
selection media
(hygromycin)
Figure 1.10. Procedure to generate transgenic C.roseus hairy root cultures. C. roseus
seedlings are wounded, and transformed A. rhizogenes from a freshly grown liquid
culture are inoculated on the wound. Hairy roots appeared at the wound site 2-3 weeks
after infection. After hairy roots reached 1-4 cm in length (usually about six weeks after
infection), they are excised and transferred to solid media containing hygromycin for the
selections. After the solid media selection process, hairy roots are adapted to liquid
culture.
ect C. roseus
1.6 Elicitation of Monoterpene Indole Alkaloid Biosynthesis and Metabolic
Engineering in C. roseus
The biosynthesis of alkaloids can often be improved through various elicitation and
culture manipulation strategies. Elicitation of MIA biosynthesis using biotic and abiotic
elicitors has been successful at increasing the alkaloid yields in both tissue and cell
culture systems9. When elicitors are present, a number of signal-transduction pathways
are activated, which subsequently lead to transcriptional activation of many alkaloid
biosynthetic genes and transcription factors95. For example, methyl jasmonate (MeJA), a
plant hormone, has been shown to increase the expression of several biosynthetic genes,
including TDC, STR, AVLBS and three other genes that are involved in the biosynthesis
of secologanin and tryptophan 01 .Addition of jasmonic acid, another plant hormone, to C.
roseus hairy root cultures led to increased accumulations of the majority of alkaloids
typically found in root tissue including ajmalicine 19, serpentine 32, lochnericine 33 and
horhammericine 341 204. Similarly, elicitation with extracts from the plant pathogen
Phytophthora cactorum and the cell walls of the fungi Pennicillium citrinum stimulated
alkaloid production in C. roseus cell suspension cultures 0 5 . Abiotic elicitors, such as light
and heavy metals, also affect MIA biosynthesis in C. roseus. Visible"6' 07 and UV-
lights108' 109 have been demonstrated to increase alkaloid accumulations in cell and hairy
root cultures. Treating C. roseus cell suspension cultures with cadmium"0 and rare-earth
elements such as vanadium, cerium, yttrium and neodymiumn, 112 also improved the
yield of total alkaloids.
In addition to elicitation and growth condition optimization, metabolic engineering
strategies have also been utilized to improve alkaloid production in plant tissue and cell
cultures (Figure 1.11). The increasing availability of systems biology datasets has led to
more effective metabolic engineering efforts to expand the capacity for alkaloid
biosynthesis in plant cultures. For example, overexpression of strictosidine synthase
(STR) in C. roseus plant culture led to 10-fold higher STR activity compared to wild type
lines and higher levels of the downstream alkaloids, ajmalicine 19, serpentine 32,
catharanthine 22 and tabersonine 23 116'117. Interestingly, alkaloid levels in highly
productive lines were unstable; after two years of subculture, the transgenic cell lines lost
their ability to produce high levels of alkaloids. Constitutive overexpression of
tryptophan decarboxylase (TDC) only enhanced tryptamine 12 production but not levels
of downstream alkaloids" 3 . Cell cultures overexpressing TDC also exhibited slow growth
as high levels of tryptamine seemed to be detrimental to C. roseus. Tryptophan 11
biosynthesis has previously been shown to be feedback-inhibited; accumulation of
tryptophan 11 can inhibit expression of anthranilate synthase (AS)" 4 . Overexpression of
both Arabidopsis thaliana feedback-resistant AS and tryptophan TDC in C. roseus did
improve the yields of early precursors tryptophan 11 and tryptamine 12, but failed to
increase the yields of downstream alkaloids" 4-116 . These studies suggest that the
availability of tryptophan 11 and tryptamine 12 do not appear to be rate-limiting in MIA
biosynthesis. Conversely, secologanin 13 availability has been shown to be rate-limiting
as improvements in secologanin branch pathway successfully increased the alkaloid
yields in cell and hairy root cultures' 17 119. Overexpression of geraniol 10-hydroxylase
(G1OH) in C. roseus hairy root cultures led to a three-fold increase in alkaloid
accumulations120 . Similarly, overexpression of both 1-deoxy-D-xylulose synthase (DXS)
and geraniol 10-hydroxylase (GIH) in C. roseus hairy roots led to increased
accumulations of ajmalicine 19, lochnericine 33 and tabersonine 23121.
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Figure 1.11. Summary of metabolic engineering efforts of monoterpene indole alkaloids
in C. roseus. Enzymes that are highlighted in gray ovals have been targeted for
overexpression in C. roseus cell suspension or hairy root cultures.
Downstream enzymes have also been targeted for metabolic engineering (Figure 1.11).
Overexpression of deacetylvindoline 4-0-acetyltransferase (DAT), which catalyzes the
acetylation of deacetylvindoline 30 to form vindoline 31, led to a four-fold increase in the
accumulation of horhammericine 34, an alkaloid not in the vindoline pathway 2 2 . The
authors concluded that there is crosstalk between vindoline biosynthesis and
horhammericine pathway. Specifically, overexpression of DAT inhibited the activity of
minovincinine 19-0-acetyltransferase (MAT), the enzyme that turns over
horhammericine. Complex relationships between metabolic pathways such as these are
among the many factors that often hamper the ability to target overproduction of a
particular metabolite in plant cell and tissue cultures predictably.
Over the past decade, the alkaloid metabolic regulatory machinery, such as transcription
factors, has emerged as another target for metabolic engineering efforts. Transcriptomic
analysis of alkaloid biosynthetic genes has led to the identification of several
transcription factors in MIA biosynthesis'i '23. Targeting transcription factors that
upregulate the expression of multiple MIA biosynthetic genes simultaneously, as
compared to overexpressing one or two biosynthetic genes at a time, was hypothesized to
lead to higher overproduction of MIAs. For example, a metabolic engineering strategy
was devised to exploit the utility of the ORCA3 transcription factor to upregulate the
expression of many MIA biosynthetic genes simultaneously (Figure 1.11)101.
Surprisingly, overexpression of ORCA3 in C. roseus cell cultures did not significantly
improve MIA synthesis. While ORCA3 upregulates the expression of many alkaloid
biosynthetic genes, it does not appear to regulate the expression of GIH, the enzyme in
the terpenoid pathway that leads to the synthesis of secologanin 1301. A ~3-fold increase
in MIA accumulation levels of ORCA3-overexpressing cell culture occurred only after
the media was supplemented with loganin, the precursor of secologanin 13. Therefore,
there appears to be a bottleneck in the terpenoid pathway that can be overcome by
loganin feeding. Altogether, these studies suggest that MIA biosynthesis is tightly
regulated. Consequently, it is often hard to predict the outcome of metabolic engineering
designs in the native plant host.
1.7 Reconstitution of Alkaloid Biosynthetic Pathways in Microbial Hosts
The past decade has witnessed an increasing interest in engineering of microorganisms,
particularly Escherichia coli and Saccharomyces cerevisiae, for the synthesis of high-
value natural products124 . Because of their smaller genome size, the degree of complexity
in microorganisms is significantly lower than that of plants. Notably, microbial
genetics-with key features that include the coordinately regulated and clustering of
genes that encode biosynthetic pathways-are significantly more tractable. Moreover,
microorganisms have fewer intracellular organelles compared to plant cells; thus,
transport of metabolites between enzymatic steps are likely negligible. The difficult
genetic manipulation of plants coupled to the tractability of microorganisms has
encouraged significant interest in microbial engineering for the synthesis of several plant-
derived metabolites 2 s 2 9
More recently, alkaloids joined the list of plant-derived natural products that have been
successfully fermented in microbes 26 12 8 . In one study, reconstitution of alkaloid
biosynthetic pathways in E. coli and S. cerevisiae has led to scalable productions of
several benzylisoquinoline alkaloids (BIAs) (Figure 1.12)128. In BIA-producing plants,
the first committed step of all BIAs begins with the condensation of dopamine 36 and 4-
hydroxyphenyl-acetaldehyde 37 to form (S)-norcoclaurine 38 (Figure 1.12, left panel)"130
131. This reaction is catalyzed by the enzyme norcoclaurine synthase (NCS). (S)-
norcoclaurine 38 is then sequentially methylated by norcoclaurine 6-0-methyltransferase
(6-OMT) and coclaurine-N-methyltransferase (CNMT). The resulting dimethylated
intermediate is hydroxylated by the cytochrome-P450 CYP80B3, and further methylated
by 3'-hydroxy-N-methylcoclaurine-4'-O-methyltransferase (4'-OMT) to yield (S)-
reticuline 39. To reconstitute reticuline biosynthesis in E. coli, Micrococcus luteus
monoamine oxidase (MAO) was introduced together with Coptis japonica NCS, 6-OMT,
CNMT, and 4'-OMT in a plasmid-based expression systems (Figure 1.12, center
panel)128 .The utilization of the microbial MAO allowed the incorporation of the
hydroxyl group early in the reticuline pathway through the synthesis of 3,4-
dihydroxyphenyl-acetaldehyde 47 from dopamine 36, thereby precluding the need to
express the plant P450 CYP80B3 in the bacterium, which is usually challenging. (R, S)-
reticuline 40 (approximately 11mg/L) could be detected in the culture media of the
engineered E. coli upon induction of enzyme expression and supplementation of the
media with dopamine 36. Interestingly, while in vitro studies of plant NCS indicated that
the enzyme is stereoselective and produces the (S)-enantiomer exclusively, both
enantiomers of reticulene 40 were observed in the growth media, suggesting the presence
of a chemical non-stereoselective reaction. Nevertheless, the availability of (R, S)-
reticuline 40 set the stage for the production of downstream BIAs. Co-culturing the
reticuline-producing E. coli with S. cerevisiae expressing the C.japonica berberine
bridge enzyme (BBE) led to the production of (S)-scoulerine 42 (8.3 mg/L) after 2-3 days
of incubation.
While the study highlighted above is a tremendous achievement in microbial engineering,
its significance is hampered by the utilization of two microbial systems. The use of two
microbial systems likely led to lower efficiency of alkaloid biosynthesis because of the
need to transport metabolites between cells. Hawkins and Smolke overcame this problem
by reconstituting part of the artificial BIA pathways entirely in S. cerevisiae (Figure
1.12, right panel) 26 . Instead of using the natural intermediate norcoclaurine 38, Hawkins
and Smolke used the commercially available norlaudanosoline 48 to produce (R, S)-
reticuline 40 in engineered S. cerevisiae expressing 6-OMT, CNMT, and 4'-OMT from
plants (Thalictrumflavum and Papaver somniferum). By choosing enzymes that had
optimal catalytic efficiency and promoters that led to optimal expression levels, the
authors successfully produce (R, S)-reticuline 40 in titres reaching 150 mg/mL. To
produce alkaloids (S)-scoulerine 42, (S)-tetrahydrocolumbamine and (S)-
tetrahydroberberine, which are further downstream, three additional enzymes from T.
flavum, P. somniferum and a reductase partner from Arabidopsis thaliana were
introduced into the (R, S)-reticuline-producing strain. The authors showed that the
introduction of a human cytochrome P450 enzyme (CYP2D6) and its reductase partner
into (R, S)-reticuline-producing strain led to the production of (S)-salutaridine 41, an
intermediate in the morphine branch pathway.
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Figure 1.12. Reconstitution of benzylisoquinoline alkaloid pathway in microorganisms.
Plant pathway (left). Reconstituion in both E. coli and S. cerevisiae (center).
Reconstitution in S. cerevisiae only (right). Modified enzymatic steps and metabolites are
highlighted in red. NCS, norcoclaurine synthase; 6-OMT, norcoclaurine 6-0-
methyltransferase; CNMT, coclaurine-N-methyltransferase; 4' -OMT, 3 '-hydroxy-N-
methylcoclaurine-4'-O-methyltransferase; DRS, 1,2- dehydroreticuline synthase; DRR,
1,2-dehydroreticulene reductase; BBE, berberine bridge enzyme; SMT, scoulerine 9-0-
methyltransferase; MAO, bacterial monoamine oxidase; CYP2D6, human cytochrome
P450 enzyme; CYP80G2, CYP719B 1 and CYP719A 1, plant cytochrome P450 enzymes.
Adapted from Nature Chemical Biology 2009, 5, 292-300.
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Efforts to reconstitute monoterpene indole alkaloid (MIA) pathways in microbial systems
have been hampered by the paucity of cloned biosynthetic genes. Consequently, the only
MIAs that have been successfully produced through microbial fermentation at this time
are pathway intermediates that are well upstream of the higher-value alkaloids vinblastine
4 and vincristine 5. In one study, expression of C. roseus strictosidine synthase (STR)
and strictosidine glucosidase (SGD) in S. cerevisiae led to the production of strictosidine
15 and cathenamine 17 when the precursors secologanin 13 and tryptamine 12 were
supplemented to the media 3 2 .As was also the case in reconstitution of BIA pathways,
supplementation of the yeast culture media with expensive intermediate metabolites was
necessary for alkaloid production. Enzymes responsible for the multi-step conversion of
geraniol 14 to secologanin 13 have not all been identified. Therefore reconstitution of
secologanin pathway in yeast is not possible at this time. However, since a major goal of
microbial fermentation is to produce complex molecules from inexpensive and
commercially available starting substrates, it is imperative to identify these enzymes and
express them in yeast or E. coli to make microbial fermentation of high-value alkaloids
commercially feasible.
The studies highlighted above demonstrated the power of microbial engineering in
producing structurally complex alkaloids. Interestingly, these studies also revealed that
the plant enzymes involved in BIA synthesis appeared to have relatively flexible
substrate specificity. Therefore, as this field, recently coined "synthetic biology",
progresses, it may be advantageous to extend the goals of microbial engineering to
encompass the production of unnatural alkaloids in the search for new medicines.
1.8 Chemical Derivatizations of Monoterpene Indole Alkaloids
Functional group modification of natural products can lead to the generation of
compounds with improved or altered pharmacological properties133 . Extensive efforts
have focused on using synthetic strategies to produce alkaloid analogs. Beginning in the
1960s, several analogs of MIAs have been synthesized either via total synthesis or semi-
synthesis (Figure 1.13)138 142. Notably, ring contraction and dehydration of vinblastine 4
afforded vinorelbine 49, which was approved for the treatment of non small-cell lung
cancer (NSCLC) in 1995 134136. Similarly, vindesine 50, another vinblastine analog with
modifications in the vindoline portion of the molecule, has been approved for treatment
of melanoma in Europe137 . Finally, vinflunine 51, a fluorinated derivative of vinblastine,
is currently in phase III clinical trials for treatment of bladder cancer80'81 .
Vinblastine 4 and vincristine 5 are the main targets for most of the chemical
derivatization efforts reported mainly because of their established anticancer properties.
The earliest attempts to diversify MIAs focused mostly on halogenation reactions.
Bromination of vinblastine 4 and vincristine 5 with N-bromosuccinamide at room
temperature afforded 10-bromovinblastine 4a and 10-bromovincristine 5a in moderate
yields 38 . Similarly, iodination of vinblatine 4 and vincristine 5 can be achieved using N-
iodosuccinamide to yield 10-iodovinblastine 4b and 10-iodovincristine 5b (Figure
1.14)138. The abundance and versatility of palladium-catalyzed cross-coupling reactions
today allows further modification of halogenated alkaloids. Figure 1.14 summarizes
palladium-mediated coupling reactions of halogenated vinblastine 4 and vincristine 5,
including the Suzuki-Miyaura, Negishi, Sonagashira and Stille coupling reactions as well
as nitrillation, thioetherification, and carboxylation 13
N
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Figure 1.13. Examples of vinblastine analogs that have been approved for clinical use or
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Figure 1.14. Synthetic diversification of MIAs via palladium-catalyzed cross-coupling
reactions. Adapted from Bioorg Med Chem Lett 2009, 19, 1245-9.
1.9 Research Goals and Thesis Overview
The research goals that are addressed in this thesis are the following:
A: To Expand the Diversity of Plants' Natural Products
Medicinal plants have been a source and inspiration for medicinal chemists.
Catharanthus roseus (Madagascar periwinkle) produces over 130 monoterpene indole
alkaloids (MIAs), many of which have pharmaceutical properties, such as the antitumor
agents vinblastine 4 and vincristine 5. Expanding the diversity of plants' natural products
via functional group modification can yield "unnatural" products with altered or
improved biological activities. Chapter 2 describes the introduction of a biosynthetic
enzyme with redesigned substrate specificity into periwinkle. The resulting transgenic
plant hairy root culture was able to produce a variety of unnatural MIA compounds by
incorporating tryptamine 12 analogs that the re-engineered enzyme was designed to
accept. Chapter 3 describes the introduction of a new functional group- the
organohalide- into periwinkle MIAs. Prokaryotic halogenase enzymes were transformed
into the genome of periwinkle, which lacks the biosynthetic capability to produce
halogenated compounds. These prokaryotic halogenases competently functioned in the
plant cell to generate halogenated tryptophan 11 analogs, which were then incorporated
into alkaloid metabolism to yield a variety of halogenated MIAs. A new functional
group-the organohalide- was thereby integrated into the complex metabolism of
periwinkle in a predictable and regioselective manner. Finally, chapter 4 describes the
suppression of tryptamine 12 biosynthesis in periwinkle for the production of unnatural
MIAs. Alkaloid production almost completely disappeared in silenced cultures, but could
be rescued by the addition of exogenous tryptamine 12 to the culture media. A
representative unnatural tryptamine analog was also incorporated into the pathway to
yield a variety of unnatural alkaloids.
B: To Explore Plant Cell Culture as a Platform for Synthetic Biology
The past decade has witnessed an increasing interest in engineering of microorganisms,
particularly Escherichia coli and Saccharomyces cerevisiae, for the synthesis of high-
value plant natural products. Up until now, this so-called 'synthetic biology' approach
has been demonstrated exclusively in microbial systems. The organisimal complexity and
genetic intractability of plants have prevented widespread interest in using plants as a
platform for synthetic biology. Chapter 3 describes the successful engineering of plant
cell culture to autonomously produce halogenated alkaloids. The yields of unnatural
alkaloids in plant cultures are comparable to reconstitution of alkaloid pathways in
microorganisms. In short, we demonstrated that plant cell cultures are indeed a viable
platform for synthetic biology efforts.
C: To Complement Synthetic Biology with Organic Chemistry
While halogenation, in and of itself, often has profound effects on the bioactivity of
natural products, halides could also serve as a useful handle for further chemical
derivatization. Chapter 5 describes the post-biosynthetic chemical derivatizations of
halogenated alkaloid analogs via palladium-catalyzed Suzuki-Miyaura cross-coupling
reactions to yield aryl and heteroaryl analogs of MLAs. The complementation of synthetic
biology and organic chemistry approaches provides an effective route to form a library of
analogs in a synergistic fashion-a library not attainable using either approach alone.
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CHAPTER 2
OVEREXPRESSING AN ENGINEERED GENE IN C. ROSEUS CELL CULTURE
Part of this chapter is published as a brief communication in
Nature Chemical Biology 2009, 5, 151-153
2.1 Introduction
Natural products are a rich source of medicinally and commercially important
compounds such as drugs, fragrances, dyes, flavors and insecticides'. Functional group
substitution of natural products can yield analogs of natural products, or "unnatural
products", with improved or altered medicinal properties 2 . Incorporation of genes with re-
engineered substrate specificity into existing natural product biosynthetic pathways has
resulted in production of unnatural microbe-derived compounds from non-natural starting
substrates3 . Significant progress in plant metabolic engineering has enabled fine-tuning of
production levels of natural products in plants4 and heterologous expression of natural
compounds in plants '. However, biosynthesis of unnatural plant-derived compounds has
primarily focused on relatively short flavonoid6 or carotenoid7 pathways that can be
heterologously expressed in microbial hosts. To the best of our knowledge, production of
unnatural products in plants is unprecedented. It is important to explore the capacity,
scope and limitations for metabolic engineering of unnatural products-or metabolic
reprogramming-within the plant cell environment.
Monoterpene indole alkaloid biosynthesis in C. roseus is exceptionally complicated and
only partially characterized'. This pathway produces a variety of alkaloids with diverse
biological activities and complex molecular architecture from the iridoid terpene
secologanin 1 and tryptamine 2 (Figure 2.1 and Chapter 1). Some successes have been
recently reported for heterologous expression of benzylisoquinoline type alkaloids in
microbes9'10 . However, the scarcity of cloned biosynthetic genes makes heterologous
expression of monoterpene indole alkaloids impossible at present. Furthermore, the
complexity of this pathway makes the prospects for monoterpene indole alkaloid
expression in microbes a daunting undertaking. For example, biosynthesis of tabersonine
5, an early precursor for the anti-cancer bis-indole alkaloids, requires an estimated 15
distinct enzymatic steps from the geraniol terpene and tryptamine precursors8 . Moreover,
the biosynthesis of these alkaloids is organelle and cell-type specific, requiring highly
regulated inter- and intracellular trafficking of biosynthetic intermediates. In light of
these difficuties, plant cell culture is therefore a more suitable system for exploring
unnatural monoterpene indole alkaloid biosynthesis.
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Figure 2.1. Biosynthesis of monoterpene indole alkaloids in C. roseus. Secologanin 1, a
complex terpenoid derived from geraniol, and tryptamine 2, derived from tryptophan,
form monoterpene indole alkaloids 4-7 via the biosynthetic intermediate strictosidine 3.
Strictosidine synthase, the enzyme that catalyzes formation of strictosidine 3, has
expanded substrate specificity enabling turnover of tryptamine analogs 2a-c when the
point mutation Val214Met (V214M) is incorporated into the protein sequence.
Previous precursor directed biosynthesis studies in C. roseus have revealed that one
major bottleneck in the production of unnatural alkaloids is the narrow substrate
specificity of strictosidine synthase, the enzyme that catalyzes formation of the
strictosidine biosynthetic intermediate 3 from secologanin 1 and tryptamine 2 (Figure
2.1)"' . While some analogs of tryptamine and secologanin starting materials can be
turned over by the strictosidine synthase enzyme, many substrates are not recognized by
this enzyme, such as tryptamine analogs with substituents at the 5 and alpha positions.
The reported crystal structure of strictosidine synthase 3 from Rauvolfia serpentina has
enabled design of enzyme mutants with broadened substrate specificities, thereby
allowing enzymatic production of a greater variety of strictosidine analogs as previously
reported" 4 15 . When fed to wild type C. roseus cultures, strictosidine analogs substituted
at the ester and 5 positions were incorporated only into heteroyohimine type alkaloids
(i.e. ajmalicine 4)" 4. However, a strictosidine analog substituted at the 10 position, 3c,
appeared to be incorporated into many branches of the pathway (Figure 2.1)". The
strictosidine synthase mutant (V214M) that is able to catalyze the formation of 3a-c was
therefore chosen for transformation into C. roseus to explore the prospects of metabolic
reprogramming in this medicinal plant.
This chapter describes the introduction of a re-engineered alkaloid biosynthetic gene into
Catharanthus roseus (Madagascar periwinkle) cell culture. The resulting transgenic cell
culture produces a variety of unnatural alkaloid compounds when co-cultured with simple
and commercially available precursors that the re-engineered enzyme has been designed
to accept. This work highlights the power of genetic engineering to retailor the structures
of complex alkaloid natural products in plant culture.
2.2 Results and Discussion
2.2.1 Generation and Verification of Transgenic Hairy Root Cultures
We used Agrobacterium rhizogenes to generate hairy root culture of C. roseus
transformed with the re-engineered strictosidine synthase. Transformed hairy root cell
culture produces a range of alkaloids including ajmalicine 4, tabersonine 5 and serpentine
6 (Figure 2.1)16. Using previously established transformation protocols' 7 , the strictosidine
synthase mutant gene containing the point mutation V214M was transformed into hairy
root culture under the control of the 35S CMV promoter (derived from pCAMBIA
vector, Figure 2.2). In addition to this, we also transformed C. roseus with the
strictosidine synthase mutant gene under the control of an inducible promoter (derived
from a pTA7002 vector).
The constitutive system (derived from pCAMBIA vector) requires no inducer for
expression and may therefore be simpler to work with. However, the effects of
constitutive expression of strictosidine synthase through all developmental stages on
hairy root growth and alkaloid production are not well understood. Detailed molecular
and biochemical studies suggest that alkaloid biosynthesis is developmentally and
temporally regulated' 8 . Previous attempts to overexpress strictosidine synthase by Canel
et al in C. roseus cell suspension culture were well tolerated by the cells19. Since cell
suspension cultures are dedifferentiated cells with many strikingly different features from
hairy roots, it was unclear how findings pertaining to cell suspension system could be
translated into the hairy root system. The inducible expression system (derived from
pTA7002 vector) was therefore generated as an alternative to allow temporal control of
gene expression and alkaloid production. We envisioned that if constitutive expression of
the mutant strictosidine synthase gene has detrimental effects on hairy root growth, then
inducing the expression at specific times in the culture would overcome this problem.
PCR analysis of genomic DNA confirmed incorporation of the strictosidine synthase
sequence encoding the V214M point mutation, the 35S CMV promoter, and the
hygromycin antibiotic selection marker (HPT), thereby indicating that the strictosidine
synthase mutant was incorporated into the C. roseus genome (Figure 2.3A-C).
Specifically, PCR amplification of genomic DNA from all of the selected transformed
lines (pCAMV214M_31: lanes 4-6, pCAMV214M_37: lanes 7-9, and pCAMV214M_49:
lanes 10-12) was successful for all three sets of primers (Figure 2.3A). PCR-
amplification of genomic DNA from hairy root transformed with A. rhizogenes lacking
the pCAMBIA vector (provided by Professor Jacqueline Shanks (Iowa State) and
Professor Carolyn Lee-Parsons (Northeastern)) was successful only when STR specific
primers were used (lanes 1-3). These results indicated that STR mutant was successfully
incorporated into the C. roseus genome in all chosen lines. Similarly, in the inducible
system, PCR amplification of genomic DNA from a representative transformed line
(pTAV214M_26: lane 2-5) were successful was all set of primers (Figure 2.3B).
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Figure 2.2. Schematic diagram of strictosidine synthase mutant (STRvm) constitutive
expression system (pCAMV214M) and inducible expression system (pTAV214M)
constructs.
CaMV35S: Cauliflower Mosaic Virus 35S promoter; STRvm: strictosidine synthase with
the Val214Met mutation; Nos PolyA: poly(A) signal from nopaline synthase; HPT:
hygromycin phosphotransferase; GVG factor: chimeric transcription factor containing
GAL4 DNA-binding domain and VP16 transactivating domain and rat-glucocorticoid
receptor hormone binding domain.
Figure 2.3A. 1% agarose gel of PCR amplification of pCAMV214M and wild-type hairy
root genomic DNA.
Lane: template, primers.
1: wild-type, STR 7: pCAMV214M cell line 37, STR
2: wild-type, HPT 8: pCAMV214M cell line 37, HPT
3: wild-type, CaMV35S 9: pCAMV214M cell line 37, CaMV35S
4: pCAMV214M cell line 31, STR 10: pCAMV214M cell line 49, STR
5: pCAMV214M cell line 31, HPT 11: pCAMV214M cell line 49, HPT
6: pCAMV214M cell line 31, CaMV35S 12: pCAMV214M cell line 49, CaMV35S
Figure 2.3B. 1% agarose gel of PCR amplification of pTAV214M hairy root genomic
DNA.
Lane: template, primers.
1: DNA ladder
2: pTAV214M cell line 26, HPT
3: pTAV214M cell line 26, STRV214M (specific for V214M mutation)
4: pTAV214M cell line 26, STRV214M (specific for V214M mutation)
5: pTAV214M cell line 26, HPT-STR
2 kb
I k b
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Additionally, a primer pair was designed to match the point mutation corresponding to
the V214M sequence change at the 3' end of the forward primer (STRV214Mfor and
STRV214Mrev) (Figure 2.3C). These primers readily amplified a 500bp region of the
mutant gene. However, the mismatch at the 3' end prevented efficient amplification of
the native STR gene in wild type hairy root cultures.
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Figure 2.3C. 1% agarose gel of PCR amplification of pCAMV214M and wild-type hairy
root genomic DNA demonstrating V214M point mutation
Lane: template, primers
1: wild-type, STR 4: pCAMV214M cell line 31, STR
2: wild-type, STRV214M 5: pCAMV214M cell line 31, STRV214M
(specific for V214M mutation) (specific for V214M mutation)
3: wild-type, HPT 6: pCAMV214M cell line 31, HPT
2.2.2 Evaluation, Isolation and Characterization of Alkaloids from Engineered C.
roseus
Transgenic hairy root lines that have been transformed with the pCAMV214M construct
(constitutive system) were cultured in liquid Gamborg's B5 media in the presence of 0.5
mM 5-chlorotryptamine 2a, 5-methyltryptamine 2b, or 5-bromotryptamine 2c. These
substrate analogs are only turned over by the V214M mutant enzyme, and are not
recognized by wild type strictosidine synthase". The substrate analog concentration of
0.5 mM has been previously determined to be optimal for feeding studies (McCoy and
O'Connor, unpublished). After one week of culture, the plant material was lysed and
alkaloids were extracted into organic solvent. Liquid chromatography mass spectral (LC-
MS) analysis of these extracts indicated appearance of novel compounds that appeared to
be derived from the exogenous substrates 2a-c (Figure 2.4-2.8 and Appendix A).
Unnatural alkaloids could be rapidly assigned by LC-MS as deriving from 2a and 2c,
since chlorine and bromine exhibit a characteristic isotopic signature (35Cl/37Cl ratio of
3:1 and 79Br/8 Br ratio of 1:1), (Figure 2.4 (iv, v), Figure 2.5 (iii, iv) and Appendix A).
Control experiments clearly indicated that these compounds were not present when the
tryptamine analog was absent from the media (Figure 2.4-2.5 (i)). Hairy root lines
transformed with the wild type strictosidine synthase gene also failed to produce
chlorinated alkaloids when cultivated with 2a (Figure 2.4, (ii) and Appendix A). Hairy
root cultures infected with A. rhizogenes lacking the V214M mutant did not produce
these compounds when cultivated in the presence of tryptamine analogs 2a-c (Figure 2.4
(iii), Figure 2.5 (ii), and Appendix A). High-resolution mass spectral (HRMS) analysis
was performed on all unnatural alkaloids (Table 2.1).
For transgenic hairy root lines that have been transformed with the pTAV214M construct
(inducible system), 10 or 30 pM dexamethasone (an artificial glucocorticoid receptor
ligand for activation of gene expression) was added to two to three-week old liquid
culture. Since previous reports suggest that mutant enzyme expression peaks
approximately 72 hours after induction, 0.5 mM 5-chlorotryptamine 2a was added to the
liquid media at this point and processed in the same manner as in the constitutive system.
Despite various induction conditions, we did not observe the formation of unnatural
alkaloids after culturing these lines with 5-substituted tryptamine analogs 2a (Appendix
A).
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Figure 2.4. Unnatural alkaloid production in C. roseus hairy root culture expressing re-
engineered strictosidine synthase V214M (I). Extracted LC-MS traces for a
representative unnatural alkaloid (mlz 337+34) derived from 5-chlorotryptamine 2a. This
compound is not observed when 2a is absent from the media (i), nor in control hairy root
cultures transformed with wild type strictosidine synthase gene (ii), nor in control
cultures transformed with no plasmid (iii). The compound displays the isotopic
distribution expected for a chlorinated compound (iv, v). LC-MS spectra are normalized
to the same y-axis scale.
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Figure 2.5. Unnatural alkaloid production in Catharanthus roseus hairy root culture
expressing re-engineered strictosidine synthase V214M (II). Extracted LC-MS traces for
a representative unnatural alkaloid (m/z 353+78) derived from 5-bromotryptamine 2c.
This compound is not observed when 2c is absent from the media (i), nor in control
cultures transformed with no plasmid (ii). The compound displays the isotopic
distribution expected for a brominated compound (iii, iv). LC-MS spectra are normalized
to the same y-axis scale.
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Figure 2.6. Unnatural alkaloid production in Catharanthus roseus hairy root culture
expressing re-engineered strictosidine synthase V214M. Extracted LC-MS traces
showing production of two unnatural alkaloids derived from 2a (i, iii), along with the
traces showing production of the parent natural alkaloids from the same cultures (ii, iv).
Asterisked compounds 4a (i) and 5a (iii), were isolated and characterized by NMR.
Asterisked compound 4 (ii) and 5 (iv) was assigned based on coelution with an authentic
standard (Bestchemistry, Zhjiang, China). LC-MS spectra of i and ii are normalized to the
same y-axis scale to allow comparison of the relative amounts of 4 relative to 4a; iii and
iv are normalized to allow comparison of the relative amounts of 5 and 5a.
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Figure 2.7. Unnatural alkaloid production in Catharanthus roseus hairy root culture
expressing re-engineered strictosidine synthase V214M (IV). Extracted LC-MS traces
showing production of two unnatural alkaloids derived from 2b (i, iii), along with the
traces showing production of the parent natural alkaloids from the same cultures (ii, iv).
Asterisked compounds 4 (ii) and 5 (iv) were assigned based on coelution with an
authentic standards (Bestchemistry, Zhjiang, China). LC-MS spectra of i and ii are
normalized to the same y-axis scale to allow comparison of the relative amounts of 4
relative to 4b; iii and iv are normalized to allow comparison of the relative amounts of 5
and 5b.
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Figure 2.8. Unnatural alkaloid production in Catharanthus roseus hairy root culture
expressing re-engineered strictosidine synthase V214M (V). Extracted LC-MS traces
showing production of two unnatural alkaloids derived from 2c (i, iii), along with the
traces showing production of the parent natural alkaloids from the same cultures (ii, iv).
Asterisked compounds 4 (ii) and 5 (iv) were assigned based on coelution with an
authentic standards (Bestchemistry, Zhjiang, China). LC-MS spectra of i and ii are
normalized to the same y-axis scale to allow comparison of the relative amounts of 4
relative to 4c; iii and iv are normalized to allow comparison of the relative amounts of 5
and 5c.
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Table 2.1. Tabulated high-resolution mass spectral data of the major unnatural alkaloids
produced from transgenic hairy root lines and 2a-c.
a b c
Ajmalicine 4 4a* 4b*** 4c***
N H Expected [M+H] 353.1865 387.1490 367.2022 431.0970
N 0 Observed [M+H] 353.1856 387.1483 367.2015 431.0983
H MeO2C Accuracy (ppm) -2.5 2.1 -1.9 3.0
RT (min) 3.85 4.95 4.67 5.19
Tabersonine 5 5a* 5b*** 5c
NExpected [M+H] 337.1916 371.1526 351.2073
Observed [M+H] 337.1922 371.1528 351.2064 not obs.
H CO2Me Accuracy (ppm) 1.8 0.5 -2.6
RT (min) 4.28 5.51 5.07
Serpentine 6 6a*** 6b*** 6c***
N H Expected [M+H] 349.1552 383.1162 363.1709 427.0657
N 0 Observed [M+H] 349.1548 383.1177 363.1699 427.0650
H -
MeO 2C Accuracy (ppm) -1.1 3.9 -2.8 -1.6
RT (min) 4.07 4.94 4.91 5.17
Catharanthine 7 7a** 7b*** 7c
Expected [M+H] 337.1916 371.1526 351.2073
Observed [M+H] 337.1916 371.1531 351.2059 not obs.
CO2Me Accuracy (ppm) 0.0 1.3 -4.0
RT (min) 4.09 5.17 4.90
Isositsirikine
I / iExpected [M+H] 355.2022 389.1636 369.2178 433.1127
N N
H H' Observed [M+H] 355.2020 389.1632 369.2182 433.1118
Accuracy (ppm) -0.6 1.0 1.1 -2.1
MeO 2C H CH2OH RT (min) 2.99 4.13 3.82 4.38
Cathenamine
N Expected [M+H] 351.1709 385.1319 365.1865
N Observed [M+H] 351.1724 385.1328 365.1860 not obs.
H-
MeO 2C Accuracy (ppm) 4.3 2.3 -1.4
RT (min) 4.52 5.70 5.32
RT = retention time, LC gradient 10-60%
*Assigned based on exact mass, retention
acetonitrile/water (0.1% TFA) in 13 minutes
time, UV spectra, 'H-NMR, and known alkaloid profile of
C. roseus. ** Assigned based on exact mass, retention time, UV spectra, and alkaloid profile.
Assigned based on exact mass, retention time and alkaloid profile.
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Figure 2.9. UV spectra of alkaloid standards and isolated alkaloids from pCAMV214M
hairy root (cell line 31) fed with 5-chlorotryptamine (0.5 mM). A. 10-chloroajmalicine
4a; B. ajmalicine standard; C.10-chlorotabersonine 5a; D. tabersonine standard; E.
Unknown chlorinated alkaloid with m/z 371 with UV spectra comparable to that of
catharanthine 7; F. catharanthine standard.
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Figure 2.10. UV spectra of isolated alkaloids from pCAMV214M hairy root (cell line
31) fed with 5-methyltryptamine (0.5 mM). A. 10-methylajmalicine 4b; B. 10-
methyltabersonine 5b.
Although a variety of unnatural alkaloids clearly appear to be formed from tryptamine
analogs 2a-c in these transgenic cultures (Figure 2.4-2.8 and Appendix A), analysis of
the flux of 2a-c into downstream metabolites will require extensive characterization of all
alkaloid products. Only a limited analysis is addressed in this chapter. When 5-
chlorotryptamine 2a (0.5 mM) was added to the culture media, approximately equal
amounts of natural ajmalicine 4 and chlorinated ajmalicine 4a were produced (Figure
2.6). Compound 4a was purified and characterized by 'H NMR, 'H-13 C HSQC NMR, UV
spectroscopy and high-resolution mass spectrometry (m/z 387.1483, isolated yield of
approximately 1.5 mg/150 mL culture) (Table 2.1, Figure 2.9, and Appendix A). The
aromatic region of 'H NMR and 'H- 3 C HSQC spectra of 4a supports the presence of the
chlorine group at the 10-position (Figure 2.11).
Cultivation of transgenic hairy roots in the presence of 5-methyltryptamine 2b (0.5 mM)
resulted in production of methylated ajmalicine 4b at levels greater than natural
ajmalicine 4 (Figure 2.7 and Appendix A). Compound 4b could not be readily separated
from a contaminating product, but 'H NMR, UV spectroscopy and high-resolution mass
spectrometry (m/z 367.2015) of the partially purified compound supported a structural
assignment of 4b (Table 2.1, Figure 2.10, and Appendix A).
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Figure 2.11. Aromatic region of 'H NMR and 'H-13 C HSQC spectra of 4a isolated from
transgenic C. roseus hairy root culture expressing V214M cultured with 500 mM 2a.
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Figure 2.12. Aromatic region of 'H NMR and 'H-13 C HSQC spectra of 5b isolated from
transgenic C. roseus hairy root culture expressing V214M cultured with 500 mM 2b.
When hairy root cultures were cultivated with 5-methyltryptamine 2b (500 p M), higher
levels of methylated tabersonine 5b relative to natural tabersonine 5 were observed
(Figure 2.7 and Appendix A). Compound 5b was isolated and characterized by 'H
NMR, 'H- 3 C HSQC, 'H- 3 C HMBC NMR, UV spectroscopy and high-resolution mass
spectrometry (m/z 351.2064, isolated yield of approximately 2 mg/150 mL culture)
(Table 2.1, Figure 2.10, 2.12 and Appendix A). Cultivation with 5-chlrotryptamine 2a
(500 g M) led to formation of chlorinated tabersonine 5a, also produced at higher levels
than natural tabersonine 5 (Figure 2.6 and Appendix A). Although 5a could not be
readily purified from contaminating alkaloid products, characterization of the partially
purified compound by 'H NMR, UV spectroscopy and high-resolution mass spectrometry
(m/z 371.1528) supported a structural assignment of 5a (Table 2.1, Figure 2.10, and
Appendix A).
While hairy roots that have been transformed with A. rhizogenes lacking the
pCAMV214M plasmid produce only trace amounts of catharanthine 7, for reasons that
remain unclear, cultures transformed with A. rhizogenes harboring the pCAMV214M
plasmid (and other pCAMBIA-derived plasmids) displayed enhanced production of 7,
though the yields vary significantly from line to line (Figure 2.13). Low levels of a
compound with molecular weight and UV spectrum consistent with a chlorinated
catharanthine analog derived from 2a was also observed in transgenic lines expressing
the V214M mutant (Table 2.1, Figure 2.4,2.9 and Appendix A).
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Figure 2.13. LC-MS trace of catharanthine production in transgenic hairy roots. Hairy
roots that do not express the mutant STR produce only trace amounts of catharanthine 7.
All lines expressing the mutant STR displayed enhanced production of 7.
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2.2.3 Verification of Expression of Mutant STR Enzyme by Real Time RT-PCR
We quantified the total levels of strictosidine synthase mRNA (mRNA encoding wild
type plus V214M mutant strictosidine synthase) in several hairy root lines. Three
unnatural alkaloid producing hairy root lines showed robust production of strictosidine
synthase mRNA at levels approximately 10 to 30 fold higher than what was observed in
hairy root cultures not transformed with the pCAMBIA plasmid harboring the V214M
mutant gene (Figure 2.14). RT-PCR of hairy root lines that were transformed with
V214M under the control of an inducible promoter also showed low levels of
strictosidine synthase mRNA in this particular system. The apparent negligible
expression of the V214M mutant in these lines was consistent with the observation that
no unnatural alkaloid production was produced in these lines after incubation with 5-
substituted tryptamine analog 2a (Appendix A).
REAL-TIME RT-PCR OF TRANSGENIC HAIRY ROOTS
FOLOCHANGE 1.00 0.44 1.10 175 134 26.16 16.04 9.11
30.0
a fold Increase in 'STR' expression
22.5
15.0
7.5
WT pTAV214M 3 +i pTAV214M 3 -i pTAV214M 26 +i pTAV214M 26-i pCAMV214M 31 pCAMV214MS7 pCAMV214M49
Figure 2.14. Real-time RT-PCR analysis shows relative expression levels of 'STR' (sum
total of both wild-type and V214M mutant) in transgenic hairy roots. All chosen
pCAMV214M hairy root lines (cell line 31, 37 and 49) produce STR mRNA at levels
approximately 10 to 30 fold higher than the expression level of the endogenous STR
observed in "wild type" culture transformed with A. rhizogenes lacking plasmid.
pTAV214M hairy roots (cell line 3 and 26) do not show significant changes in mRNA
expression levels of the enzyme either with (+ i) or without (- i) treatment with the
glucocorticoid inducer, dexamethasone (10 [M).
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2.2.4 In vitro Enzymatic Assay of Transformed Hairy Roots Expressing STR
Mutant
Strictosidine synthase from crude plant tissue lysates has been shown to be catalytically
active. Gratifyingly, lysates from cultures transformed with V214M converted 2a and 2b
to strictosidine 3a and 3b in vitro (Figure 2.15A-B). LC-MS analysis indicated the
formation of the corresponding 10-chloro and 10-methylstrictosidine analogs 3a and 3b
in samples with crude lysate from pCAMV214M hairy roots in all chosen lines. The
strictosidine analog peaks co-eluted with chemically synthesized standards 20.
Additionally, substantial levels of deglycosylated strictosidine (cathenamine) analogs
were formed in these crude extracts (Figure 2.16A-B). Deglycosylated strictosidine, or
cathenamine, is the next biosynthetic intermediate of the pathway, and is formed after
strictosidine is deglycosylated by the enzyme strictosidine glucosidase (SGD) (Chapter
1). Cathenamine analogs were observed as evidenced by formation of a product with the
correct molecular weight and retention time, indicating that the endogenous SGD of the
hairy roots efficiently deglycosylated the strictosidine analogs 3a and 3b (Figure 2.16A-
B). Interestingly, no downstream alkaloid biosynthesis (i.e. 4, 5 or 6) was observed in the
hairy root lysates. These observations confirm Yerkes and O'Connor's findings that
biosynthetic enzymes downstream of SGD are extremely labile and great care must be
taken to preserve the activity of these enzymes in cell free lysates. Strictosidine and
cathenamine analogs were not observed in negative controls. Samples with crude lysates
from hairy roots transformed with wild-type A. rhizogenes, samples lacking hairy root
extracts and samples without tryptamine analogs each failed to produce strictosidine
analogs 2a and 2b and the corresponding deglycosylated strictosidine (cathenamine)
analogs. Some background reaction occurred in the absence of hairy root extract with
substrate 2b, as evidenced by formation of a small amount of 3b in the control reaction
that lacked hairy root lysate. However, formation of 3b was significantly enhanced upon
addition of lysate derived from transformed hairy root lines containing the V214M gene
(Figure 2.15B). The corresponding strictosidine and cathenamine analogs were not
formed when 5-bromotryptamine 2c was used as the tryptamine analog substrate (data
not shown). This was consistent with Bernhardt and O'Connor's findings that the
catalytic efficiency of the Val124Met enzyme for 5-bromotryptamine is significantly
lower than for 5-chloro and 5-methyltryptamine.
For the inducible system, 10 pM or 30 p M dexamethasone (an artificial glucocorticoid
receptor ligand required for activation of gene expression in pTA7002) was added to two
or three-week-old hairy roots in liquid culture. Since previous reports suggest that
inducible protein expression peaks approximately 72 hours after induction, hairy roots
were harvested at this point and processed in the same manner as described for the
constitutive system. Despite various expression and induction conditions, we did not
observe the formation of strictosidine analogs 3a or 3b when the crude lysates from two
chosen lines (pTAV214M cell lines 3 and 26) were incubated with tryptamine analogs 2a
or 2b (data not shown). These results were consistent with the real time reverse
transcriptase PCR data that indicated negligible expression of the V214M mutant in these
lines (Figure 2.14).
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Figure 2.15A-B. LC-MS traces of an in vitro enzymatic assay of pCAMV214M hairy
root (cell lines 31, 37 and 49) lysates with 1 mM secologanin and 1 mM 5-
chlorotryptamine la (A) or 5-methyltryptamine lb (B). m/z 565 corresponds to 10-
chlorostrictosidine 3a and m/z 545 corresponds to 10-methylstrictosidine 3b.
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Figure 2.16A-B. LC-MS traces of an in vitro enzymatic assay of pCAMV214M hairy
root (cell lines 31, 37 and 49) lysates with 1 mM secologanin and 1 mM 5-
chlorotryptamine 2a (top) or 5-methyltryptamine 2b (bottom). m/z 385 corresponds to 10-
chlorocathenamine (deglycosylated strictosidine 3a) and m/z 365 corresponds to 10-
methylcathenamine (deglycosylated strictosidine 3b).
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As an additional control, we verified that the production of unnatural strictosidine
analogs was specifically due to overexpression of the STR V214M mutant and not a
result of other genetic changes related to the Agrobacterium-mediated transformation.
Lysate from hairy roots overexpressing wild-type strictosidine synthase ("pCAMWT")
was incubated with either 5-chlorotryptamine 2a, 5-methyltryptamine 2b or tryptamine 2
using conditions described above. Formation of 10-chlorostrictosidine 3a or 10-
chlorocathenamine was not observed when lysates from pCAMWT control hairy roots
were incubated with 5-chlrotryptamine 2a (Figure 2.17A and Figure 2.18A). While the
formation of 10-methylstrictosidine 3b was not observed, a small amount of 10-
methylcathenamine formed when lysates from pCAMWT control hairy roots were
incubated with 5-methyltryptamine 2b (Figure 2.17B and Figure 2.18B). This suggests
that 10-methylstrictosidine 3b could form from a chemical reaction (background, as was
also observed in the no enzyme control (hairy root extraction buffer)) and was
subsequently deglycosylated by strictosidine glusosidase. Formation of both strictosidine
3 and cathenamine was observed when lysates from pCAMWT control hairy roots were
incubated with tryptamine 2 suggesting that enzymes remain active under the assay
conditions (Figure 2.17C and Figure 2.18C). These results confirm that genetic changes
that occur exclusively as a result of the plant transformation (i.e. changes that are
unrelated to the expression of the engineered STR) do not give rise to the formation of
unnatural strictosidine intermediates.
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Figure 2.17 A-B. LC-MS traces of an in vitro enzymatic assay of pCAMWT hairy root
(cell lines 8 and 9) lysates with 1 mM secologanin and 1 mM 5-chlorotryptamine la (A)
or 5-methyltryptamine lb (B). m/z 565 corresponds to 10-chlorostrictosidine 3a and m/z
545 corresponds to 10-methylstrictosidine 3b.
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Figure 2.17 C. LC-MS traces of an in vitro enzymatic assay of pCAMWT hairy root
(cell lines 8 and 9) lysates with 1 mM secologanin and tryptamine (C). m/z 531
corresponds to strictosidine.
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Figure 2.18 A-B. LC-MS traces of an in vitro enzymatic assay of pCAMWT hairy root
(cell lines 8 and 9) lysates with 1 mM secologanin and 1 mM 5-chlorotryptamine la (A)
or 5-methyltryptamine lb (B). m/z 385 corresponds to 10-chlorocathenamine and m/z 365
corresponds to 10-methylcathenamine.
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Figure 2.18 C. LC-MS traces of an in vitro enzymatic assay of pCAMWT hairy root
(cell lines 8 and 9) lysates with 1 mM secologanin and tryptamine (C). m/z 351
corresponds to cathenamine.
To ensure that a large amount of wild type strictosidine synthase could not turn over 5-
chlorotryptamine 2a and 5-methyltryptamine 2b, various concentrations (1 nM, 10 nM
and 100 nM; wild type enzyme kcat/Km 208333 M s" for tryptamine; no detectable
activity for 2a, 2b or 2c) of recombinant wild-type strictosidine synthase (CrSTR) were
added to lysates of control hairy root cultures lacking V214M expression. Assay
conditions were identical to those used in the above section. Formation of 10-
chlorostrictosidine 3a or 10-methylstrictosidine 3b was not observed when lysates of
control hairy roots were incubated with 5-chlorotryptamine 2a and 5-methyltryptamine
2b, respectively, even in the presence of 100 nM recombinant CrSTR (Figure 2.19 A-C).
Collectively, these data indicate that production of unnatural strictosidine biosynthetic
intermediates and the downstream unnatural alkaloid products strictly correlates with
overexpression of the engineered enzyme displaying the desired unnatural substrate
specificity.
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Figure 2.19 A-B. LC-MS traces of the in vitro enzymatic assay of wild-type hairy root
lysates 'spiked' with 1 nM, 10 nM or 100 nM recombinant wild-type strictosidine
synthase (CrSTR) in the presence of 1 mM secologanin and 1 mM 5-chlorotryptamine
(A) and 5-methyltryptamine (B). m/z 565, 10-chlorostrictosidine 3a; and m/z 545, 10-
methylstrictosidine 3b.
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Figure 2.19 C. LC-MS traces of the in vitro enzymatic assay of wild-type hairy root
lysates 'spiked' with 1 nM, 10 nM or 100 nM recombinant wild-type strictosidine
synthase (CrSTR) in the presence of tryptamine (C). m/z 351, strictosidine 3.
2.2.5 Regeneration of C. roseus Plants from Transformed Hairy Roots Expressing
STR Mutant
Differentiated C. roseus plants exhibit several advantages over hairy roots and other cell
cultures. In particular, C. roseus plants produce the alkaloids vindoline, vinblastine and
vincristine, which are not observed in hairy root culture (Chapter 1). In order to obtain
analogs of these more complex alkaloids, we developed a method to obtain transgenic C.
roseus plants that express the V214M STR mutant. A regeneration process of C. roseus
plants from hairy root culture has previously been reported. We applied this strategy
using the transgenic hairy roots containing the V214M STR gene to yield whole plants
(Figure 2.20). The regenerated plants exhibit normal growth and flower regularly. While
we have been able to "self' wild type plants (grown from commercial seeds, not
regenerated from hairy roots), efforts to "self' regenerated plants have not been
successful. Real time PCR analysis has shown that the leaves of the regenerated plant
express the V214 strictosidine synthase mutant gene. Mass spectrometry analysis of leaf
extracts indicate that the leaves of the transgenic plants have a very similar expression
profile as wild type plant leaves (Figure 2.21).
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Figure 2.20. Regeneration of C. roseus plants from root culture transformed with the
V214M mutant of strictosidine synthase.
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Figure 2.21. Accumulations of catharanthine 7 and vindoline, two representative
alkaloids, in both wild type leaves from a plant grown from seed, and in leaves derived
from the regenerated plant shown in Figure 2.20.
2.3 Conclusions
Fermentation is an attractive way to produce a diversity of natural product-inspired
molecules. Although plants have been previously engineered to produce greater amounts
of a known natural product or a known biosynthetic intermediate by metabolic
engineering strategies, use of plants or plant cell culture as a reactor for unnatural product
production has not been widely demonstrated. This chapter describes the introduction of
a re-engineered alkaloid biosynthetic gene into C. roseus cell culture. The resulting
transgenic cell culture produces a variety of unnatural alkaloid compounds when co-
cultured with simple and commercially available precursors that the re-engineered
enzyme has been designed to accept. The results highlighted in this chapter demonstrate
that metabolic reprogramming of alkaloid metabolism can be achieved in medicinal plant
cell culture, even though the genetic, biochemical and regulatory aspects of the pathway
are still not fully understood. We envision that our work will demonstrate the potential
for reprogramming complex alkaloid pathways to improve the scope and practicality of
unnatural product biosynthesis in plants.
2.4 Experimental Methods
2.4.1 Construction of Plant Expression Vectors Containing STR Mutant Gene
The native strictosidine synthase (STR) gene with the complete signal sequence for
correct localization (accession number X61932) was obtained by reverse-transcription
PCR amplification of mRNA isolated from C. roseus hairy root culture (Qiagen, Rneasy
kit). Site-directed mutagenesis was then performed to introduce the Val214Met mutation
using overlapping mutagenic primers (5' gaaagagctacatATGcccggcggtgcag 3' and 5'
ctgcaccgccgggCATatgtagctctttc 3') (Stratagene, Quikchange). For constitutive STR
mutant expression, the mutant STR gene was ligated into the NcoI/BstEII site
downstream of the CaMV 35S promoter in the pCAMBIA 1305.1 vector 2 2 (Figure 2.22)
to yield the construct pCAMV214M. A construct harbouring the wild-type STR under
control of the constitutive promoter, pCAMWT, was also generated as a control. For
inducible STR mutant expression, the mutant STR gene was ligated into the Xhol/SpeI
site downstream of the GAL4-UAS promoter in the pTA7002 vector23 (Figure 2.22) to
yield the construct pTAV214M. Both pCAMBIA 1305.1 and pTA7002 also contain a
hygromycin plant selection marker and a kanamycin bacterial selection marker. Complete
constructs for both constitutive and inducible expression were sequenced to ensure
plasmid integrity.
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Figure 2.22. Schematic diagrams of strictosidine synthase (STR) mutant inducible
expression system (left) and constitutive expression system (right) constructs.
2.4.2. Generation of Transgenic Hairy Root Cultures
The constructs containing the STR Val214Met mutant gene, as well as the construct
containing the wild type STR gene, were each transformed into Agrobacterium
rhizogenes ATCC 15834 via electroporation (1mm cuvette, 1.25 kV). Transformation of
C. roseus seedlings with the generated Agrobacterium strains was performed as
previously reported 7 . Briefly, 250-300 C. roseus seedlings (Vinca Little Bright Eyes,
Nature Hills Nursery) were germinated aseptically on Gamborg's B5 media (full strength
basal salts, full strength vitamins, 30 g/L sucrose, pH 5.7) and grown in a 16-hour light 8-
hour dark cycle at 26 *C for three weeks. Seedlings were then wounded with extra-fine
forceps at the stem tip, and transformed 3-5 pL of A. rhizogenes from a freshly grown
liquid culture were inoculated on the wound.
Hairy roots appeared at the wound site 2-3 weeks after infection for about 80% of the
seedlings infected. After hairy roots reached 1-4 cm in length (usually about six weeks
after infection), they were excised and transferred to Gamborg's B5 solid media (half
strength basal salts, full strength vitamins, 30 g/L sucrose, 6 g/L agar, pH 5.7) containing
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hygromycin for selection (three weeks on 0.01 mg/mL in first selection and three weeks
on 0.03 mg/mL in second selection) and the antibiotic cefotaxime (0.25 mg/mL in both
selections) to remove remaining bacteria. All cultures were grown in the dark at 26'C.
After the solid media selection process, hairy roots were subcultured at least once in
media lacking both hygromycin and cefotaxime prior to adaptation to liquid culture.
To adapt the line to liquid culture, approximately 200 mg of hairy roots (typically five 3-
4 cm long stem tips) from each line that grew successfully on solid media were
transferred to 50 mL of half-strength Gamborg's B5 liquid media. The cultures were
grown at 26'C in the dark at 125 rpm. All lines were maintained on a 21-28 day
subculture cycle depending on the growth rate of each line.
Table 2.2 Hairy roots selection and adaptation processes.
Plasmid # transformed # hairy roots after # hairy roots after
hairy roots solid media liquid media
selection adaptation
pCAMV214M 240 53 29
pCAMWT 280 74 5*
pTAV214M 270 44 15
* only 5 (out of 74) lines were selected for adaptation to liquid media
The solid media selection and liquid media adaptation processes are summarized in
Table 2.2. Hairy root transformants were screened for survival in solid media
supplemented with hygromycin and subsequently for fitness and fast growth in liquid
media. The number of transformants decreased significantly after solid media selection
for each of the constructs transformed. Adaptation to liquid media further eliminated
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slow growing lines. After the selection and adaptation processes, four to eight hairy root
lines from each STR mutant that grew the most rapidly in liquid media were chosen for
alkaloid production and mutant enzyme expression assays.
2.4.3 Verification of Transferred DNA (T-DNA) Integration by Genomic DNA
Analysis
To verify the integration of transferred DNA (T-DNA) into the plant genome, the
genomic DNA from transformed hairy roots was isolated (Qiagen Dneasy kit) and then
subjected to PCR amplification using T-DNA specific primers with STR primers serving
as a positive control (see below). Specifically, primers for PCR amplification were
designed to amplify the complete STR gene (STRfor and STRjrev), an 800bp region of
the selection marker HPT gene (HPT-for and HPT-rev), and a 500bp region of the
CaMV 35S promoter (CaMV 35Sfor and CaMV 35S-rev). Additionally, a primer pair
was designed to match the point mutation corresponding to the V214M sequence change
at the 3' end of the forward primer (STRV214Mfor and STRV214M.rev). These
primers readily amplified a 500bp region of the mutant gene. However, the mismatch at
the 3' end prevented efficient amplification of the native STR gene in wild type hairy
root cultures
PCR primers for verification of T-DNA integration of transformed hairy roots.
Primer Name Primer Sequence ('5 - 3')
1 STR for CCATGGCAAACTTTTCTGAATCTAAATCC
2 STR rev GGTCACCCTAGCTAGAAACATAAGAATTTC
3 HPT for GCCTGAACTCACCGCGACGTC
4 HPT rev CCTCCAGAAGAAGATGTTGGC
5 CaMV 35S for TAGAGGACCTAACAGAAC
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6 CaMV 35S rev CCGTGTTCTCTCCAAATG
7 STRV214M for CCTTATTATTGAAAGAGCTACATATG
8 STRV214M rev GCTAGAAACATAAGAATTTCCCTTG
2.4.4 Evaluation of Alkaloid Production in Engineered C. roseus
Transgenic hairy root lines were evaluated for alkaloid production after substrate analog
feeding. Transformed hairy roots were initially grown in half-strength Gamborg's B5
liquid media supplemented with the corresponding tryptamine analog at 0.5 mM
concentration. Co-cultivation with tryptamine analogs 5-chlorotryptamine 2a, 5-
methyltryptamine 2b and 5-bromotryptamine 2c at this relatively high concentration at
the initial growth phase resulted in growth retardation. Hairy roots fragmented and
became brown a few days after addition of the tryptamine analogs. To address this
problem, tryptamine analogs (and 10 pyM dexamethasone for the inducible expression
system) were added to the liquid culture towards the end of the log phase and the
beginning of the stationary phase (usually after three weeks). After one week of co-
cultivation with the substrate, hairy roots were ground with a mortar, pestle and 106 pm
acid washed glass beads in methanol (10 mL/g of fresh weight hairy roots) from the
harvested tissue. The crude natural product mixtures were filtered and subsequently
subjected to LC-MS analysis. In total, three hairy root lines transformed with A.
rhizogenes harboring the pCAMV214M plasmid and two hairy root lines with
pTAV214M plasmid were evaluated for alkaloid production. Additionally, hairy roots
transformed with wild-type A. rhizogenes lacking the plasmid were also evaluated.
These crude alkaloid mixtures were diluted 1/100 with methanol for mass spectral
analysis. Samples were ionized by ESI with a Micromass LCT Premier TOF Mass
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Spectrometer. The LC was performed on Acquity Ultra Performance BEH C18, 1.7 rim,
2.1 x 100 mm column on a gradient of 10-60% acetonitrile/water (0.1% TFA) over 13
minutes at a flow rate of 0.6 mL/min. The capillary and sample cone voltages were 1300
and 60 V, respectively. The desolvation and source temperature were 300 and 100 *C.
The cone and desolvation gas flow rates were 60 and 800 L/hour. Analysis was
performed with MassLynx 4.1. Accurate mass measurements were obtained in W-mode.
The spectra were processed using the Mass Lynx 4.1 mass measure, in which the mass
spectrum of peaks of interest was smoothed and centered with TOF mass correction,
locking on the reference infusion of reserpine.
2.4.5 Purification and Isolation of Alkaloids from Transformed Hairy Roots
Supplemented with 5-chlorotryptamine 2a and 5-methyltryptamine 2b
Root tips (10-15) from transformed hairy roots (line 31) were subcultured in 150 mL
Gamborg's B5 liquid media and grown at 26'C in the dark at 125 rpm for three weeks
prior to supplementing the media with either 5-chlorotryptamine 2a or 5-
methyltryptamine 2b. After one week of co-cultivation, hairy roots were extracted as
described above in methanol (10 mL/g of fresh weight hairy roots). Alkaloid extracts
were filtered, concentrated under vacuum and redissolved in 20% acetonitrile/water
(0.1% TFA) (1 mL/g of fresh weight hairy roots).
For 5-chlorotryptamine 2a feeding, the redissolved mixture was purified on a 10 x 20 mm
Vydec reverse phase column using a gradient of 20-60% acetonitrile/water (0.1% TFA)
over 35 minutes. Alkaloids were monitored at 228 nm and fractions containing the
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alkaloid analogs of interest, as determined by the characteristic isotopic distribution
expected for chlorinated molecules (35C1/37Cl) from LC-MS analysis, were combined and
concentrated under vacuum (Figure 2.23). Isolated alkaloids were analyzed by LC-MS
(same parameters as above), analytical HPLC, and where possible, NMR (Bruker
AVANCE-600 NMR spectrometer equipped with a 5mm 1H{13C,31P} cryo-probe).
Fractions a-d (Figure 2.23) were characterized by LC-MS, compared to characteristic
UV spectra of known alkaloids and, when greater than 1 mg quantities were obtained in
sufficient purity, also by 'H NMR and 'H-13C HSQC. Chlorinated alkaloids generally
displayed longer retention times than the natural alkaloids. Fraction a corresponded to
ajmalicine 4; fraction b corresponded to catharanthine 7; fraction c corresponded to 10-
chloroajmalicine 4a; and fraction d appeared to be a mixture of 15-chlorotabersonine 5a
and another chlorinated alkaloid also with m/z 371.
For 5-methyltryptamine 2b feeding, similar procedures were performed to feed and
isolate alkaloids from transgenic hairy roots. One notable difference was in the
purification step: since methylated alkaloids are generally more hydrophilic than
chlorinated alkaloids, the redissolved alkaloid mixture was purified on a 10 x 20 mm
Vydec reverse phase column using a gradient of 20-50% acetonitrile/water (0.1% TFA)
over 35 minutes.
Alkaloids were monitored at 228 nm and fractions containing the alkaloid analogs of
interest, as determined by LC-MS analysis, were combined and concentrated under
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vacuum (Figure 2.24). All isolated alkaloids were characterized by LC-MS, compared to
characteristic UV spectra of known alkaloids and, when greater than 1 mg quantities were
obtained in sufficient purity, also by 'H NMR and 'H-"C HSQC. Fraction a appeared to
be a mixture of 10-methylajmalicine 4b and another compound with m/z 379; fraction b
contained a mixture of 15-methyltabersonine 5b and a compound with m/z 353. Fraction
b was further purified on a 10 x 20 mm Vydex reverse phase column using an isocrat
28% acetonitrile/water (0.1% TFA) to obtain 15-methyltabersonine 5b in over 85%
purity.
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Figure 2.23. HPLC trace of alkaloids from pCAMV214M hairy root (cell line 31) fed
with 5-chlorotryptamine 2a (0.5 mM). Fractions a, b, c and d were collected and
analyzed.
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Tabulated NMR data for 10-chloroajmalicine 4a (Fraction c in Figure 2.23)
'H NMR (600 MHz, CD 30D): 6 7.64 (d, J = 1.8 Hz, 1H), 7.53 (d, J = 1.8 Hz, 1H), 7.39
(d, J= 9.0 Hz, 1 H), 7.17 (dd, J= 1.8, 8.4 Hz, 1H), 4.87 (m, 1H), 4.59 (qd, J= 3.6, 6.6
Hz, 1H), 3.89 (dd, J = 5.7, 12.6 Hz, 1H), 3.79 (s, 3H), 3.70 (dd, J = 3.0, 12.0 Hz, 2H),
3.45 (dd, J= 1.2, 1.8 Hz, 1H), 3.25 (m, 1H), 3.22 (m, 1H), 3.15 (dd, J= 4.2, 16.2 Hz,
1H), 2.84 (br t, J= 11.4 Hz, 1H), 2.26 (m, 1H), 1.53 (m, 1H), 1.28 (d, J= 6.6 Hz, 3H);
3C NMR (500 MHz, CD30D): 8 156.20, 124.05, 118.88, 114.07, 73.61, 63.03,55.67,
54.54, 51.88, 40.94, 32.28, 30.29, 20.30, 14.74 (note that quaternary carbon peaks are not
observed in 'H-13C HSQC ;ESI-MS (m/z): [MI' calcd. for C2 H23N20 3Cl, 387.1490;
found, 387.1483.
NH\C1,
N
H CO2Me 5a
NMR data for 15-chlorotabersonine 5a (Fraction d in Figure 2.23)
'H NMR (500 MHz, CD30D): 8 7.68 (d, J = 2.0 Hz, 1H), 7.26 (dd, J= 2.0, 8.0 Hz, 1H),
7.03 (d, J = 8.0 Hz, 1H), 6.06 (d, J = 10.5 Hz, 1H), 6.00 (dd, J = 4.0, 10.5 Hz, 1H), 4.21
(d, J= 10.0 Hz, 1H), 3.80 (s, 3H), 3.67 (m, 1H), 3.57 (m, 1H), 3.17 (m, 1H), 2.94 (m,
1H), 2.34 (d, J= 17.5 Hz, 1H), 1.83 (d, J= 7.0 Hz, 1H), 1.78 (dd, J= 2.5, 7.0 Hz, 2H),
1.67 (d, J= 6.50 Hz, 1H), 1.14 (t, J= 7.50, 1H), 0.73 (t, J= 7.5 Hz, 3H); ESI-MS (m/z):
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[M]* calcd. for C21H23N 2O2Cl, 371.1526; found, 371.1528.
'Iii
:;{
Figure 2.24. HPLC trace of alkaloids from pCAMV214M hairy root (cell line 31) fed
with 5-methyltryptamine 2b (0.5 mM). Fractions a and b were collected and analyzed.
Me
MeO 2C 4b
Tabulated NMR data for 10-methylajmalicine 4b (Fraction a in Figure 2.24)
'H NMR (500 MHz, CD30D): 8 7.60 (d, J = 1.5 Hz, 1H), 7.01 (d, J = 9.0 Hz, 1H), 6.93
(dd, J= 4.5, 8.0 Hz, 1H), 4.81 (dd, J= 4.0, 11.0 Hz, 1H), 4.57 (dd, J= 4.0, 6.5 Hz, 1H),
3.89 (m, 1H), 3.77 (s, 3H), 3.66 (m, 2H), 3.45 (m, 1H), 3.25 (m, 1H), 3.22 (m, 1H), 3.13
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(m, 1H), 2.84 (m, 1H), 2.41 (s, 3H), 2.25 (m, 1H), 1.52 (m, 1H), 1.26 (d, J = 6.5 Hz, 3H);
ESI-MS (m/z): [M]* calcd. for C22H27N20 3, 367.2022; found, 367.2015.
NMe
N
H CO2Me 5b
NMR data for 10-methyltabersonine 5b (Fraction b in Figure 2.24)
'H NMR (600 MHz, CD30D): 8 7.40 (s, 1H), 7.08 (d, J = 8.0 Hz, 1H), 6.93 (d, J= 7.9
Hz, 1H), 6.06 (d, J = 10.0 Hz, 1H), 6.00 (dd, J = 4.4, 10.1 Hz, 1H), 4.22 (d, J = 15.4 Hz,
1H), 4.01 (d, J= 14.0 Hz, 1H ), 3.93 (s, 1H), 3.80 (s, 3H), 3.67 (m, 1H), 3.57 (m, 1H),
2.92 (d, J = 16.6 Hz, 1H), 2.42 (m, 1H), 2.33 (s, 3H), 2.19 (br s, 2H), 1.29 (s, 1H), 1.19
(m, 2H), 0.71 (t, J= 7.0 Hz, 3H); 13C NMR (500 MHz, CD30D): 6 135.49, 130.89,
122.80,122.62, 111.49,72.15,54.30,51.98,51.78,44.44,30.96,28.80,21.25,7.81 (note
that quaternary carbon peaks are not observed in 'H-13C HSQC); ESI-MS (m/z): [M]*
calcd. for C22H27N20 2, 351.2073; found, 351.2064.
2.4.6 Verification of Expression of Mutant STR Enzyme by Real Time RT-PCR
Real time RT-PCR was used to assess the expression levels of STR (sum total of both
mutant V214M STR and native STR). Expression levels in hairy roots infected with A.
rhizogenes lacking the pCAMV214M STR mutant construct were compared to
expression levels in hairy roots harboring pCAMV214M. mRNA from transformed hairy
roots was isolated and purified from contaminant DNA using Qiagen RNeasy Plant Mini
Kit and Rnase-free Dnasel, respectively. The resulting mRNA was then reverse-
109
transcribed to cDNA using Qiagen QuantiTect Reverse transcription kit and then
subjected to PCR with specific primers (see below), Qiagen SYBR Green PCR kit and a
Biorad DNA Engine Opticon 2 system. The threshold-cycle (CT) was determined as the
cycle with a signal higher than that of the background plus 10 x standard deviation (SD).
C. roseus 40S ribosomal protein S9 (Rps9), a house keeping gene, was used to adjust the
amount of the total mRNA in all samples. Real time RT-PCR was performed in triplicate
and the data are pictured as the relative expression levels of STR (sum total of both
V214M mutant and native STR) mRNA in transgenic hairy roots as well as hairy roots
lacking the pCAMBIA plasmid. Hairy root lines containing the pTAV214M construct
also failed to show expression of the V214M mutant STR both in the presence and
absence of dexamethasone, the inducer.
PCR primers for real-time RT-PCR of transformed hairy roots. Primers were designed
using GenScript web tool (http://www.genscript.com/ssl-bin/app/primer)
Primer Name Primer Sequence ('5 -> 3') Amplicon size
Homol STR for GTCCAAGATGGCCGAGTTAT 140
Homol STR rev TATGTCCTCCCACACAATGG
STR V214M for TATTATTGAAAGAGCTACATATG 134
STR V214M rev CTCTGCACTGCCTTTCTTG
Rbps9_for TTGAGCCGTATCAGAAATGC 122
Rbps9_rev CCCTCATCAAGCAGACCATA
2.4.7 In vitro Enzymatic Assay of Transformed Hairy Roots Expressing STR
Mutant
After at least three rounds of subculture in liquid media, transformed hairy roots were
subjected to an enzymatic assay to evaluate the expression of the STR mutant in vitro. In
the constitutive expression system (hairy roots transformed with pCAMV214M), hairy
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roots subcultured for three weeks were harvested and ground with a mortar, pestle and
106 pm acid washed glass beads in extraction buffer (0.1 M phosphate buffer, 2 mM
EDTA, 4 mM DTT, 0.1 y M pepstatin, 0.1 y M leupeptin, 1% PVP, pH 7.2) at 4 'C. The
hairy root extracts were centrifuged for 10 min at 13000 rpm at 4 *C to remove cell
debris, concentrated, and assayed for STR V214M enzymatic activity without further
purification. Total protein concentration in the extracts was quantified using Biorad
Protein Assay Solution.
A typical reaction mixture contained 0.1 M phosphate buffer pH 7, 2.5 mM DTT, 1 mM
secologanin, and 1 mM tryptamine analog 2a-c. Approximately 2 0 mg of crude enzyme
was added to 100 mL reaction mixture and the reaction was incubated at 30 'C for 4
hours. To quench the reaction, 625 p1L of methanol was added to 50 m L of the reaction
mixture and the resulting solution was centrifuged, filtered through a 0.2 mm filter and
then subjected to LC-MS analysis. Samples were ionized by ESI with a Micromass LCT
Premier TOF Mass Spectrometer. The LC was performed on an Acquity Ultra
Performance BEH C18, 1.7 [tm, 2.1 x 100 mm column on a gradient of 10-60%
acetonitrile/water (0.1% TFA) over 7 minutes at a flow rate of 0.6 mL/min. In total, three
lines (pCAMV214M_31, pCAMV214M_37, and pCAMV214M_49) with constitutive
mutant STR expression were assayed for enzymatic activity. Lysate from hairy roots
overexpressing wild-type strictosidine synthase and hairy roots infected with A.
rhizogenes lacking plasmid ( "wild type hairy root") were used as negative controls.
Additionally, any non-enzymatically catalyzed background reaction that occurred simply
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in the presence of the hairy root extraction buffer was also measured (no enzyme
control).
2.4.8 Regeneration of C. roseus Plants from Transformed Hairy Roots Expressing
STR Mutant
Regeneration of transformed hairy roots expressing STR mutant to whole plants was
performed as previously reported2 1 .Briefly, one-centimeter-long root tips of two-week-
old transformed hairy roots were excised and transferred to shoot regeneration media (full
strength Murashige and Skoog basal salts and vitamins, 31 [M 6-benzyladenine, 5.4 tM
a-naphthaleneacetic acid, 30 g/L sucrose, pH 5.7). After nine weeks on this media,
explants were transferred to root regeneration media (half strength Murashige and Skoog
basal, full strength Murashige and Skoog vitamins, 30 g/L sucrose, pH 5.7). After four
weeks on this media, regenerated plants were transferred to full strength Gamborg's B5
media (full strength basal salts, full strength vitamins, 30 g/L sucrose, pH 5.7). After
three weeks of acclimation, regenerated plants were transferred to Miracle gro soil and
maintained in a culture room.
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CHAPTER 3
INTRODUCING PROKARYOTIC HALOGENASES
INTO C. ROSEUS CELL CULTURE
Part of this chapter is published as a letter in
Nature 2010, 468, 461-464
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3.1 Introduction
Halogenated metabolites, once considered 'chance products of nature', have now been
observed in many natural product biosynthetic pathways'. However, out of over 4000
halogenated natural products that have been reported in literatures, only a few are from
terrestrial plants 2. While halogenating enzymes are undoubtedly present in certain plant
species, no plant-derived halogenase has been reported. Given the impact that
halogenation can have on the biological activity of natural products', introduction of
halides into medicinal plant metabolism would provide the opportunity to rationally
engineer a broad variety of novel plant products with altered, and perhaps improved,
pharmacological properties. Moreover, the halogen moiety can serve as a chemical
handle for further chemical derivatization.
While none of the halogenase enzymes from plants have been identified, numerous
halogenase enzymes from soil bacteria have been identified and characterized
extensively" 3 -. One class of halogenase that chlorinates aromatic substrates utilizes a
flavin cofactor, along with a partner flavin reductase, to catalyze transfer of the halide to
the substrate. Two of these enzymes, PyrH6 '7 and RebH-", chlorinate the indole ring of
tryptophan in the 5 and 7 positions, respectively. We envisioned that the introduction of
these enzymes into other natural product pathways would allow regioselective
incorporation of halogens onto a range of tryptophan-derived alkaloid products",
provided that the downstream enzymes could accommodate the chlorinated tryptophan
precursor.
116
Previous work has shown that the downstream alkaloid biosynthetic enzymes of
Catharanthus roseus are not particularly substrate specific13-i5 (Chapter 2 and Chapter
4). For example, when C. roseus cell culture is supplemented with a variety of
halogenated tryptamines, the corresponding halogenated alkaloid analogs are produced in
isolable yields13-i. Therefore, we envisioned that if prokaryotic halogenases could
function in the eukaryotic plant cell, and if tryptophan decarboxylase could convert
halogenated tryptophan into halogenated tryptamine, then we could engineer C. roseus to
produce halogenated alkaloids de novo by integrating these prokaryotic genes to the C.
roseus genome (Figure 3.1).
C02H N
tryptophan NH2
RebH NH2  decarboxylase secologanin j - H
reductase (C. roseus N
NN HH 0M
C0HXH X XCO2H x X = CI 7-chlorotryptamine 2a X = CI 5a 19,20-dihydro-
5 NH2  X = CI 7-chiorotryptophan la X = Br 7-bromotryptamine 2a X = Br 5c akuammicine5 X = Br 7-bromotryptophan I si NN6 C02H tryptophanST mI
trpopa ~N 2 decarboxylase aI NH2  HTv I
-0- H
Pyrn CO2Mecologanin
XC =oes CSa1,-Hydo
H ajmalicine 6bMeO2Credu 5-chlorotryptophan b 5-chlorotryptamine 2b
CI
NH CO2Metabersonine 7b
Figure 3.1. RebH and PyrH, along with a partner reductase, halogenate the indole ring of
tryptophan 1 to yield chloro-tryptophan. After transformation of these enzymes into C.
roseus, halogenated tryptophan la and lb can be decarboxylated by tryptophan
decarboxylase (C. roseus) to form chlorotryptamine 2a and 2b, and then converted into
chlorinated monoterpene indole alkaloids.
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This chapter describes the successful introduction of chlorination biosynthetic machinery
from soil bacteria into the medicinal plant C. roseus, which lacks the biosynthetic
capability to produce halogenated compounds. These prokaryotic halogenases function
within the context of the eukaryotic plant cell to generate chlorinated tryptophan, which
is then shuttled into monoterpene indole alkaloid metabolism to yield chlorinated
alkaloids. Moreover, when the plant culture media was supplemented with bromide salts,
accumulation of brominated alkaloids was observed in crude plant extracts. Altogether,
we have introduced a new functional group-a halide-into complex plant metabolism to
rationally alter product outcome.
3.2 Results and Discussion
3.2.1 Determining the Steady-State Kinetic Constants of TDC for Tryptophan
Substrate Analogs, 5- and 7-chlorotryptophan la and lb
Since RebH and PyrH do not turnover tryptamine, our strategy requires that tryptophan
decarboxylase from C. roseus can competently decarboxylate halogenated tryptophan.
We heterologously expressed tryptophan decarboxylase from C. roseus in Escherichia
coli (Figure 3.2). Purified enzyme was assayed with tryptophan 1, 7-chlorotryptophan la
and 5-chlorotryptophan lb .The steady state kinetics for C. roseus tryptophan
decarboxylase and tryptamine substrates are summarized in Table 3.1 and Figure 3.3 A-
C. These steady state kinetic data indicated that the catalytic efficiency of the
decarboxylase was approximately 30 folds lower with the halogenated substrates la and
lb than with tryptophan 1. Nevertheless, the activity of the enzyme suggested that
halogenated tryptophan la and lb could be decarboxylated in vivo.
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Table 3.1. Kinetic constants for C. roseus tryptophan decarboxylase and tryptamine
substrates.
Tryptamine substrates Km (mM) kca(min-1) k,/ Km(mM-1min-')
Tryptophan 1 51.7 9.2 5.1 ± 0.1 0.099
7-chlorotryptophan la 499 74 1.6 ± 0.04 0.00327
5-chlorotryptophan lb 538 48 2.5 ± 0.08 0.00455
protein flow-
ladder crude through
wash
1
wash
2
wash
3 elution
kDa
75
50
37
Figure 3.2. SDS-PAGE of C.roseus tryptophan decarboxylase (TDC) purification from
Ni-NTA affinity resin (Qiagen Ni-NTA Spin Kit).
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Figure 3.3 A. Steady state kinetic data for C. roseus tryptophan decarboxylase (TDC)
with tryptophan 1.
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Figure 3.3 B (top) and C (bottom). Steady state kinetic data for C. roseus tryptophan
decarboxylase (TDC) with 7-chlorotryptophan la (B) and 5-chlorotryptophan lb (C).
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3.2.2 Construction of Halogenase Plant Expression Vectors pCAMPyrH/RebF/
STRvm and pCAMRebH/RebF
We considered two strategies for merging the prokaryotic chlorination machinery with
the plant alkaloid pathway. The first strategy involves reconstitution of both the plant
alkaloid biosynthetic pathway and the prokaryotic chlorination machinery in a microbial
host, such as Escherichia coli or Saccharomyces cerevisiae. The second strategy involves
introduction of the prokaryotic halogenase enzymes into C. roseus. We chose the latter
strategy, which is transferring the halogenase enzymes into C. roseus, rather than moving
the plant biosynthetic enzymes into a microbial host. Most of the monoterpene indole
alkaloid biosynthetic genes have not been identified, and therefore heterologous
expression of this pathway in a microbial host is not possible at present. Moreover,
reconstitution of plant alkaloid pathways continues to be a challenging endeavour that
requires sophisticated and time-consuming genetic manipulation and yield optimization"6 '
17. Additionally, many alkaloids use complex starting materials (such as secologanin for
monoterpene indole alkaloids) that are only produced by a few specialized plants, so
reconstitution of plant alkaloid pathways must also include biosynthesis of these
precursors. For example, ajmalicine (6; Figure 3.1), one of the simplest of the
monoterpene indole alkaloids, requires an estimated 14 discrete enzymes for biosynthesis
from tryptophan and the terpene geraniol18 ; reconstitution of a pathway of this length (in
tandem with the prokaryotic chlorination machinery) is a challenging engineering
problem. Therefore, we believe that exploring alkaloid metabolic engineering in the host
plant-rather than in a heterologous host-is a more appropriate strategy to achieve our
goal of introducing halides into medicinal plant metabolism.
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To produce 7-chlorotryptophan in planta, we generated an expression construct
containing complementary DNA encoding the 7-tryptophan chlorinase RebH and its
required partner flavin reductase, RebF, in a plant expression vector (pCAMBIA130019),
both under the control of constitutive Cauliflower Mosaic Virus (CaMV) 35S promoters
(Figure 3.4). For production of 5-chlorotryptophan, an expression construct encoding the
5-chlorinating enzyme PyrH, along with RebF as the partner reductase, was generated.
No signal sequence was added to the halogenase genes, to ensure that RebH, PyrH and
RebF would produce chlorinated tryptophan in the cytosol, where it would most readily
encounter the decarboxylase, which is also localized in the cytosol 20 .The halogenase
genes, RebH, PyrH and RebF were codon-optimized to ensure efficient expression in
plant cell culture. PCR analysis of genomic DNA indicated that the prokaryotic
chlorination machinery and the hygromycin antibiotic selection marker (HPT) were
incorporated into the C. roseus genome (Figure 3.5-3.6).
We used Agrobacterium rhizogenes to generate hairy root culture of C. roseus
transformed with the halogenase genes21. One of the early biosynthetic enzymes,
strictosidine synthase, cannot turn over 5-chlorotryptamine 2b1 ,22 . Therefore, when
transforming C. roseus with PyrH and RebF, we also introduced a mutant of strictosidine
synthase (STRvm) that can convert 5-chlorotryptamine to 10-chlorostrictosidine 4b .
The construction of STRvm constitutive expression plasmid is described in Chapter 2.
After a selection process, we cultivated the transformed root culture on standard
Gamborg's B5 plant media and monitored chlorinated alkaloids using liquid
chromatography-mass spectrometry (LC-MS).
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T-DNA Nos RebH CaMV
Border (L) PoIyA 35S
T-DNA Nos CaMV
Border (L) PoIyA PyrH 35S
CaMV RebF Nos
35S PolyA
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Nos HPT CaMV T-DNA
PoIyA 35S Border (R)
Nos CaMV T-DNA
PoIyA 35S Border (R)
Figure 3.4. Schematic diagram of prokaryotic halogenase plant expression plamids
pCAMRebHRebF and pCAMPyrHRebF.
CaMV35S: Cauliflower Mosaic Virus 35S promoter; Nos PolyA: poly(A) signal from
nopaline synthase; RebH: codon-optimized RebH; PyrH: codon-optimized PyrH, RebF:
codon-optimized RebF; and HPT: hygromycin phosphotransferase.
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TDC RebH RebF HPTTDC RebH RebF HPT
Figure 3.5. 1% agarose gel
genomic DNA.
Lane: template, primers.
1: RebF/H cell line 4, TDC
2: RebF/H cell line 4, RebH
3: RebF/H cell line 4, RebF
4: RebF/H cell line 4, HPT
5: RebF/H cell line 5, TDC
6: RebF/H cell line 5, RebH
7: RebF/H cell line 5, RebF
8: RebF/H cell line 5, HPT
9: RebF/H cell line 6, TDC
10: RebF/H cell line 6, RebH
11: RebF/H cell line 6, RebF
12: RebF/H cell line 6, HPT
13: RebF/H cell line 10, TDC
14: RebF/H cell line 10, RebH
* 0 
d
17 18 19 20 21 22 23 24 MW
TDC RebH RebF HPTTDC RebH RebF HPT
TDC RebH RebF HPT
f PCR amplification of RebF/H and wild-type hairy root
RebF/H cell line 10, RebF
RebF/H cell line 10, HPT
RebF/H cell line 11, TDC
RebF/H cell line 11, RebH
RebF/H cell line 11, RebF
RebF/H cell line 11, HPT
wild type, TDC
wild type, RebH
wild type, RebF
wild type, HPT
pCAMRebH/RebF plasmid, TDC
pCAMRebH/RebF plasmid, RebH
pCAMRebH/RebF plasmid, RebF
pCAMRebH/RebF plasmid, HPT
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Figure 3.6. 1% agarose gel of PCR amplification of PyrH/RebF/STRvm and wild-type
hairy root genomic DNA.
Lane: template, primers.
1: PyrH/RebF/STRvm cell line 1, TDC
2: PyrH/RebF/STRvm cell line 1, PyrH
3: PyrH/RebF/STRvm cell line 1, RebF
4: PyrH/RebF/STRvm cell line 1, STRvm
5: PyrH/RebF/STRvm cell line 1, HPT
6: PyrH/RebF/STRvm cell line 3, TDC
7: PyrH/RebF/STRvm cell line 3, PyrH
8: PyrH/RebF/STRvm cell line 3, RebF
9: PyrH/RebF/STRvm cell line 3, STRvm
10: PyrH/RebF/STRvm cell line 3, HPT
11: PyrH/RebF/STRvm cell line 6, TDC
12: PyrH/RebF/STRvm cell line 6, PyrH
13: PyrH/RebF/STRvm cell line 6, RebF
14: PyrH/RebF/STRvm cell line 6, STRvm
15: PyrH/RebF/STRvm cell line 6, HPT
16: PyrH/RebF/STRvm cell line 7, TDC
17: PyrH/RebF/STRvm cell line 7, PyrH
18: PyrH/RebF/STRvm cell line 7, RebF
19: PyrH/RebF/STRvm cell line 7, STRvm
20: PyrH/RebF/STRvm cell line 7, HPT
21: wild type, TDC
22: wild type, PyrH
23: wild type, RebF
24: wild type, STRvm
25: wild type, HPT
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3.2.3 Evaluation of Alkaloid Production in Transgenic C. roseus Hairy Roots
Transformed hairy roots were cultured in solid Gamborg's B5 media for two to three
weeks prior to alkaloid extractions. Gratifyingly, we observed formation of chlorinated
tryptophans la and lb and chlorinated alkaloids in both the RebF/H and
PyrH/RebF/STRvm hairy root lines (Figure 3.7-3.9, Table 3.2-3.3 and Appendix B).
These results indicate that RebH, PyrH and the partner reductase function productively in
the plant cell environment, demonstrating that the flavin halogenases are highly
transportable among kingdoms. Since production of both chlorinated tryptamine and
chlorinated alkaloids was observed in the transformed lines, we conclude that tryptophan
decarboxylase can competently turn over halogenated tryptophan substrates in vivo.
Hairy roots transformed with RebH and RebF, which produce 7-chlorotryptophan la,
yielded a major chlorinated product at m/z 359 (Figure 3.7 C and Table 3.2). An
authentic standard of 12-chloro-19,20-dihydroakuammicine 5a co-eluted with this
compound. The identities of the two smaller peaks at m/z 359 are not known. However,
the two compounds also exhibit the characteristic isotopic pattern of chlorine (3 5Cl/37Cl
ratio of 3:1) and are likely isomers of 5a. Natural products containing the akuammicine
scaffold have a variety of pharmacological activities24-2 6 .Although the parent compound,
19,20-dihydroakuammicine 5 has been isolated in good yields from other plants27 , it is
not a major alkaloid in C. roseus hairy root culture. However, when wild-type C. roseus
cell lines were incubated with 7-chlorotryptamine, 12-chloro-19,20-dihydroakuammicine
was also the major chlorinated product (Figure 3.11). Therefore, the relatively high
accumulation of 12-chloro-19,20-dihydroakuammicine 5a in the RebH/RebF hairy root
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line is likely due to substrate specificity of downstream enzymes for 7-chlorotryptamine
2a. A hairy root line transformed with the 5-chlorotryptophan enzyme system, PyrH,
RebF and STRvm, produced a variety of chlorinated alkaloids (Figure 3.9 C-D and
Table 3.3). Two representative chlorinated alkaloids, 10-chloroajmalicine 6b and 15-
chlorotabersonine 7b, were identified by co-elution with authentic standards".
Ajmalicine and tabersonine are two of the major alkaloids in C. roseus hairy root culture
(Appendix B). As expected, the alkaloid profile of PyrH/RebF/STRvm hairy roots is
similar to the alkaloid profile of STRvm hairy roots fed with 5-chlorotryptamine 2b
(Chapter 2).
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Figure 3.7 A (top) and B (bottom). Chlorinated alkaloids in C. roseus hairy root culture.
Liquid chromatography-mass spectrometry (LC-MS) chromatograms showing 7-
chlorotryptophan la (A, m/z 239) and 7-chlorotryptamine 2a (B, m/z 195) in RebF/H
hairy roots, contrasted with control cultures transformed with no plasmid. Authentic
standards of la and 2a validated the structural assignments.
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Figure 3.7 C. Chlorinated alkaloids in C. roseus hairy root culture. Liquid
chromatography-mass spectrometry (LC-MS) chromatograms showing 12-chloro-19,20-
dihydroakuammicine 5a (m/z 359) in RebF/H hairy roots (red trace), contrasted with
control cultures transformed with no plasmid (purple trace). An authentic standard of 5a
validated the structural assignment.
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Figure 3.8. 'H NMR and 'H-"C HSQC spectra of 12-chloro-19,20-dihydroakuammicine
5a and 12-bromo- 19,20-dihydroakuammicine 5c.
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Figure 3.9 A (top) and B (bottom). Chlorinated alkaloids in C. roseus hairy root culture.
Liquid chromatography-mass spectrometry (LC-MS) chromatograms showing 5-
chlorotryptophan lb (A, m/z 239) and 5-chlorotryptamine 2b (B, m/z 195) in
PyrH/RebF/STRv214m hairy roots, contrasted with control cultures transformed with no
plasmid. Authentic standards of lb and 2b validated the structural assignments.
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Figure 3.9 C (top) and D (bottom). Chlorinated alkaloids in C. roseus hairy root culture.
Liquid chromatography-mass spectrometry (LC-MS) chromatograms showing 10-
chloroajmalicine 6b (C, m/z 387) and 15-chlorotabersonine 7b (D, m/z 371) in
PyrH/RebF/STRv2l4m hairy roots, contrasted with control cultures. Authentic standards
of 6b and 7b are shown. The other major peak at m/z 371 had an exact mass and UV
spectra consistent with a chlorinated catharanthine 8 analog.
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Table 3.2. High-resolution MS data for alkaloids observed in RebF/H hairy root extracts.
19,20-dihydro- 12-chloro 12-bromo*
akuammicine (R = Cl) (R = Br)
N
Expected [M+H] 359.1526 403.1021
- Observed [M+H] 359.1520 403.1011
R H C 2CH3  Accuracy (ppm) -1.7 -2.5
RT (min) 2.43 2.48
* This brominated alkaloid was observed in media supplemented with potassium bromide
(see section 3.4.8).
Table 3.3. High-resolution MS data for alkaloids observed in PyrH/RebF/STRv214m
hairy root extracts.
ajmalicine 6 10-chloro 6b
(R = Cl)
C1 N H Expected [M+HI 
387.1490
Observed [M+H] 387.1483
-11H
N Accuracy (ppm) 2.1
MeO2C RT (min) 2.26
tabersonine 7 15-chloro 7b
(R = Cl)
N H Expected [M+H] 371.1526C1 Observed [M+H] 371.1528
Accuracy (ppm) 0.5
N RT (min) 2.47H CO 2Me _______
catharanthine 8 10-chioro 8b
(R = Cl)
CI N Expected [M+H] 371.1526
Observed [M+H] 371.1531
N CO2Me Accuracy (ppm) 1.3H RT (min) 2.31
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3.2.4 Quantification of Chlorinated Alkaloid Production in Transformed Hairy
Roots
Chlorinated alkaloid production was stable over the course of at least six subcultures
(Figure 3.10). The alkaloid 12-chloro-19,20-dihydroakuammicine 5a was produced at
26 ±4 tg per gram of fresh root weight of a representative cell line averaged over six
subcultures. For comparison, wild-type cell lines produced ~25 [g per gram of fresh
tissue weight of chlorinated alkaloids when the medium was supplemented with 200 mM
7-chlorotryptamine 2a (Figure 3.11). Similarly, 10-chloroajmalicine and 15-
chlorotabersonine 7b were produced at 2.8 ± 0.9 and 4.0 ± 1.0 Rg per gram of fresh root
weight, respectively, for a representative cell line averaged over four subcultures (Figure
3.12). Additionally we determined whether the yields of chlorinated alkaloids could be
improved by supplementing the hairy root media with chloride salts. Different
concentrations of KCl (3 mM - 20 mM) were added to the media, but increasing amounts
of exogenous chloride salt did not significantly affect the yields of chlorinated alkaloids
(Figure 3.13).
Tryptophan 1 does not accumulate in either wild type or transformed hairy roots.
However, accumulation of 7-chlorotryptophan la (50 ± 12 Rg per gram of fresh root
weight for a representative RebH/RebF cell line; Figure 3.10) and 5-chlorotryptophan lb
(8 ± 2 Rg per gram of fresh root weight for a representative PyrH/RebF/STRvm cell line;
Figure 3.12) was observed, suggesting that decarboxylation of chlorinated tryptophan is
a bottleneck in vivo, a step that could potentially be subjected to future engineering
efforts. This is consistent with the 30-fold-lower catalytic efficiency of the decarboxylase
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enzyme for halogenated tryptophan in vitro. Interestingly, overexpression of tryptophan
decarboxylase, in addition to RebH and RebF, in C. roseus hairy roots resulted in lower
accumulation of 7-chlorotryptophan la, but not higher accumulation of chlorinated
alkaloids (Glenn and O'Connor, unpublished).
N
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Figure 3.10. Tabulated amounts of chlorinated alkaloid production in RebF/H hairy roots
after subsequent subcultures.
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Figure 3.11. Chlorinated alkaloid production in wild type line incubated with 7-
chlorotryptamine la.
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Figure 3.12. Tabulated amounts of chlorinated alkaloid production in
PyrH/RebF/STRv214m hairy roots (line 1) after subsequent subcultures.
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Figure 3.13. Tabulated amounts of chlorinated alkaloid 5a, 7-chlorotryptophan la and 7-
chlorotryptamine 2a in response to increasing KCl concentration.
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Previous in vitro studies of RebH demonstrated that the enzyme can utilize bromide to
yield brominated tryptophan Ic". To assess the capacity of RebH for bromination in vivo,
we supplemented a low-chloride cell culture medium with KBr. The in vitro halide
specificity of RebH correlated with the products generated in vivo, as we observed the
formation of a compound that co-eluted with an authentic standard of 12-bromo- 19,20-
dihydroakuammicine 5c (21 ± 8 and 49 ± 20 [tg per gram of fresh root weight with
10 mM and 20 mM KBr supplementation, respectively; Figure 3.14-3.15). Production of
brominated alkaloids did not seem to affect the yields of chlorinated alkaloids (Figure
3.16). We also assessed the capacity of RebH to iodinate in vivo. Supplementation of the
media with KI (0-20 mM) failed to yield either iodinated tryptophan or iodinated
alkaloids (Figure 3.17). These results correlated with in vitro studies demonstrating that
RebH does not accept iodide as a substrate".
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Figure 3.14. Extracted LC-MS chromatograms showing the presence of 12-bromo-19,20-
dihydroakuammicine 5c (m/z 403) in RebF/H hairy roots. Hairy roots are grown in media
supplemented with KBr (0 - 20 mM final concentration) for two weeks prior to alkaloid
extractions. 12-bromo-19,20-dihydroakuammicine 5c is not observed in control cultures
transformed with no plasmid after incubation in potassium bromide supplemented media.
An authentic standard of 12-bromo-19,20-dihydroakuammicine 5c is used to validate the
structural assignment (Appendix B).
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Figure 3.15. Brominated alkaloid production levels in selected RebF/H and wild type
hairy roots growing on solid media that have been supplemented with KBr (0 - 20 mM).
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Figure 3.16. Brominated and chlorinated alkaloids production levels in selected RebF/H
hairy roots growing on solid media that have been supplemented with KBr (0 - 20 mM).
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Figure 3.17. Extracted LC-MS traces showing the absence of iodinated alkaloids in
selected RebF/H and wild type hairy roots growing on solid media that have been
supplemented with KI (0 - 20 mM).
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3.2.5 Verification of Expression of RebH, RebF and PyrH, STRvm Enzymes by Real
Time RT-PCR
The transcript levels of the heterologous enzymes were measured by real-time PCR with
reverse transcription (Figure 3.18-3.19). In RebH/RebF hairy roots, the production of
halogenated compounds depended on the expression of both RebF and RebH.
RebH/RebF cell line 5, which accumulates the highest levels of chlorinated alkaloids, has
the highest expression levels of both RebF and RebH (Figure 3.18). In
PyrH/RebF/STRvm hairy roots, the production of halogenated alkaloids depended not
only on the expression of RebF and PyrH, but also on the expression of the strictosidine
mutant STRvm. Notably, when STRvm was not expressed in the PyrH/RebF hairy root
lines, we observed accumulation of 5-chlorotryptophan (representative cell line, 9 1 Rg
per gram of fresh root weight) and 5-chlorotryptamine (representative cell line, 20 9 Rg
per gram of fresh root weight), but did not observe downstream alkaloids (Figure 3.19,
Appendix B).
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Figure 3.18 A (top) and B (bottom). Expression levels of RebH (A) and RebF (B) in 5
different RebF/H lines measured by RT-PCR. Expression levels of the transgenic lines
are normalized to the expression levels in RebF/H hairy roots cell line 5.
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Figure 3.19 A (top) and B (bottom). Expression levels of PyrH (A) and RebF (B) in 4
different PyrH/RebF/STRv214m lines measured by RT-PCR. Expression levels of the
transgenic lines are normalized to the expression levels in PyrH/RebF/STRvm hairy roots
cell line 1.
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Figure 3.19 C. Expression levels of STRvm in 4 different pCAMPyrH/RebF/STRvm
lines measured by RT-PCR. Expression levels of the transgenic lines are normalized to
the expression levels in PyrH/RebF/STRvm hairy roots cell line 1.
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3.2.6 Morphologies of Transgenic C. roseus Hairy Roots
The morphologies of the halogen producing lines were thicker and slower growing than
those of wild type lines (Figure 3.20). Moreover, these lines did not seem to be adaptable
to liquid media. We speculated that the accumulation of chlorinated tryptophan could
unfavourably affect growth and morphology of transgenic hairy roots. Because
tryptophan serves as the precursor for other small-molecule metabolites, chlorinated
tryptophan may be diverted into other pathways such as auxins biosynthesis. Since auxins
regulate plants growth and behavioural processes, altering this pathway is likely to affect
hairy roots' morphology. Notably, 4-chloro indole acetic acid, which is found in several
species of pea, has altered activity relative to the auxin indole acetic acid 2 8 ,29 . Finally,
despite numerous attempts, regeneration of C. roseus plants from RebH/RebF and
PyrH/RebF/STRvm hairy roots did not yield viable whole plants.
3.3 Conclusions
While medicinal plants produce a wide range of complex natural products, only a few of
these contain halogen atoms. Notably, chlorinated or brominated compounds are not
found among the approximately 3,000 known monoterpene indole alkaloids produced by
plants in the Apocynaceae, Rubiaceae and Loganiaceae families. Halogenation of natural
products often plays a profound role in establishing the bioactivity of a compound, and
can serve as a useful handle for further chemical derivatization' . We have described in
this chapter that, despite the metabolic and developmental complexity of plant tissue,
transformation of prokaryotic halogenase genes into C. roseus led to the regioselective
incorporation of halides into a range of alkaloid products. Remarkably, the yield of
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RebF/H hairy roots (25 days old) in solid Gamborg's B5
media
PyrH/RebF/STRvm hairy roots (25 days old) in solid
Gamborg's B5 media
wild type line (16 days old) in
solid Gambora's B5 media
Figure 3.20. Morphology of RebF/H, PyrH/RebF/STRvm and wild type hairy roots. The
halogen producing lines were thicker and slower growing than those of wild type lines.
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chlorinated alkaloids in the most productive line (RebF/H hairy roots cell line 5, ~26 Vg
per gram of fresh weight of plant tissue) is only 15-fold lower than the yield of total
natural alkaloids (compounds 19,20-dihydroakuammicine 5 + ajmalicine 6 + tabersonine
7 + catharanthine 8) from wild-type tissue (-420 gg per gram of fresh weight of plant
tissue) (Appendix B). Moreover, our yield compares favourably to the yields of
reconstitution of other alkaloid pathways in microbial systems '. We speculated that the
yields of halogenated alkaloids could be improved further by re-engineering tryptophan
decarboxylase to exhibit higher catalytic efficiency for chlorinated tryptophan substrates.
Alternatively, since chlorinated tryptophan may potentially interfere with auxin
biosynthesis, re-engineering RebH to preferentially chlorinate tryptamine instead of the
natural substrate tryptophan could further improve the yield of chlorinated alkaloids
while alleviating the slow growth of hairy roots. These engineering efforts are currently
being investigated in our lab (Glenn and O'Connor). In summary, the ease with which we
engineered the successful production of chlorinated alkaloids in C. roseus, a plant with
limited genetic characterization, indicates that medicinal plants can provide a viable
platform for synthetic biology.
3.4 Experimental Methods
3.4.1 Heterologous Expression and Purification of C. roseus Tryptophan
Decarboxylase
The tryptophan decarboxylase (TDC) gene (accession number M25151.1) was obtained
by reverse-transcription PCR amplification of mRNA isolated from C. roseus hairy root
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culture (Invitrogen, Dynabeads@ mRNA direct kit) with PCR primers that introduce sites
for NdeI and XhoI (underlined):
5' AAAAAACATATGGGCAGCATTGATTCAACA 3' and
5' AAAAAACTCGAGTCAAGCTTCTTTGAGCAAATC 3'. The PCR fragment was
subcloned into the pGEM-T Easy Vector (Promega), and then excised and ligated into the
NdeL/XhoL site of the pET28-a plasmid (Novagen). The resulting pET28a-TDC construct
was subsequently transformed into BL21 (DE3) pLysS electrocompetent E. coli
(Promega). A single E. coli colony harboring pET28a-TDC was inoculated in 5 mL LB
media supplemented with kanamycin (0.05 mg/L) and incubated overnight at 37 'C with
shaking at 225 rpm. An aliquot of the overnight culture (1 mL) was then used to inoculate
100 mL LB media supplemented with kanamycin (0.05 mg/L) and incubated at 37 'C
with shaking at 225 rpm until an OD6 of 0.6 was reached. Cells were induced for
overexpression by the addition of isopropyl -D-galactopyranoside (IPTG, final
concentration 1 mM) and the culture was allowed to continue growth for 16 hrs at 18 'C.
Cells were harvested by centrifugation and lysed by sonication. The hexa-histidine-
tagged TDC was purified using Ni-NTA Spin Kit (Qiagen) using manufacturer's
protocols. Eluted enzyme was subsequently buffer-exchanged into phosphate buffer (50
mM NaH 2PO4, 100 mM NaCl, pH 8.0) and immediately assayed for activity. This
enzyme was not stable upon extended storage.
3.4.2 Determining the Steady-State Kinetic Constants of TDC for Tryptophan
Substrate Analogs, 5- and 7-chlorotryptophan la and lb
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Steady-state kinetic constants of TDC for 5- and 7-chlorotryptophan lb and la (Amatek)
were determined in phosphate buffer (0.1 M NaH 2PO4, 3.5 mM p-mercaptoethanol, pH
8.5) containing 1 mM pyridoxal-5'-phosphate at 30 'C (0.3 mL reaction volume) with
TDC concentrations appropriate for obtaining the initial rate of the reaction (0.6 - 0.9
RM). Aliquots (25 gL) were quenched in 1 mL methanol, containing yohimbine (500
nM) as an internal standard, at appropriate time points. The samples were centrifuged
(13,000 rpm, 5 min) to remove particulates and then analyzed by LC-MS. Samples were
ionized by ESI with a Micromass LCT Premier TOF Mass Spectrometer. The LC was
performed on an Acquity Ultra Performance BEH C18, 1.7 rim, 2.1 x 100 mm column on
a gradient of 10-90% acetonitrile/water (0.1% formic acid) over 5 minutes at a flow rate
of 0.6 mL/min. The appearance of the corresponding tryptamine analogs (either 5-or 7-
chlorotryptamine) was monitored by peak integration and normalized to the internal
standard. 5-chlorotryptamine 2b was obtained from a commercial source (Alfa Aesar). 7-
chlorotryptamine 2a was synthesized as previously reported3 1 . Eight substrate
concentrations (200 - 2500 [tM) were tested for 7-chlorotryptophan la substrate, while
six substrate concentrations (200 - 1200 [tM) were tested for 5-chlorotryptophan lb
substrate. Each concentration was assayed three times and the averaged value is reported
with standard deviations. The data were fitted using non-linear regression to the
Michaelis-Menten equation using OriginPro 7 (OriginLab, Northhampton, MA). For
reference, the kinetic constants for the natural substrate tryptophan 1 were also measured
at concentrations ranging from 15 - 350 p M.
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3.4.3 Construction of Halogenase Plant Expression Vectors pCAMPyrH/RebF/
STRvm and pCAMRebH/RebF
Construction of the plant expression vectors was designed and partly executed by
Xudong Qu (Figure 3.21).
i. The CaMV35S:Gus:NosPolyA fragment was obtained by PCR amplification of
pCAMBIA1305.1 (Cambia) with PCR primers CaMV35S-Nos polyA for and rev that
introduce sites for XbaI and KpnI at the 5' end, and PstI and SpeI at the 3' end
(underlined):
5' ACTTCTAGAGGTACCGGATCCTCTAGAGTCGACCTGCAG 3' and
5'ATTCTGCAGACTAGTCCCGATCTAGTAACATAGATGACACCG 3'
ii. The tryptophan 5-halogenase gene (PyrH, accession number AAU95674) was obtained
by PCR amplification of genomic DNA isolated from Streptomyces rugosporus NRRL
21084 with PCR primers CrPyrH for and rev that introduce sites for XhoI and NcoI at the
5' end, and SpeI and BstEII at the 3' end (underlined):
5' ACTCTCGAGCCATGGATATCCGATCTGTGGTGATCG 3' and
5'ACTACTAGTGGTAACCTCATTGGATGCTGGCGAGGTA 3'
iii. The flavin reductase gene (RebF, accession number BAC15756) was obtained by
PCR amplification of genomic DNA isolated from Lechevalieria aerocolonigenese
ATCC 39243 with PCR primers CrRebF for and rev that introduce sites for XhoI and
NcoI at the 5' end, and SpeL and PmlI at the 3' end (underlined):
5' ACTCTCGAGCCATGGATACGATCGAGTTCGACAGAC 3' and
5'ACTACTAGTCACGTGTCATCCCTCCGGTGTCCACAC3'
iv. The tryptophan 7-halogenase gene (RebH, accession number BAC15758) was
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obtained by PCR amplification of genomic DNA isolated from Lechevalieria
aerocolonigenese ATCC 39243 with PCR primers CrRebH for and rev that introduce
sites for Spel and NcoI at the 5' end, and SpeL and PmlI at the 3' end (underlined):
5' AAGACTACTAGTCCATGGATTCCGGCAAGATTGAC 3' and
5'ACTACTAGTCACGTGTCAGCGGCCGTGCTGTTGCC 3'
CaMV35S:Gus:NosPolyA, PyrH, RebH and RebF PCR fragments were individually
ligated into pGEM-Teasy vector (Promega) to yield pGEMCaMV35S, pGEMPyrH,
pGEMRebH and pGEMRebF, respectively.
v. Codon-optimization for Catharanthus roseus was performed to ensure efficient
expression of the prokaryotic halogenase and flavin reductase genes in plant cell culture.
Using codon usage database software (http://www.kazusa.or.jp/codon/), the following
codons were identified as occurring at low frequency (triplet, frequency per thousand):
GCG, 4.8; CGG, 3.3; ACG, 4.0; TCG, 6.1; CCG, 6.0; and CCC, 6.7. Site-directed
mutagenesis was performed using Stratagene QuikChange Site-Directed Mutagenesis kit
to replace rare-codons with the most frequently occurring codons encoding the
corresponding amino acids. Only codons that appeared within the first 300 nucleotides of
the genes were subjected to mutagenesis.
The site-directed-mutagenesis primers are summarized below (the sites of mutation are
underlined).
Primer Name Primer Sequence ('5 -> 3')
PyrH-SDM- GTGGGTGGTGGCACTGCTGGCTGGATGACC
forl
PyrH-SDM- GGTCATCCAGCCAGCAGTGCCACCACCCAC
rev 1
PyrH-SDM- GACATGCGGCCGTACACTACTGCTACCGCGATGAGCGCCGGC
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for2
PyrH-SDM- GCCGGCGCTCATCGCGGTAGCAGTAGTGTACGGCCGCATGTC
rev2
RebH-SDM- CCCCAATCTGCAGACTGCTTTCTTCGACTTCCTCGGA
for
RebH-SDM- TCCGAGGAAGTCGAAGAAAGCAGTCTGCAGATTGGGG
rev
RebF-SDM- ACCGCGGCCGATCACAGGGCTCTGATGAGCCTGTTTCCC
forI
RebF-SDM- GGGAAACAGGCTCATCAGAGCCCTGTGATCGGCCGCGGT
rev1
RebF-SDM- CTCGTCTGCCTGAACAGGGCTAGCGGAACGTTGCAC
for2
RebF-SDM- GTGCAACGTTCCGCTAGCCCTGTTCAGGCAGACGAG
rev2
vi. pGEMCaMV35S was digested and ligated into the KpnI/EcoRI sites of pSP72 vector
(Promega) to yield pSPCaMV35S.
vii. pGEMRebH and pGEMRebF were digested and ligated into the NcoL/PmlI sites of
pSPCaMV35S to yield pSPRebH and pSPRebF, respectively. Similarly, pGEMPyrH was
digested and ligated into the NcoI/BstEII sites of pSPCaMV35S to yield pSPPyrH.
pSPRebF was then digested and ligated into the Pstl site of pSP72 to yield pSPRebF_2.
viii. pSPRebH and pSPPyrH were digested and ligated into the XbaI/EcoRI sites of
pSPRebF_2 to yield pSPRebHRebF and pSPPyrHRebF, respectively. Finally, both
pSPRebHRebF and pSPPyrHRebF were digested and ligated into the SpeI site of
pCAMBIA1300A to yield pCAMRebHRebF and pCAMPyrHRebF. pCAMBIA1300A
was constructed by introducing an Spel restriction into pCAMBIA 1300 (Cambia). The
site-directed-mutagenesis primers are (SpeI site underlined):
5'CCCGCCTTCAGTTTAAACTAGTCAGTGTTTGACAGGAT 3'
5'ATCCTGTCAAACACTGACTAGTTTAAACTGAAGGCGGG 3'
pCAMSTRvm was constructed as previously described 2 .
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Primers: CaMV35S-Nos polyA for/rev
Template: pCAMBIA 1305.1
PCR product cloned into pGEM-T easy
EcoRebaI,lIMpamH,XbalSal,Psti,SphHindiI SpeI,PIECFU,
cAM35 Gus Nos oyA
pGEMCaMV35S
Kpnl/EcoRI fragment cloned into
Kpnl/EcoRl sites of pSP72 I
EcoRI,Xbal,KpnI,BamHI,)bal,Sall,Pst,Sph,HindilI SpeI,Psti,EcoRICIaI,EcoRV,SgIII
cAM3 Gus PloyA
MeOI prkmn,Bt H
pSPCaMV35S
pGEMRebH. pGEMRebF Ncol/Pmll
fragment cloned into Ncol/PmlI sites
of pSPCaMV35S
pGEMPyrH Ncol/BstEll fragment
cloned into Ncol/BstEll sites of
pSPCaMV35S
Primers: CrRebH for/rev, CrRebF for/rev,
CrPyrH for/rev
Templates: Lechevalieria aerocolonigenese
ATCC 39243 gDNA (for RebH and RebF)
and Streptomyces rugosporus NRRL 21084
gDNA (for PyrH)
PCR product cloned into pGEM-T easy
p
pGEMRebH
pGEMRebF
pGEMPyrH
Kaal BarrH,Mbal.Sall,Psti.SohiHindIl -- st-.E coRIClal.EcoRV.B
35 RebIH P I A
Ncal PmI,
pSPRebH
< / Vn inuIt~ %~ Val 01 iDeno" 0a. Li-nA iII ssa o-nti rC anj""iA r-mE i atn -k,
pSPRebF
Koni.BarrHlXbal.Sall,PstISphIHindI SDeIPsI,EcoRI,CIaI,EcoRVBgIIi
C 58 PyrH'N~s PloyA
pSPPyrH
Bglll.Ec oRV.CIiEcoRl.SacI,kpn,
SmelBamHI~bal,Atci,GaI IJl'
pSPRebF Pstl fragment cloned into
Pstl site of pSP72
M35 PRebF2 PloYA
pSPRebF_2
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SpelplasphiHindillPvull,.Xh 01
[1 pCAMF
pSPPyrHRebF Spel fragment
Cloned into
pSPRebH, pSPPyrH Spel site of
Xbal/EcoRl fragment pCAMBIA1 300A
cloned into Xbal/EcoRI
sites of pSPRebF_2 Xbai,ArcI,SaII,P,SphI,HindII Spd,Pad.spniljindil
pSPRebHRebF Sl- m pCAMF
_________________________ Spel fragment
Cloned into
Spel site of
pCAMBIA1300A
Figure 3.21. Construction of pCAMPyrHRebF and pCAMRebHRebF plasmids.
yrHRebF
RebHRebF
3.4.4 Generation of Transgenic C. roseus Hairy Root Cultures
The plant expression construct pCAMRebHRebF was transformed into Agrobacterium
rhizogenes ATCC 15834 via electroporation (1mm cuvette, 1.25 kV). pCAMPyrHRebF
and pCAMSTRvm were co-transformed into Agrobacterium rhizogenes ATCC 15834 via
electroporation (1mm cuvette, 1.25 kV). Transformation of C. roseus seedlings with the
generated Agrobacterium strains was performed as previously reported2 1 . Briefly, 180 -
250 C. roseus seedlings (Vinca Little Bright Eyes, Nature Hills Nursery) were
germinated aseptically on Gamborg's B5 media (full strength basal salts, full strength
vitamins, 30 g/L sucrose, pH 5.7) and grown in a 16-hour light 8-hour dark cycle at 26 *C
for three weeks. Seedlings were then wounded with extra-fine forceps at the stem tip, and
3-5 y L of A. rhizogenes from a freshly grown liquid culture were inoculated on the
wound.
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Hairy roots appeared at the wound site 2-3 weeks after infection for about 80% of the
seedlings infected. After hairy roots reached 1-4 cm in length (usually about six weeks
after infection), they were excised and transferred to Gamborg's B5 solid media (half
strength basal salts, full strength vitamins, 30 g/L sucrose, 6 g/L agar, pH 5.7) containing
hygromycin (0.03 mg/mL) for selection and the antibiotic cefotaxime (0.25 mg/mL) to
remove remaining bacteria. The total chloride concentration in Gamborg's B5
formulation is 1 mM. All cultures were grown in the dark at 26*C. After the hygromycin
selection process, hairy roots were maintained in solid media lacking both hygromycin
and cefotaxime.
To adapt the line to liquid culture, approximately 200 mg of hairy roots (typically five 3-
4 cm long stem tips) from each line that grew successfully on solid media were
transferred to 50 mL of half-strength Gamborg's B5 liquid media. The cultures were
grown at 26*C in the dark at 125 rpm. Hairy root growth in liquid media appeared to be
slower than that in solid media. Hairy root transformants were screened for survival in
solid media supplemented with hygromycin (Table 3.4). The number of transformants
decreased significantly after solid media selection for each of the constructs transformed.
Every line'that grew in the selection media was analyzed for alkaloid production.
Table 3.4. Hairy root selection and adaptation processes.
Plasmid # transformed hairy roots # hairy roots after solid
media selection
pCAMRebH/RebF 200 31
pCAMPyrH/RebF/STRvm 140 57
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3.4.5 Verification of Transferred DNA (T-DNA) Integration by Genomic DNA
Analysis
To verify the integration of transferred DNA (T-DNA) into the plant genome, the
genomic DNA from transformed hairy roots was isolated (Qiagen DNeasy kit) and then
subjected to PCR amplification using T-DNA specific primers with TDC primers serving
as a positive control (see below). Specifically, for the pCAMRebHRebF hairy roots,
primers for PCR amplification were designed to amplify the complete TDC gene
(TDC for and TDC-rev), a 660 bp region of the RebH gene (RebH for and RebH rev),
a 680 bp region of the RebF gene (RebFfor and RebFjrev) and an 800 bp region of the
selection marker HPT gene (HPTfor and HPT_rev) (see below).
PCR primers for verification of T-DNA integration of transformed hairy roots.
Primer Name Primer Sequence ('5 -> 3')
1 TDC for AAAAAACATATGGGCAGCATTGATTCAACA
2 TDC rev AAAAAACTCGAGTCAAGCTTCTTTGAGCAAATC
3 RebH for GTCTTCGATGCCGACCTCTTC
4 RebH rev GTACATGTCGATCTTCTCCTGC
5 RebF for TAGAGGACCTAACAGAAC
6 RebF rev CGTGACACTGGTCAGGGA
7 HPT for GCCTGAACTCACCGCGACGTC
8 HPT rev CCTCCAGAAGAAGATGTTGGC
PCR amplification of genomic DNA from all of the selected transformed lines
(pCAMRebH/RebF cell line 4: lanes 1-4, pCAMRebH/RebF cell line 5: lanes 5-8,
pCAMRebH/RebF cell line 6: lanes 9-12, pCAMRebH/RebF cell line 10: lanes 13-16,
and pCAMRebH/RebF cell line 11: lanes 17-20) was successful for all four sets of
primers (Figure 3.5). PCR-amplification of hairy root transformed with A. rhizogenes
lacking the pCAMBIA vector (provided by Professor Jacqueline Shanks (Iowa State) and
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Professor Carolyn Lee-Parsons (Northeastern)) genomic DNA was successful only when
TDC specific primers were used (lanes 21-24). These results indicated that RebH and
RebF were successfully incorporated into the C. roseus genome in all chosen lines.
For the pCAMPyrH/RebF/STRvm hairy roots, primers for PCR amplification were
designed to amplify the complete TDC gene (TDCfor and TDCrev), the complete
PyrH gene (PyrH-for and PyrH-rev), a 680 bp region of the RebF gene (RebFfor and
RebF rev), a 440 bp region of the STRvm gene, and an 800bp region of the selection
marker HPT gene (HPTfor and HPT_rev) (see below) (Figure 3.6).
PCR primers for verification of T-DNA integration of transformed hairy roots.
Primer Name Primer Sequence ('5 -+ 3')
1 TDC for AAAAAACATATGGGCAGCATTGATTCAACA
2 TDC rev AAAAAACTCGAGTCAAGCTTCTTTGAGCAAATC
3 PyrH for ATGATCCGATCTGTGGTG
4 PyrH rev TCATTGGATGCTGGCGAG
5 RebF for TAGAGGACCTAACAGAAC
6 RebF rev CGTGACACTGGTCAGGGA
7 STRvm for CCTTATTATTGAAAGAGCTACATATG
8 STRvm rev GCTAGAAACATAAGAATTTCCCTTG
9 HPT for GCCTGAACTCACCGCGACGTC
10 HPT rev CCTCCAGAAGAAGATGTTGGC
PCR amplification of genomic DNA from three out of four of the selected transformed
lines (pCAMPyrH/RebF/STRvm cell line 1: lanes 1-5, pCAMPyrH/RebF/STRvm cell
line 3: lanes 6-10, pCAMPyrH/RebF/STRvm cell line 6: lanes 11-15) was successful for
all five sets of primers (Figure 3.6). PCR amplification of genomic DNA from
pCAMPyrH/RebF/STRvm cell line 7 (lanes 16-20) was successful when TDC, PyrH,
RebF, HPT primers were used but not when STRvm primers were used. PCR-
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amplification of hairy root transformed with A. rhizogenes lacking the pCAMBIA vector
genomic DNA was successful only when TDC specific primers were used (lanes 21-25).
3.4.6 Evaluation of Alkaloid Production in Transgenic C. roseus Hairy Roots
Every transgenic hairy root line that survived hygromycin selection media was evaluated
for alkaloid production. Transformed hairy roots were grown in Gamborg's B5 solid
media (half strength basal salts, full strength vitamins, 30 g/L sucrose, 6 g/L agar, pH
5.7). The total chloride concentration in Gamborg's B5 formulation is ~1mM. Three-
week-old hairy roots were ground with a mortar, pestle and 106 pm acid washed glass
beads in methanol (10 mL/g of fresh weight hairy roots). The crude natural product
mixtures were filtered through 0.2 tm cellulose acetate membrane (VWR) and
subsequently subjected to LC-MS analysis. Additionally, hairy roots transformed with
wild-type A. rhizogenes lacking the plasmid were also evaluated.
These crude alkaloid mixtures were diluted 30/830 with methanol for mass spectral
analysis. Samples were ionized by ESI with a Micromass LCT Premier TOF Mass
Spectrometer. The LC was performed on an Acquity Ultra Performance BEH C18, 1.7
[tm, 2.1 x 100 mm column on a gradient of 10-90% acetonitrile/water (0.1% TFA) over 5
minutes at a flow rate of 0.6 mL/min. The capillary and sample cone voltages were 1300
and 60 V, respectively. The desolvation and source temperature were 300 and 100 *C.
The cone and desolvation gas flow rates were 60 and 800 L/hour. Analysis was
performed with MassLynx 4.1. Accurate mass measurements were obtained in W-mode.
The spectra were processed using the Mass Lynx 4.1 mass measure, in which the mass
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spectrum of peaks of interest was smoothed and centered with TOF mass correction,
locking on the reference infusion of reserpine.
3.4.7 Feeding 7-chlorotryptamine 2a to Control C. roseus Hairy Root Cultures
Transformed with No Plasmid
Alkaloid accumulation levels in hairy roots transformed with RebH and RebF were
compared to alkaloid accumulation levels in control hairy root fed with 7-
chlorotryptamine. The control hairy root line was grown for two weeks in half-strength
Gamborg's B5 solid media. Hairy roots were then transferred to the same media
supplemented with 7-chlorotryptamine 2a (0, 25, 50, 100, 200 and 750 p M final
concentration) and grown further for one week. Hairy roots were then processed and
alkaloid production analyzed as described above in section 3.4.6. Feeding studies were
performed in duplicate.
3.4.8 Brominated Alkaloid Production in Transgenic C. roseus Hairy Roots
A selected transformed hairy root line was grown for two weeks in low chloride solid
media (67 mg/L (NH 4)2SO4, 353 mg/L Ca(N0 3)2.4H20, 61 mg/L MgSO 4, 1250 mg/L
KNO3, half strength Murashige and Skoog's micronutrient salts and full strength
Murashige and Skoog's vitamins, 3 1 M total chloride concentration). Hairy roots were
transferred to the same media supplemented with either potassium bromide or potassium
iodide (10 - 20 mM final concentration) and cultivated for an additional two weeks.
Hairy roots were then processed and alkaloid production analyzed as described above in
161
section 3.4.6. Hairy roots transformed with wild-type A. rhizogenes lacking the plasmid
were also evaluated. Experiments were performed in duplicate.
3.4.9 Purification and Isolation of Alkaloids from Transformed TDC Suppressed
Hairy Roots Supplemented with 7-chlorotryptamine and 7-bromotryptamine
To obtain chlorinated and brominated alkaloid standards, root tips (10-15) from TDC-
suppressed hairy roots32 were subcultured in six 50 mL Gamborg's B5 liquid media (half
strength basal salts, full strength vitamins, 30 g/L sucrose, pH 5.7) and grown at 26*C in
the dark at 125 rpm for three weeks prior to supplementing the media with either 7-
chlorotryptamine 2a or 7-bromotryptamine 2c (750 [tM final concentration). Both
tryptamine analog substrates were synthesized as previously reported 3 1 . After two weeks
of co-cultivation, hairy roots were extracted as described above in methanol (10 mL/g of
fresh weight hairy roots). Alkaloid extracts were filtered, concentrated under vacuum and
redissolved in 25% acetonitrile/water (0.1% TFA) (1 mL/g of fresh weight hairy roots).
For cultures supplemented with 7-chlorotryptamine 2a, the redissolved mixture was
purified on a 10 x 20 mm Vydec reverse phase column using a gradient of 25 - 52 %
acetonitrile/water (0.1% TFA) over 24 minutes. Alkaloids were monitored at 228 nm and
fractions containing the alkaloid analogs of interest, as determined by the characteristic
isotopic distribution expected for chlorinated molecules (35Cl/ 37Cl) from LC-MS analysis,
were combined and concentrated under vacuum (Figure 3.22).
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For cultures supplemented with 7-bromotryptamine 2c, similar procedures were
performed to isolate alkaloids from transgenic hairy roots, except that the LC method was
extended to 26 minutes. Alkaloids were monitored at 228 nm and fractions containing the
alkaloid analogs of interest, as determined by LC-MS analysis, were combined and
concentrated under vacuum (Figure 3.23).
Isolated alkaloids from both feedings were analyzed by LC-MS (same parameters as
above), analytical HPLC, and where possible, high resolution LC-MS, UV-vis
spectroscopy, tandem MS/MS and 'H NMR, 13C NMR, and 'H-13 C HSQC using a Bruker
AVANCE-600 NMR spectrometer equipped with a 5mm 1H{ 13C,3 1P} cryo-probe
(Appendix B). Halogenated alkaloids generally displayed longer retention times than the
natural alkaloids.
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HPLC trace of alkaloids from TDCi culture
+ 7-chlorotryptamine (750 uM)
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Figure 3.22. HPLC trace of alkaloids from TDCi hairy root fed with 7-chlorotryptamine
2a (0.75 mM). Fraction A was collected and analyzed.
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Figure 3.23. HPLC traces of alkaloids from TDCi hairy root fed with 7-bromotryptamine
2c (0.75 mM). Fraction B was collected and analyzed.
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Tabulated NMR data for 12-chloro-19,20-dihydroakuammicine 5a (Fraction A in Figure
3.22).
'H NMR (600 MHz, CD30D): 8 7.39 (d, J = 7.4 Hz, 1H), 7.26 (d, J = 8.2 Hz, 1H), 6.99
(t, J= 7.9 Hz, 1H), 4.66 (s, 1H), 3.82 (s, 3H), 3.70 (m, 1H), 3.56 (m, IH), 3.40 (m, 1H),
3.30 (m, 1H), 3.16 (m, 1H), 3.05 (m, 1H), 2.18 (m, 1H), 2.12 (m, 1H), 2.04 (m, 2H), 0.95
(m, 2H), 0.78 (t, J = 7.3 Hz, 3H); 13C NMR (500 MHz, CD3OD): 8 128.80, 122.90,
118.80, 65.00, 52.10, 51.81, 51.06, 45.22, 40.04, 39.60, 29.60, 25.80, 22.30, 9.60 (note
that quaternary carbon peaks are not observed in 'H- 3 C HSQC); ESI-MS (m/z): [M]*
calcd. for C20H23ClN 20 2, 359.1526; found, 359.1520.
N
- H
N CO2MeBr H 5c
Tabulated NMR data for 12-bromo-19,20-dihydroakuammicine 5c (Fraction B in Figure
3.23)
'H NMR (600 MHz, CD 30D): 8 7.42 (d, J = 7.4 Hz, 1H), 7.39 (d, J = 7.8 Hz, 1H), 6.92
(t, J = 8.0 Hz, 1H), 4.66 (s, 1H), 3.82 (s, 3H), 3.70 (m, 1H), 3.57 (dt, J = 4.0, 13.5 Hz,
1H), 3.40 (m, 1H), 3.30 (m, 1H), 3.17 (m, 1H), 3.05 (m, 1H), 2.18 (dd, J = 7.7, 14.5 Hz,
1H), 2.12 (m, 1H), 2.04 (m, 2H), 0.95 (m, 2H), 0.78 (t, J = 7.3 Hz, 3H); 13 C NMR (500
MHz, CD 3OD): 8 168.84,166.37,143.79, 136.19, 132.55, 124.44, 120.52, 104.47,99.21,
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66.33,54.17, 53.10, 52.24, 46.65,41.41,40.76, 30.46,27.03,24.01, 11.27; ESI-MS
(m/z): [M]* caled. for C20H23BrN2O2, 403.1021; found, 403.1011.
3.4.10 Ouantification of Chlorinated Alkaloid Production in Transformed Hairy
Roots
12-chloro- 19,20-dihydroakuammicine 5a and 12-bromo- 1 9,20-dihydroakuammicine 5c
standard curves were constructed by quantifying the peak areas of several concentrations
(20 - 1400 nM) of each alkaloid authentic standard using MassLynx 4.1. Similarly, 10-
chloroajmalicine 6b, 15-chlorotabersonine 7b and 10-chlorocatharanthine 8b standard
curves were constructed by quantifying the peak areas of several concentrations (20 -
1400 nM) of each natural (i.e. non-chlorinated) alkaloid authentic standard using
MassLynx 4.1.
3.4.11 Dependence of Chlorinated Alkaloid Production on Concentrations of
Sodium Chloride
A selected transformed hairy root line was grown for two weeks in low chloride solid
media (67 mg/L (NH 4)2SO4, 353 mg/L Ca(N0 3)2.4H20, 61 mg/L MgSO4, 1250 mg/L
KNO 3, half strength Murashige and Skoog's micronutrient salts and full strength
Murashige and Skoog's vitamins, 3 [tM total chloride concentration). Hairy roots were
transferred to the same media supplemented with potassium chloride (0 - 20 mM final
concentration) and grown further for two weeks. Hairy roots were then processed and
alkaloid production was analyzed as previously described.
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3.4.12 Assessment of the Stability of Chlorinated Alkaloid Production in Subsequent
Subcultures
Ten root tips from hairy roots transformed with pCAMRebH/RebF and
pCAMPyrH/RebF/STRvm were subcultured every 3 weeks in Gamborg's B5 solid media
(half strength basal salts, full strength vitamins, 30 g/L sucrose, 6 g/L agar, pH 5.7) and
grown at 26*C in the dark. Alkaloids were isolated from twenty-one-day-old hairy roots
and analyzed as described above.
3.4.13 Verification of Expression of RebH, RebF and PyrH, STRvm Enzymes by
Real Time RT-PCR
Real time RT-PCR was used to assess the expression levels of RebH and RebF.
Expression levels in hairy roots infected with A. rhizogenes lacking the
pCAMRebH/RebF construct were compared to expression levels in hairy roots harboring
pCAMRebH/RebF. mRNA from transformed hairy roots was isolated and purified from
contaminant DNA using Qiagen RNeasy Plant Mini Kit and Rnase-free Dnasel,
respectively. The resulting mRNA was then reverse-transcribed to cDNA using Qiagen
QuantiTect Reverse transcription kit and then subjected to PCR with specific primers (see
below), Qiagen SYBR Green PCR kit and a Biorad DNA Engine Opticon 2 system. The
threshold-cycle (CT) was determined as the cycle with a signal higher than that of the
background plus 10 x standard deviation (SD). C. roseus 40S ribosomal protein S9
(Rps9), a house keeping gene, was used to adjust the amount of the total mRNA in all
samples. Real time RT-PCR was performed in triplicate and the data are pictured as the
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relative expression levels of RebH and RebF mRNA in transgenic hairy roots as well as
hairy roots lacking the pCAMBIA plasmid.
PCR primers for real-time RT-PCR of pCAMRebH/RebF transformed hairy roots.
Primers were designed using GenScript web tool (http://www.genscript.com/ssl-
bin/app/primer)
Primer Name Primer Sequence ('5 -- 3') Amplicon size
RebH for GACGGGCATCTACTTCGTCT 117
RebH rev TCGAACATCGTCTCGATCTC
RebF for CTGATGAGCCTGTTTCCCA 99
RebF rev CGTGACACTGGTCAGGGA
Rbps9_for TTGAGCCGTATCAGAAATGC 122
Rbps9_rev CCCTCATCAAGCAGACCATA
Real time RT-PCR was used to assess the expression levels of PyrH, RebF, and STRvm.
Expression levels in hairy roots infected with A. rhizogenes lacking the
pCAMPyrH/RebF/STRvm construct were compared to expression levels in hairy roots
harboring pCAMPyrH/RebF/STRvm.
PCR primers for real-time RT-PCR of pCAMPyrH/RebF/STRvm transformed hairy
roots. Primers were designed using GenScript web tool (http://www.genscript.com/ssl-
bin/app/primer)
Primer Name Primer Sequence ('5 + 3') Amplicon size
PyrH for GCCTGCTCATCAACCAGAC 137
PyrHrev CATCGCGGTAGCAGTAGTGT
RebF for CTGATGAGCCTGTTTCCCA 99
RebF rev CGTGACACTGGTCAGGGA
STRvm for TATTATTGAAAGAGCTACATATG 134
STRvm rev CTCTGCACTGCCTTTCTTG
Rbps9_for TTGAGCCGTATCAGAAATGC 122
Rbps9_rev CCCTCATCAAGCAGACCATA
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3.4.14 Ouantification of Natural Alkaloids in Wild Type Roots
The levels of natural alkaloids in wild type hairy roots were quantified as described in
section 3.4.10. The levels of the three most abundant alkaloids found in these hairy roots,
ajmalicine 6, tabersonine 7, catharanthine 8, as well as tryptophan 1 and tryptamine 2,
were measured (Appendix B).
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CHAPTER 4
SILENCING TRYPTAMINE BIOSYNTHESIS IN C. ROSEUS CELL CULTURE
Part of this chapter is published as an article in
PNAS 2009, 106, 13673-13678
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4.1 Introduction
Functional group modification of a natural product often improves the biological activity
of the compound'. However, despite the importance of plant derived natural products,
metabolic engineering strategies to yield unnatural products from complex plant
biosynthetic pathways have not been widely explored. In microbial systems, genetic
engineering of natural product biosynthetic pathways has emerged as a powerful strategy
to rapidly access complex novel molecules 2. In one strategy, termed precursor-directed
biosynthesis, the producer organism is supplemented with analogs of the naturally
occurring starting materials where, ideally, these unnatural starting materials are
converted by the enzymes of the biosynthetic pathway into the corresponding unnatural
products3 .The yields and purity of these unnatural products are typically improved if the
biosynthesis of the natural starting material is genetically silenced, and the producing
organism is forced to utilize exogenously supplied substrates for product biosynthesis.
This approach, termed mutasynthesis, was first applied several decades ago to yield novel
antibiotics in the soil bacterium Streptomycesfradiae4 . While mutasynthesis has proven
to be highly successful in microbial systems 5'6, the strategy has yet to be applied in more
complex eukaryotes, notably plants.
Tryptamine 1 is the starting substrate for over one hundred monoterpene indole alkaloids
produced by C. roseus (Figure 4.1 and Chapter 1)7'8. This substrate is derived from
decarboxylation of tryptophan 2 by tryptophan decarboxylase, an enzyme that serves as a
key link between primary metabolism and natural product metabolism 9' ". We envisioned
that if tryptamine biosynthesis was silenced, alkaloid biosynthesis could be rescued by
174
N +N H ~ N\N H.K 4CO2H strictosidine N H 0 ( N 0
NH2 tryptophan NH2  synthase H H Me Cdeabxls NH / 0e, MeO2NCdecarboxylase |\ CHO N H ajmalicine 3 serpentine 4
S N ' N ,0-GIc H
H H N,
tryptophan 2 tryptamine 1 O MeO 2C N NHMeO 2C / \
secologanin 7 strictosidine 8 N
H CO2Me QN H CO2Me
catharanthine 5 tabersonine 6
Figure 4.1 Monoterpene indole alkaloid biosynthesis in C. roseus. Tryptophan 2 is
decarboxylated by tryptophan decarboxylase to yield tryptamine 1, which reacts with
secologanin 7 to form strictosidine 8. After numerous rearrangements, strictosidine 8 is
converted into over one hundred monoterpene indole alkaloids, such as ajmalicine 3,
serpentine 4, catharanthine 5 and tabersonine 6.
introducing exogenous tryptamine or tryptamine analogs to plant cell culture (Figure
4.2). Precursor-directed biosynthesis with wild type C. roseus plants and tissue culture
has already demonstrated that tryptamine analogs can be taken up by the plant and
incorporated into a wide variety of alkaloids1 -1 . However, if tryptamine 1 is required for
plant growth or survival, silenced cell lines would not be viable. Studies of down-
regulating or suppressing tryptamine biosynthesis in plants have not been reported, and
little information is available in the literature to provide a definitive role for tryptamine, a
metabolite that is found throughout the plant kingdom 4 . Overproduction of tryptamine
has been shown to deter insect feeding'5 , but this role is non-essential in the controlled
environment of plant cell culture. Additionally, 5-hydroxytryptamine (serotonin), which
may be produced by hydroxylation of tryptamine, has been implicated in certain
physiological roles such as flower development 6 . Moreover, tryptamine, or its precursor
tryptophan, may also be involved in auxin biosynthesis". Again, these proposed roles are
unlikely to be essential to plant tissue culture.
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Figure 4.2. Silencing of tryptamine biosynthesis in C. roseus. Tryptamine 1 is produced
by enzymatic decarboxylation of tryptophan 2. Trypamine 1 reacts with secologanin 7 to
yield a variety of monoterpene indole alkaloids. Ajmalicine 3, serpentine 4, catharanthine
5 and tabersonine 6 are produced in Catharanthus roseus hairy root culture.
Despite the uncertainty pertaining to the physiological role of tryptamine in plants,
suppression of tryptophan decarboxylase nevertheless provided an attractive entry point
for introduction of new substrate analogs. In prokaryotic pathways, the gene of interest is
usually deleted or "knocked out" using homologous recombination-based strategies.
However, although some success has been achieved with homologous recombination in
higher plants'", strategies to down-regulate or knockdown specific gene expression levels
using RNA-mediated silencing are extremely well established for plants. Moreover, these
transgenic lines can be constructed in a relatively short time (- 6-9 months) 9 2 1
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This chapter describes mutasynthesis of the monoterpene indole alkaloids in the
medicinal plant Madagascar periwinkle (Catharanthus roseus). Specifically, we used
RNA-mediated silencing of tryptophan decarboxylase to suppress tryptamine
biosynthesis in C. roseus culture. We show that alkaloid production almost completely
disappeared in silenced cultures but could be rescued by the addition of exogenous
tryptamine to the culture media. A representative unnatural tryptamine analog, 5-
fluorotryptamine la, was also incorporated into the pathway to yield several unnatural,
fluorinated alkaloids. Silencing of this early biosynthetic enzyme did not impact the
expression of known downstream alkaloid biosynthetic enzymes, indicating that changes
can be made in the early part of this pathway without adversely affecting the alkaloid
biosynthetic machinery. Notably, regenerated C. roseus plants from these transformed
hairy roots exhibited severe growth retardation and were not viable. Together, these
experiments demonstrate that while tryptamine and monoterpene indole alkaloids do not
appear to play an essential role in growth or development in C. roseus hairy root culture,
they may be vital for whole plant survival in a non-controlled environment.
4.2 Results and Discussion
4.2.1 Generation and Verification of Transgenic Hairy Root Cultures
Tryptophan decarboxylase, a pyridoxal phosphate dependent enzyme that produces
tryptamine 1 from tryptophan 2 10, was targeted for gene silencing1',22-24 (Figure 4.2).
The plasmid designed to suppress tryptophan decarboxylase (pTDCi, created by Justin
Maresh based on pHELLSGATE vector"; Figure 4.3) was transformed into
Agrobacterium rhizogenes, which was then used to infect C. roseus seedlings to generate
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hairy root culture as previously described25 ,26 . PCR analysis of genomic DNA confirmed
the incorporation of the tryptophan decarboxylase-silencing construct in two selected
transgenic lines (Figure 4.4). Specifically, PCR amplification of genomic DNA from
TDCi cell lines 3 and 15 was successful for all four sets of primers (strictosidine synthase
(STR), Cauliflower Mosaic Virus 35S promoter (CaMV35S), kanamycin resistance gene
(NPTII) and pyruvate dehydrogenase kinase (PDK) intron). PCR amplification of
genomic DNA from hairy root transformed with A. rhizogenes lacking the pTDCi
plasmid (designated "wild type line" and was provided by Professor Jacqueline Shanks
(Iowa State) and Professor Carolyn Lee-Parsons (Northeastern)) was successful only
when STR specific primers were used (lanes 1-4). These results indicated that the TDC
silencing construct was successfully incorporated into the C. roseus genome in both
chosen lines.
T-DNA CaMV 408 bp PDK qd 80 Terminator Nos NPTll Terminator T-DNA
Border (R) 35S TDC intron OOT promoter Border (L)
pTDCi
Figure 4.3. Schematic diagram of tryptophan decarboxylase silencing construct.
CaMV35S: Cauliflower Mosaic Virus 35S promoter; 408bp TDC: a 408 bp fragment at
the 5' end of tryptophan decarboxylase; PDK intron: the intron region of pyruvate
dehydrogenase kinase; NPTII: kanamycin resistance gene.
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Figure 4.4. 1% agarose gel of PCR amplification of TDCi and wild-type hairy root
genomic DNA.
Lane: template, primers.
1: wild type; STR. 7: TDCi cell line 3; NPTII.
2: wild type; CaMV35S. 8: TDCi cell line 3; PDK intron.
3: wild type; NPTII. 9: TDCi cell line 15; STR.
4: wild type; PDK intron. 10: TDCi cell line 15; CaMV35S.
5: TDCi cell line 3; STR. 11: TDCi cell line 15; NPTII.
6: TDCi cell line 3; CaMV35S. 12: TDCi cell line 15; PDK intron
4.2.2 Alkaloid Production in Tryptophan Decarboxylase Silenced Lines
Hairy root lines harboring the pTDCi silencing plasmid were cultured in liquid media,
and alkaloids were extracted from the plant tissue according to standard protocols.
Production of all major tryptamine derived alkaloids ajmalicine 3, serpentine 4,
catharanthine 5 and tabersonine 6 was significantly decreased in the five silenced lines
that were examined (Figure 4.5 A-D). We observed negligible changes in alkaloid
production levels after at least seven subcultures suggesting that suppression of alkaloid
production is stable (Figure 4.6).
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Figure 4.5 A (top) and B (bottom). Extracted LC-MS chromatograms showing the
absence of A. ajmalicine and B. serpentine. Wild type lines are shown for comparison.
LC-MS spectra are normalized to the same y-axis scale.
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Figure 4.5 C (Top) and D (bottom). Extracted LC-MS chromatograms showing the
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4.2.3 Gene Expression in Tryptophan Decarboxylase Silenced Lines
We quantified the levels of tryptophan decarboxylase mRNA in silenced lines. Real time
reverse transcription PCR (RT-PCR) confirmed that the tryptophan decarboxylase gene
was significantly down regulated at the mRNA level in two representative lines harboring
the pTDCi silencing plasmid (Figure 4.7). Tryptophan decarboxylase is regulated by the
transcription factor Orca32 7 , which also controls a number of other alkaloid biosynthetic
genes including strictosidine synthase (STR)28 and strictosidine glucosidase (SGD)29,
enzymes that act immediately after tryptophan decarboxylase in the alkaloid biosynthetic
pathway. To ensure that silencing of tryptophan decarboxylase did not affect the
expression levels of these other genes in the alkaloid biosynthetic pathway, we quantified
the expression levels of Orca3, STR and SGD. Gratifyingly, the mRNA levels of all three
genes did not appear to be affected, indicating that the tryptophan decarboxylase gene
could be silenced without perturbing the downstream pathway (Figure 4.7). In contrast,
Allen and coworkers showed that down-regulation of a late stage morphine biosynthetic
gene had an unpredictable effect on morphine biosynthesis, suggesting that suppression
of a single metabolic enzyme can sometimes affect expression of other pathway
enzymes3 0. Finally, the gene encoding the alpha subunit of anthranilate synthase , an
enzyme involved in tryptophan 2 biosynthesis, showed modest decreases in expression
levels in the silenced lines (Figure 4.7). This is consistent with a previous study which
demonstrated that increased concentrations of tryptophan inhibit anthranilate synthase
expression. In the silenced lines, where tryptophan is no longer diverted to tryptamine
biosynthesis, concentrations of tryptophan could increase, resulting in the decreased
expression of anthranilate synthase. A full transcriptional analysis of the monoterpene
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Figure 4.7. Real-time reverse transcriptase PCR (RT-PCR) of the mRNA encoding
tryptophan decarboxylase, anthranilate synthase, strictosidine synthase, strictosidine
glucosidase and Orca3. Levels of these genes are normalized to 100% in the wild type
line. The gene expression levels of two representative silenced lines relative to the wild
type levels are also shown. Levels represent the average of three trials, with error bars
representing the standard deviation.
184
indole alkaloid pathway was not performed since the majority of the pathway enzymes
have not been characterized at the genetic level.
4.2.4 Unnatural Alkaloid Production in Tryptophan Decarboxylase Silenced Lines
Alkaloid biosynthesis could be rescued by feeding tryptamine 1 or isotopically labeled
d4-(deuterium) tryptamine to silenced cultures. We measured formation of the major
alkaloids of hairy root culture, namely ajmalicine 3, serpentine 4, catharanthine 5 and
tabersonine 6 (Figure 4.1 and Figure 4.8-4.10). The identity of these alkaloids was
assigned by exact mass and co-elution with authentic standards (Table 4.1). Isotopically
labeled d5-L-tryptophan (500 pM) was also incubated with a wild type and a
representative silenced line. As expected, the wild type culture could incorporate the
exogenous isotopically labeled tryptophan into alkaloids while the suppressed line could
not, clearly indicating that the required decarboxylation reaction did not occur when
tryptophan decarboxylase was knocked down (Figure 4.9 A-C).
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Figure 4.8. Extracted LC-MS chromatograms showing the presence of ajmalicine 3,
serpentine 4, catharanthine 5 and tabersonine 6. These compounds are only present when
tryptamine 1 is added to the culture media. Results using a concentration of 1.0 mM
tryptamine are shown. Authentic standards of ajmalicine 3, serpentine 4, catharanthine 5,
and tabersonine 6 are used to validate the structural assignments of these compounds
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Figure 4.9 A-C. Extracted LC-MS chromatograms showing the presence of deuterated
A. ajmalicine 3, B. serpentine 4, C. catharanthine 5 and tabersonine 6. In the tryptophan
decarboxylase suppressed line, these compounds are only present when aa,b,b-d4-
tryptamine (CDN Isotopes) is added to the culture media. In the wild type line, deuterated
alkaloids are present when either aa,b,b-d4-tryptamine (CDN Isotopes) or 2',4',5',6',7'-
d5-tryptophan (CDN isotope) is added to the culture media. Results using a concentration
of 0.5 mM d4-tryptamine or 0.5 mM d5-tryptophan are shown. LC-MS spectra are
normalized to the same y-axis scale.
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Table 4.1. High-resolution MS data for alkaloids observed in hairy root extracts.
R=H R=F
R N H/
N NH
H
MeO 2C
R N H\
NH CO 2Me
R N H
N
H
MeO 2C
R N
H Co2Me
RT = retention
Ajmalicine
Expected [M+H]
Observed [M+H
Accuracy (ppm)
RT (min)
Tabersonine
Expected [M+H]
Observed
Accuracy
RT (min)
[M+H]
(ppm)
Serpentine
Expected [M+H]
Observed [M+H]
Accuracy (ppm)
RT (min)
Catharanthine
Expected [M+H]
Observed [M+H]
Accuracy (ppm)
RT (min)
time, LC gradient 10-60% acetonitrile/water (0.1% TFA) in 13 minutes
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3
353.1865
353.1856
-2.5
4.25
6
337.1916
337.1922
1.8
4.65
4
349.1552
349.1548
-1.1
4.45
5
337.1916
337.1916
0.0
4.48
3a
371.1765
371.1760
-3.0
4.66
6a
355.1816
355.1811
-3.1
5.20
4a
367.1452
367.1453
-1.4
4.72
5a
355.1816
355.1818
-1.1
4.88
I
A hairy root line that showed maximal suppression of alkaloid production (cell line 3)
was incubated with varying concentrations of tryptamine 1 (62.5 - 2500 yM) in the cell
culture media. The production of ajmalicine 3, serpentine 4, catharanthine 5, and
tabersonine 6 were monitored by mass spectrometry in tandem with high performance
liquid chromatography (Figure 4.8, 4.10). The production levels increased as more
tryptamine 1 was added to the media, though catharanthine 5 and tabersonine 6
production was highest at 1000 g M tryptamine 1. Notably, growth inhibition and
browning of wild type hairy roots was typically observed when exogenous tryptamine
was added to the media of wild type cultures at concentrations of 1000 pM or greater.
However, this was not observed in the silenced lines where the natural tryptamine
production was suppressed.
concentration of tryptamine
2 -- - ---
1.8 EM 0pM
1.6 62.5 pM1.4
1.2 c 125 pM
1 250 pM
0 on500 pM
0.4 MT 1000 pM
0.2 - 2500 pM
0
Tabersonine Serpentine Catharanthine Ajmalicine
Figure 4.10. Levels of ajmalicine 3, serpentine 4, catharanthine 5 and tabersonine 6
production in a representative silenced line supplemented with tryptamine 1 (0, 62.5, 125,
250, 500, 1000, 2500 gM) in the culture media. Levels were estimated in C. roseus
extracts by LC-MS and represent the average of three trials, with error bars representing
the standard deviation.
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The suppression of natural alkaloid biosynthesis in these transformed lines provided the
first opportunity to explore the prospects of mutasynthesis- replacement of natural
alkaloids with unnatural products- in plant culture. A representative tryptamine analog,
5-fluorotryptamine la (Figure 4.2), was chosen to illustrate the potential of
mutasynthesis for the monoterpene indole class of alkaloids. Previous precursor-directed
feeding studies have shown that 5-fluorotryptamine substrate la could be turned over by
downstream biosynthetic enzymes to yield a variety of fluorinated monoterpene indole
alkaloid analogs13 . A representative silenced line (cell line 3) was incubated with varying
concentrations (250 - 2500 p M) of 5-fluorotryptamine la (Figure 4.11). Two
representative fluorinated alkaloids, fluoro-ajmalicine 3a, and fluoro-serpentine 4a were
identified by exact mass (Table 4.1), UV spectrum (Figure 4.12) and by co-elution with
authentic standards that were previously characterized by NMR13 (Figure 4.11). When
supplemented with natural tryptamine 1, silenced hairy root cultures produced
catharanthine 5 and tabersonine 6 as the only observable compounds with m/z 337. When
supplemented with 5-fluorotryptamine la, silenced lines yielded two compounds at m/z
(337 + 18), the expected molecular weight of fluoro-catharanthine 5a (expected,
355.1816; observed, 355.1818) and fluoro-tabersonine 6a (expected, 355.1816; observed,
355.1811). Additionally, UV spectra (Figure 4.12) and tandem MS/MS (Figure 4.13) of
these two compounds matched authentic standards of catharanthine 5 and tabersonine 6,
suggesting a structural assignment of 5a and 6a.
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Figure 4.11. Extracted LC-MS chromatograms showing the presence of fluorinated
ajmalicine 3a, serpentine 4a, catharanthine 5a and tabersonine 6a. These compounds are
only present when 5-flourotryptamine la is added to the culture media. Results using a
concentration of 1.0 mM 5-fluorotryptamine are shown. Authentic standards of
fluorinated ajmalicine are serpentine are also shown.
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Figure 4.12 A-D. UV spectra of alkaloid standards and selected unnatural alkaloids from
TDCi hairy root fed with 5-fluorotryptamine la (0.5 mM). A. 5-fluoroajmalicine 3a. B.
ajmalicine 3 standard. C. 5-fluorotabersonine 6a. D. tabersonine 6 standard.
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Figure 4.12 E-H. UV spectra of alkaloid standards and selected unnatural alkaloids from
TDCi hairy root fed with 5-fluorotryptamine la (0.5 mM). E. 5-fluorocatharanthine 5a.
F. catharanthine 5 standard. G. 5-fluoroserpentine 4a. H. serpentine 4standard.
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Figure 4.13 A (top) and B (bottom). MS/MS analysis for (A) catharanthine 5 standard
and (B) fluorinated catharanthine 5a. (A) Catharanthine is identified as the m/z = 337.2
ion showing the fragments m/z = 173.1 and 144.1. (B) Fluorinated catharanthine is
identified as the m/z = 355.2 (337.2 + 18) ion showing the fragments m/z = 191.1 (173.1
+ 18) and 162.1 (144.1 + 18).
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Figure 4.13 C (top) and D (bottom). MS/MS analysis for (C) tabersonine 6 standard
and (D) fluorinated tabersonine. (C) Tabersonine is identified as the m/z = 337.2 ion
showing the fragments m/z = 305.2, 277.2, 249.1, 228.1, 196.1 and 168.1. (D)
Fluorinated tabersonine is identified as the m/z = 355.2 (337.2 + 18) ion showing the
fragments m/z = 323.2 (305.2 + 18), 295.2 (277.2 + 18), 267.1 (249.1 + 18), 246.1 (228.1
+ 18), 214.1 (196.1 + 18), and 186.1 (168.1 + 18).
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Mutasynthesis often leads to higher yields and purity of unnatural products over
precursor-directed feeding since the biosynthesis of the natural starting material is
genetically silenced, and the producing organism is forced to utilize exogenously
supplied substrates for product biosynthesis. This proved to be the case for TDC silenced
lines; the complex mixture of alkaloid products was greatly simplified, since no natural
alkaloids derived from endogenous tryptamine 1 were present (Figure 4.14). We also
compared the yields of fluorinated alkaloids in both wild type and a representative
silenced line fed with 5-fluorotryptamine using mass spectrometry in tandem with high
performance liquid chromatography (Figure 4.15). The levels of fluorinated ajmalicine
3a and the compound assigned as catharanthine 5a were greater in the representative
silenced line, suggesting that some pathway branches could support increased production
levels of the desired nonnatural compounds when not challenged with competing natural
substrate. Yields of fluorinated serpentine 4a remained approximately the same in
silenced and wild type cultures, suggesting that serpentine biosynthesis may be tightly
regulated. Surprisingly, the yield of the compound assigned as fluorinated tabersonine 6a
was approximately two-fold higher in the wild type line compared to the silenced line,
suggesting that tabersonine biosynthesis was somewhat adversely affected by suppression
of tryptophan decarboxylase or the transformation process (Figure 4.15). The proportions
of the fluorinated alkaloids produced in the silenced cultures are different from the
proportions of fluorinated alkaloids produced with the wild lines. As the genes involved
in the biosynthesis of ajmalicine 3, serpentine 4, catharanthine 5 and tabersonine 6 are
identified, it will become possible to understand the underlying mechanism for the
different alkaloid accumulation levels between wild type and silenced lines.
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Figure 4.14. Metabolite production in wild type and TDCi line as evidenced by high
performance liquid chromatography analysis of C. roseus hairy root extracts. The
alkaloid extracts were run on a Hibar RT 250-4 prepacked reverse phase column using a
gradient of 10-60% acetonitrile/water (0.1% TFA) over 25 minutes at 1 mL/min.
Alkaloids were monitored at 280 nm. i, fluoro-ajmalicine 3a; ii, fluoro-catharanthine 5a;
iii, fluoro-tabersonine 6a; and iv, fluoro-serpentine 4a.
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Figure 4.15. Quantification of unnatural alkaloid production in a suppressed and wild
type line fed with 5-fluorotryptamine la (500 pyM, 1000 pM and 2500 pM). Production
levels were evaluated in C. roseus extracts by mass spectrometry and represent the
average of three measurements. Top. Levels of fluorinated alkaloids produced in a
representative silenced line incubated with 5-fluorotryptamine la. Bottom. Levels of
fluorinated alkaloids produced in a wild type line incubated with 5-fluorotryptamine la.
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The levels of natural (non-fluorinated) ajmalicine 3, serpentine 4, catharanthine 5 and
tabersonine 6 alkaloids were also quantified in wild type cultures fed with 5-
fluorotryptamine la (Figure 4.16). In the wild type line, natural ajmalicine 3 levels were
significantly greater than fluorinated ajmalicine 3a, while catharanthine 5 or 5a was not
observed at all in the wild type hairy root line for reasons that are not clear2 6. Natural
serpentine 4 was produced at approximately the same level as fluorinated serpentine 4a in
the wild type line. At high concentrations of 5-fluorotryptamine la, levels of natural
tabersonine 6 and the compound assigned as fluorinated tabersonine 6a were similar. We
speculated that the flux of the unnatural substrate through some branches of the pathway
increased when the natural, endogenous substrate was unavailable.
5-F-tryptamine
f 250 pM3.5
V i500 pM
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2.5 =n2500 pM
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0
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Figure 4.16. Quantification of unnatural alkaloid production in wild type line fed with 5-
fluorotryptamine la (500 pM, 1000 pM and 2500 pM). Production levels were evaluated
in C. roseus extracts by mass spectrometry and represent the average of three
measurements. c. Levels of natural, non-fluorinated alkaloids produced in a wild type line
incubated with 5-fluorotryptamine la.
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4.2.5 Accumulation of Secologanin in Tryptophan Decarboxylase Silenced Lines
In C. roseus, tryptamine 1 reacts with the iridoid terpene secologanin 7 to form
strictosidine 8 (Figure 4.1). The absence of tryptamine should therefore lead to increased
accumulation of secologanin. Yields of secologanin 7 were estimated by mass
spectrometry analysis of crude C. roseus extracts. While secologanin 7 is not normally
found in large quantities in wild type C. roseus plants or tissue, silenced lines showed a
dramatic increase in 7 (Figure 4.17). Approximately 0.15 g of secologanin per g dry
weight in a representative silenced culture was observed, indicating that silencing of
tryptophan decarboxylase led to dramatically increased secologanin 7 levels. When
tryptamine 1 or a tryptamine analog was added to this silenced culture, the levels of
secologanin decreased as this iridoid terpene was converted into alkaloids. Nevertheless,
0.11 g secologanin 7 per g culture dry weight remained even when 500 p M tryptamine 1
was incubated with this silenced culture for 7 days. The levels of secologanin 7 in these
silenced lines appeared to far exceed the capacity for downstream alkaloid biosynthesis
(approximately 5 mg monoterpene indole alkaloid per gram of dry culture weight)
(Figure 4.10, 4.15-4.16).
Although most of the genes involved in secologanin biosynthesis remain uncharacterized,
real time reverse transcription PCR indicated that one or both of the two best
characterized secologanin biosynthetic genes, secologanin synthase (SLS)3 3'3 4 and
geraniol-lO-hydroxylase (G1OH)3 5 , were upregulated in seven silenced lines (Figure
4.18). As stated above, high concentrations of secologanin (0.11 g/ g dry weight) were
observed even after tryptamine was added to silenced lines, indicating that tryptamine
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does not repress secologanin production. Therefore, while the exact mechanism of how
secologanin is upregulated remains unclear, silencing of tryptophan decarboxylase clearly
affects the expression of upstream biosynthetic enzymes. Further work to explore the
regulatory network of alkaloid biosynthetic genes in C. roseus is imperative.
secologanin standard
m/z 389
wild type
m/z 389
TDCi
m/z 389
/OMcMeO2CO
Time (minutes)
Figure 4.17. Secologanin 7 production in wild type and tryptophan decarboxylase
suppressed lines as evidenced by LC-MS analysis of C. roseus extracts. An authentic
standard of secologanin 7 is also shown.
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Figure 4.18. Expression levels of SLS and GOH in 7 different TDC-suppressed lines
measured by RT-PCR. Expression levels of the silenced lines are normalized to the
expression levels in the wild type hairy root line. TDC (tryptophan decarboxylase)
expression levels are shown for comparison. SLS (secologanin synthase), G1OH
(geraniol- 10-hydroxylase).
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4.2.6 Regeneration of C. roseus Plants from Tryptophan Decarboxylase Silenced
Lines
The lack of tryptamine 1 and downstream alkaloids, along with secologanin 7
accumulation, did not appear to affect the growth or morphology of the silenced cultures,
indicating that tryptamine and downstream alkaloids do not play an essential role in C.
roseus hairy root culture development (Figure 4.19). While the endogeneous role of
alkaloids in plants has not been fully elucidated, current evidence suggests that alkaloids
are generally involved in plant defense against pathogens, insects, and herbivores due to
their potent toxicity3 6. We envisioned that the regeneration of alkaloid deficient C. roseus
plants from TDCi hairy roots would give further insight into this long-standing
assumption. A regeneration process of C. roseus plants from hair root culture has
previously been reported ". We applied this strategy using the TDCi hairy roots to yield
whole plants (Figure 4.20). Interestingly, the regenerated plants exhibited significant
growth retardation and died several days after they were transferred to Miracle Gro soil.
Together, these experiments suggest that while tryptamine and monoterpene indole
alkaloids do not appear to play an essential role in growth or development in C. roseus
hairy root culture, they may be vital for whole plant survival in a non-controlled
environment.
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Figure 4.19. Two-week-old wild-type (left) and TDCi (right) hairy roots in solid
Gamborg's B5 media.
EI~
root regeneration plantlet growth
(4 weeks) (3 weeks)
growth in soil
(7 days)
Figure 4.20. Regeneration of alkaloid deficient C. roseus plants from TDCi root culture.
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4.3 Conclusions
Fermentation is an attractive and powerful strategy for large-scale production of natural
product analogs. Replacement of an endogenous starting material with an unnatural
compound, a strategy that has been broadly applied in prokaryotic biosynthetic pathways,
has now been successfully used in a plant alkaloid pathway to yield exclusively unnatural
alkaloid products. Downregulation of tryptophan decarboxylase in C. roseus hairy root
culture allowed the strategic incorporation of exogenously supplied tryptamine substrate
1 into the monoterpene indole alkaloid pathway. Using this strategy, natural alkaloid
production was suppressed, and only unnatural alkaloids were produced when a
fluorinated tryptamine analog la was introduced to the culture media. Silencing
tryptophan decarboxylase did not impact the expression levels of either the key
transcription factor Orca3 or the known downstream biosynthetic enzymes, strictosidine
synthase and strictosidine glucosidase. We envision that RNA silencing methods can also
be used with other known downstream biosynthetic enzymes-or even unknown ones as
they become identified-to more effectively engineer the production of the desired
unnatural alkaloid in plants and plant culture. In conclusion, our strategy allows for
practical and efficient production of novel monoterpene indole alkaloids that are not
synthetically accessible.
4.4 Experimental Methods
4.4.1 Construction of pTDCi Vector
The construction of pTDCi vector was designed and executed by Justin Maresh. A 408
base pair fragment at the 5' end of the tryptophan decarboxylase open reading frame,
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which did not show significant homology to any known C. roseus genes, flanked by
attB 1 (forward) and attB2 (reverse) was obtained by reverse-transcription PCR
amplification from C. roseus seedling mRNA (forward primer:
CACCGCAGCATTGATTCAACAAATGTAG; reverse primer:
AGCTATCGATGGTACCTCATTTCTAATTCGGTGGCGGCTG). The resulting PCR
product was then inserted into pENTR-TOPO (Invitrogen) vector via BP clonase
mediated recombination using the manufacturer's protocol. The gene fragment from the
intermediate clone was subsequently inserted into pHELLSGATE12 using LR clonase
mediated recombination. The final pTDCi construct was verified by sequencing to ensure
plasmid integrity.
4.4.2 Generation of pTDCi Hairy Roots
The pTDCi vector was transformed into A. rhizogenes ATCC 15834 via electroporation
(1mm cuvette, 1.25 kV). Transformation of C. roseus seedlings with the generated
Agrobacterium strain was performed as previously reported2 5 . Briefly, 250-300 C. roseus
seeds (Vinca Little Bright Eyes, Nature Hills Nursery) were germinated aseptically and
grown in a 16-hour light/dark cycle for 2-3 weeks on standard Gamborg's B5 media (full
strength basal salts, full strength vitamins, 30 g/L sucrose, pH 5.7). Seedlings were
wounded with a scalpel at the stem tip, and transformed A. rhizogenes from a freshly
grown liquid culture was inoculated on the wound. Hairy roots appeared at the wound
site 2-3 weeks after infection. Root tips longer than 5 mm were excised after 6 weeks and
transferred to Gamborg's B5 solid media (half strength basal salts, full strength vitamins,
30 g/L sucrose, 6 g/L agar, pH 5.7) containing kanamycin (0.1 mg/mL) for selection, and
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cefotaxime (0.25 mg/mL) for removal of the remaining bacteria. Lines were cultured on
media with and without tryptamine (50 tM), in case tryptamine proved to be essential for
cell survival. Since tryptamine did not appear to be required for survival of these lines, all
subsequent culture media used for second and third rounds of subculturing was not
supplemented with tryptamine. All cultures were grown in the dark at 26'C. After the
selection process, hairy roots were subcultured at least once on solid media lacking both
kanamycin and cefotaxime prior to adaptation to liquid culture.
To adapt hairy roots to liquid media, approximately 200 mg of hairy roots (typically five
3-4 cm long stem tips) from each line that grew successfully on solid media were
transferred to 50 mL of half-strength Gamborg's B5 liquid media (half strength basal
salts, full strength vitamins, 30 g/L sucrose, pH 5.7). The cultures were grown at 26*C in
the dark at 125 rpm. All lines were maintained on a 14-21 day subculture cycle
depending on the growth rate of each line.
4.4.3 Verification of Transferred DNA (T-DNA) Integration by Genomic DNA
Analysis
The genomic DNA from transformed hairy roots was isolated (Qiagen DNeasy kit) and
subjected to PCR amplification using T-DNA specific primers with STR primers serving
as a positive control. Specifically, primers for PCR amplification were designed to
amplify the complete STR gene, a region of the CaMV 35S promoter, the antibiotic
resistance NPTII gene and the PDK intron.
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4.4.4 Quantification of mRNA Production of Biosynthetic Genes by Real Time RT-
PCR
mRNA from transformed hairy roots was isolated and purified from genomic DNA using
Qiagen RNeasy Plant Mini Kit and RNase-free DNaseI, respectively. The resulting
mRNA was then reverse-transcribed to cDNA using Qiagen QuantiTect Reverse
transcription kit and subjected to PCR analysis with Qiagen SYBR Green PCR kit and a
Biorad DNA Engine Opticon 2 system. The threshold-cycle (CT) was determined as the
cycle with a signal higher than that of the background plus 10 x standard deviation (SD).
C. roseus 40S ribosomal protein S9 (Rps9), a house keeping gene, was used to normalize
the amount of the total mRNA in all samples.
4.4.5 Assessment of Alkaloid Production Rescue by Addition of Tryptamine
Ten root tips from hairy roots transformed with pTDCi were subcultured in 50 mL
Gamborg's B5 liquid media and grown at 26'C in the dark at 125 rpm for eighteen days
prior to supplementing the media with tryptamine 1 (Alfa Aesar) at 0, 62.5, 125, 250,
500, 1000 and 2500 p M. After one week of co-cultivation with the substrate, hairy roots
were ground with a mortar, pestle and 100 pm glass beads in methanol (10 mL/g of fresh
weight hairy roots) from the harvested tissue. The crude natural product mixtures were
subjected to LC-MS analysis (Micromass LCT Premier TOF Mass Spectrometer). Peak
integration and analysis was performed with MassLynx 4.1. To convert peak area to
milligrams, standard curves of the natural alkaloids ajmalicine 3, serpentine 4,
catharanthine 5 and tabersonine 6 were constructed. The levels shown in Figures 4.10,
4.15 and 4.16 represent the average of three feeding experiments, with the with error bars
representing the standard deviation.
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4.4.6 Assessment of Alkaloid Mutasynthesis
Ten root tips from hairy roots transformed with pTDCi were subcultured in 50 mL
Gamborg's B5 liquid media and grown at 26'C in the dark at 125 rpm for eighteen days
prior to supplementing the media with either d4-tryptamine (500 p M) (Aldrich), d5-L-
tryptophan (500 p M) (Aldrich), or 5-fluorotrytamine la (250, 500, 1000, 2500 g M) (MP
Biomedicals). After one week of co-cultivation with the substrates, hairy roots were
processed as described above. Authentic standards of fluorinated ajmalicine 3a and
fluorinated serpentine 4a were previously isolated and characterized13
4.4.7 Expression Levels of Secologanin Biosynthetic Genes SLS and G10H
Primers for real-time RT-PCR of transformed hairy roots for secologanin synthase (SLS)
(SLS for: GGATTGGGCATGGTTTACTC and SLSrev:
CCATGGGTTTAGACAAGGCT, amplicon size 140 bp) and geraniol-lO-hydroxylase
(G1OH) (G1OH_for: TGCTTGGACCTGTTTGTAGC and G1OH_rev:
TCCTCTGCCGATTACTTGTG amplicon size 132 bp).
4.4.8 Regeneration of C. roseus Plants from Transformed Hairy Roots Expressing
STR Mutant
Regeneration of transformed hairy roots expressing STR mutant to whole plants was
performed as previously reported37 . Briefly, one-centimeter-long root tips of two-week-
old transformed hairy roots were excised and transferred to shoot regeneration media (full
strength Murashige and Skoog basal salts and vitamins, 31 ItM 6-benzyladenine, 5.4 [M
a-naphthaleneacetic acid, 30 g/L sucrose, pH 5.7). After nine weeks on this media,
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explants were transferred to root regeneration media (half strength Murashige and Skoog
basal, full strength Murashige and Skoog vitamins, 30 g/L sucrose, pH 5.7). After four
weeks on this media, regenerated plants were transferred to full strength Gamborg's B5
media (full strength basal salts, full strength vitamins, 30 g/L sucrose, pH 5.7). After
three weeks of acclimation, regenerated plants were transferred to Miracle gro soil and
maintained in a culture room.
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CHAPTER 5
CHEMOGENETIC APPROACHES TO
FURTHER DERIVATIZE HALOGENATED ALKALOIDS
214
5.1 Introduction
Modification of natural products can yield analogs of natural products, or "unnatural
products", with improved or novel medicinal properties'. Traditional approaches to
generate analogs include total and semi-syntheses, precursor-directed biosynthesis,
mutasynthesis and combinatorial biosynthesis2 -7 . More recently, Goss and coworkers
have utilized a new approach that involves the introduction of a gene to complement a
native biosynthetic pathway followed by postbiosynthetic chemical derivatization'. Using
this "chemogenetic" approach, the team successfully generated analogs of the uridyl
peptide antibiotic pacidamycin.
N N.H\
CO2H strictosidine N H N
NH2 crbox as NH2 synthase -G , , 
CO2Me /H CO2Metrytoha / C. c-Glc 19,20-dthydro
decarboxylase 9 HO !'N ~H 'akuammicine 5 tabersonine 7
CIN - C" IN A-GIC H _ 0 __
tryptophan 1 tryptamine 2 Ne02C  MeO2C N N
secologanin 3 strictosidine 4 -
SCO2Me CO2MeH
akuammicine 6 catharanthine 8
Figure 5.1 Biosynthesis of monoterpene indole alkaloids in C. roseus.
The biosynthesis of monoterpene indole alkaloid (MIA) in C. roseus is exceptionally
complicated and only partially characterized. This pathway produces a variety of
alkaloids with diverse biological activities and complex molecular architecture from the
iridoid terpene secologanin 3 and tryptamine 2 (Figure 5.1 and Chapter 1). Until now,
only traditional approaches have been applied to generate analogs of MIAs 2 ,1o-15. New
approaches are required to broaden the scope of alkaloid analogs to contain other
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pharmacologically important functional groups, such as the aryl and heteroaryl groups,
that might alter drug potency and specificity while reducing undesirable side effects.
Over the past decade, the O'Connor group and others have utilized several strategies to
generate halogenated analogs of structurally diverse classes of MIAs at all four possible
positions of the indole ring (Figure 5.2 and Chapter 2-4), 10-15. For example, precursor-
directed biosynthesis in C. roseus has led to the production of chlorinated and brominated
analogs at the 4- and 7- positions of the indole ring12 . Similarly, RNAi-silencing of
endogenous tryptamine biosynthesis followed by halogenated precursors feeding afforded
chlorinated and brominated analogs at the 4- and 7- positions of the indole ring (Chapter
4)". This strategy, termed mutasynthesis, simplified the alkaloid profile since no natural,
non-halogenated alkaloids derived from endogenous tryptamine 2 were present.
Analogs at the 5- and 6- positions cannot be obtained via precursor-directed biosynthesis
or mutasynthesis due to the stringent substrate specificity of strictosidine synthase (STR),
the enzyme that catalyzes formation of strictosidine 4, 12 .To overcome this problem, we
applied a combinatorial biosynthetic approach by introducing a re-engineered STR gene
with a broadened substrate scope (V214M mutant) 0 into C. roseus cell culture (Figure
5.2 and Chapter 2)"4. The resulting transgenic cell culture produced chlorinated and
brominated analogs at the remaining 5- and 6- positions when co-cultured with the
corresponding tryptamine 2 analogs. Finally, we introduced prokaryotic halogenases that
chlorinate tryptophan 1, the immediate precursor of tryptamine 2, into C. roseus cell
culture (Chapter 3)15. These halogenases, RebF with either PyrH or RebF, function
216
Combinatorial
biosynthesis
(chapter 2) Z
Combinatorial c
biosynthesis
(chapter 2)
Precursor-directed biosynthesis
and mutasynthesis (chapter 4)
Precursor-directed biosynthesis,
mutasynthesis (chapter 4) and
combinatorial biosynthesis (chapter 3)
Figure 5.2 Approaches to
of the indole ring"".
generate halogenated MIA analogs at the 4 possible positions
N CHX H 02Me /
precursor-directed5
biosynthesis, N X/ N
mutasynthesis s H CO2Mecombinatorial biosynthesis 7
N X = Cl, Brx H C02Me
Pd(0) (catalytic)
base, ligand
R1-B(R)2
N
SCO.Me
N HH
R1 NH C 2Me
Figure 5.3 Strategy for synthetic diversification of monoterpene indole alkaloids using
palladium-catalyzed Suzuki-Miyaura coupling reaction. Halogenated alkaloids are
obtained via genetic engineering of C. roseus either with or without precursor-feeding.
These analogs are further modified synthetically via suitable cross-coupling reactions.
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R1 = aryl, heteroaryl
within the context of the plant cell to generate chlorinated tryptophan at 5- and 7-
position, respectively, which is then incorporated into monoterpene indole alkaloid
metabolism to yield chlorinated alkaloids. Thus, these hairy roots autonomously produce
halogenated alkaloids without the need for precursor-feeding.
While halogenation, in and of itself, often has profound effects on the bioactivity of
natural products 6 , we envisioned that halides could also serve as a useful handle for
further chemical derivatization8 . Using metal-catalyzed cross-coupling reactions, these
halogenated analogs can be derivatized with functional groups that could further improve
the bioactivity and bioavailability of the compounds. Achieving this goal requires two
steps: (1) obtain halogenated analogs by genetic engineering of C. roseus either with or
without precursor-feeding and (2) modify these halogenated analogs synthetically via
suitable cross-coupling reactions. This chapter demonstrates that the introduction of a
chemical handle-the organohalogens-into the indole moiety of the alkaloids, followed
by postbiosynthetic chemical derivatizations using palladium-catalyzed Suzuki-Miyaura
cross-coupling reactions robustly afforded aryl and heteroaryl analogs of MIAs (Figure
5.3).
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5.2 Results and Discussion
5.2.1 Generations of Halogenated Alkaloids
To achieve our first goal, we considered several options for obtaining halogenated
analogs. Since wild type STR accepts 7-chlorotryptamine 2a and 7-bromotryptamines
2b1, we decided to use the TDC-suppressed hairy root lines 3 to obtain halogenated
analogs. The yields and purity of halogenated products are higher in TDC-suppressed
lines fed with halogenated tryptamine substrates compared to feeding of the wild type
line (Figure 5.6). Specifically, we obtained alkaloid analogs with chlorine and bromine at
the 7-position of the indole ring by culturing TDC-suppressed hairy root lines in liquid
Gamborg's B5 media in the presence of either 0.6 mM 7-chlorotryptamine 2a or 7-
bromotryptamine 2b (Figure 5.4). After one week of culture, the plant material was lysed
and alkaloids were extracted into an organic solvent. Liquid chromatography mass
spectral (LC-MS) analysis of these extracts indicated accumulation of one major product,
12-chloro-19,20-dihydroakuammicine 5a (for 7-chlorotryptamine 2a feeding) or 12-
bromo-19,20-dihydroakuammicine 5b (for 7-bromotryptamine 2b feeding) (Figure 5.7).
Alternatively, 12-chloro-19,20-dihydroakuammicine 5a can also be obtained from
transgenic hairy roots that express prokaryotic halogenases, RebF and RebH (Figure
55)".
219
exogenously added
\NH2
R H
1a
R = C, Br
I Pd(0 ) (catalytic) N
R base, ligand 2H
R H CO2CH3 R1 H CO2CH3
R = Cl, Br R1 = aryl, heteroaryl
Figure 5.4 Strategy for synthetic diversification of monoterpene indole alkaloids at the 7-
position of the indole ring using palladium-catalyzed Suzuki-Miyaura coupling reaction
(I). Feeding of either 7-chlorotryptamine 2a or 7-bromotryptamine 2b to TDC-suppressed
hairy root cultures (chapter 4) will produce 12-chloro-19,20-dihydroakuammicine 5a and
12-bromo-19,20-dihydroakuammicine 5b, respectively. These halogenated alkaloids can
undergo the Suzuki-Miyaura coupling reactions with aryl and heteroaryl boronic acid
substrates to form the corresponding alkaloid analogs.
N Pd(0) (catalytic) N
base, ligand
*H am'HNR1-B(R)2 N
C1H CO2CH3R1HC2H ~
R= aryl, heteroaryl
Figure 5.5 Strategy for synthetic diversification of monoterpene indole alkaloids at the 7-
position of the indole ring using palladium-catalyzed Suzuki-Miyaura coupling reaction
(II). RebH/RebF hairy root cultures produce 12-chloro-19,20-dihydroakuammicine 5a
(m/z 359) (chapter 3), which can undergo the Suzuki-Miyaura coupling reactions with
aryl and heteroaryl boronic acid substrates to form the corresponding alkaloid analogs.
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Figure 5.6 Extracted LC-MS chromatograms showing 12-chloro-19,20-
dihydroakuammicine 5a (m/z 359) production in crude extracts from TDC-suppressed
(top) and wild type (bottom) hairy root cultures fed with 0.6 mM 7-chlorotryptamine 2a.
LC-MS spectra are normalized to the same y-axis scale.
TDCi + 7-bromotryptamine 2c
extracted with n-butanol
N
Jr H CO2CH3
TDCi+ 7-chlorotryptamine 2b
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Time (min)
Figure 5.7 Extracted LC-MS chromatogram showing 12-chloro-19,20-
dihydroakuammicine 5a (m/z 359, top) and 12-bromo-19,20-dihydroakuammicine 5b
(m/z 403, bottom) production in crude extracts from TDC-suppressed hairy root culture
fed with 7-chlorotrypamine 2a and 7-bromotryptamine 2b, respectively. LC-MS spectra
are normalized to the same y-axis scale.
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Tryptamine analogs with substituents at the 6-position are not accepted by wild type
STR12 . Therefore, to obtain analogs of alkaloids with chlorine at the 6-position of the
indole ring, we cultured transgenic hairy root lines that express V214M mutant STR
enzyme (STRvm)14 in liquid Gamborg's B5 media in the presence of 0.6 mM 6-
chlorotryptamine 2c (Figure 5.8). After one week of culture, the plant material was
processed as described above. LC-MS analysis of these extracts indicated accumulations
of three major analogs: 1 1-chloro-19,20-dihydroakuammicine 5c, 1 1-chloroakuammicine
6c and 1 1-chlorotabersonine 7c (Figure 5.9).
N N
N 
N
exogenously added E-H x 
-es
me Cl N 02Me N H Pd(0 ) (catalytic) R1 N 0 2Me
NH2H / base, ligand H ,
N N N N
a H CO2Me H CO2Me
I - H R1 = aryl, heteroarylCI ~N CMeR, ~NH 02Me H C02Me
Figure 5.8 Strategy for synthetic diversification of monoterpene indole alkaloids at the 6-
position of the indole ring using palladium-catalyzed Suzuki-Miyaura coupling reaction.
Feeding of 6-chlorotryptamine to STRvm hairy root cultures (chapter 3) will produce 11-
chloro-19,20-dihydroakuammicine 5c, 1 1-chloroakuammicine 6c and 11-
chlorotabersonine 7c. These halogenated alkaloids can undergo the Suzuki-Miyaura
coupling reactions with aryl and heteroaryl boronic acid substrates to form the
corresponding alkaloid analogs.
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Figure 5.9 Extracted LC-MS chromatograms showing 11-chloroakuammicine 6c (m/z
357, bottom), 1 1-chloro-19,20-dihydroakuammicine 5c (m/z 359, middle) and 11-
chlorotabersonine 7c (m/z 371, top) production in crude extracts from STRvm hairy root
culture fed with 6-chlorotrypamine 2c. LC-MS spectra are normalized to the same y-axis
scale.
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M
5.2.2. Suzuki-Mivaura Coupling of Halogenated Alkaloids with Arvl and Heteroaryl
Boronic Acids
With halogenated analogs readily available as a component of crude plant extracts, we
then set out to achieve our second goal by exploring chemical functionalization reactions
that will derivatize halogenated analogs under sufficiently mild reaction conditions. Voss
and coworkers demonstrated the utilization of iodinated analogs of several alkaloids,
which were obtained through semisynthesis, in several cross-coupling reaction conditions
2
that are unlikely to be applicable to chlorinated analogs, which are less reactive2
Prompted by the work of Goss and coworkers", we turned our attention to the palladium-
catalyzed Suzuki-Miyaura cross-coupling reactions. While crossing-coupling reactions of
aryl iodides and bromides with arylboronic acids are well precedented, reactions
involving aryl chlorides require the use of more recently developed catalyst systems,
which employ highly active and sterically demanding ligands, such as Sphos". Since
non-halogenated metabolites present in crude extracts are unlikely to interfere with the
progression of the cross-coupling reactions, as demonstrated by the work of Goss and
coworkers', crude extracts containing chlorinated and brominated alkaloids were used
directly in the cross-coupling reactions without any purification. In our experience,
preparative high-performance liquid chromatography (HPLC) using a reverse phase
column can sufficiently purify alkaloid analogs from other metabolites for structural
14,15
characterization .Therefore, we envisioned using preparative HPLC to purify the
resulting aryl and heteroaryl analogs from crude reaction mixtures.
We performed the Suzuki-Miyaura cross-coupling reactions of 12-chloro-19,20-
224
dihydroakuammicine 5a and 12-bromo- 19,20-dihydroakuammicine 5b using six aryl and
heteroaryl boronic acid substrates (Figure 5.4 and Table 5.1). Gratifyingly, small-scale
coupling reactions of crude extracts containing either 12-chloro-19,20-
dihydroakuammicine 5a or 12-chloro-19,20-dihydroakuammicine 5b from 100 mg of
fresh hairy roots with every boronic acids tested went to completion as observed by LC-
MS in under one hour at 100 *C. LC-MS chromatograms showing the progression of the
cross-coupling reactions at 0 and 10 min time points are shown in Figure 5.10-5.13.
Crude extracts from transgenic hairy roots that express prokaryotic halogenases (RebF
and RebH) (Chapter 3) were also used as substrates for the Suzuki-Miyaura cross-
coupling reactions with three representative boronic acids, phenylboronic acid 9d, 4-
methylphenylboronic acid 9g and 4-methoxyphenylboronic acid 9f. LC-MS analysis of
crude reaction mixtures demonstrated that the reactions were completed in ten minutes
(Figure 5.14).
Encouraged by these results, we performed large-scale cross-coupling reactions using
crude extracts from 14-23 grams of hairy roots with three different boronic acids,
phenylboronic acid 9d, 4-fluorophenylboronic acid 9e and furanylboronic acid 9i.
Standard work-up followed by reverse-phase preparative HPLC purification of the
reaction mixture afforded milligram quantities of these analogs (Table 5.1). 'H and 13 C
NMR spectroscopy, high-resolution mass spectrometry, tandem MS/MS and UV
absorption spectra confirmed their identities (Table 5.2, Figure 5.15-5.16 and Appendix
C). High-resolution mass spectrometry and tandem MS/MS were used to confirm the
identities of the three remaining analogs 5f, 5g and 5h (Table 5.2 and Figure 5.15).
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Figure 5.10 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of TDC-suppressed hairy root extracts containing 12-chloro-19,20-
dihydroakuammicine 5a (m/z 359, bottom) and 12-chloro-19,20-dihydroakuammicine 5b
(m/z 403, top) with phenylboronic acid 9d to form 12-phenyl-19,20-dihydroakuammicine
5d (m/z 401).
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Figure 5.11 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of TDC-suppressed hairy root extracts containing 12-chloro-19,20-
dihydroakuammicine 5a (m/z 359, bottom) and 12-chloro-19,20-dihydroakuammicine 5b
(m/z 403, top) with 4-methylphenylboronic acid 9g to form 12-(4-methylphenyl)-19,20-
dihydroakuammicine 5g (m/z 415).
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Figure 5.12 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of TDC-suppressed hairy root extracts containing 12-chloro-19,20-
dihydroakuammicine 5a (m/z 359, bottom) and 12-chloro-19,20-dihydroakuammicine 5b
(m/z 403, top) with 4-methoxyphenylboronic acid 9f to form 12-(4-methoxyphenyl)-
19,20-dihydroakuammicine 5f (m/z 431).
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Figure 5.13 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of TDC-suppressed hairy root extracts containing 12-chloro-19,20-
dihydroakuammicine 5a (m/z 359) with 4-fluorophenylboronic acid 9e (bottom), 4-
carboxyphenylboronic acid 9h (middle) and furanylboronic acid 9i (top). Expected
products were 12-(4-fluorophenyl)- 19,20-dihydroakuammicine 5e (m/z 419), 12-(4-
carboxyphenyl)- 19,20-dihydroakuammicine 5h (m/z 445) and 12-furanyl-19,20-
dihydroakuammicine 5i (m/z 391).
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Figure 5.14 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of RebH/F hairy root extracts containing 12-chloro-19,20-dihydroakuammicine
5a (m/z 359) with phenylboronic acid 9d (bottom), 4-methylphenylboronic acid 9g
(middle) and 4-methoxyphenylboronic acid 9f (top). Expected products were 12-phenyl-
19,20-dihydroakuammicine 5d (m/z 401), 12-(4-methylphenyl)- 19,20-
dihydroakuammicine 5g (m/z 415) and 12-(4-methoxyphenyl)-19,20-
dihydroakuammicine 5f (m/z 431).
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Table 5.1. Suzuki-Miyaura cross-coupling reactions of 12-chloro- 19,20-
dihydroakuammicine 5a with aryl and heteroaryl boronic acids 9d-i.
N 5% mol Pd(OAc)2, SPhos, NK2CO 3, n-butanol
+ R1-B(OH) 2  A'
N 0 2Me 100 celcius, 10-60 min. H 
boronic acid substrates products isolated yield (%)*
B(OH) 2  N
N' -'H 50
9d - H CO 2CH 3
5d
B(OH) 2  N
F- 
-- H 51
--- H CO 2CH 3
9ex/
F
5e
B(OH)2  N
Meo H
-N - 'H Small-scale reaction
- H CO 2 CH3  Product not isolated
MeO
5f
B(OH) 2  N
Me 
-- N 'H Small-scale reaction
9g - H CO2 CH3  Product not isolated
Me
5g
B(OH) 2  N
HOOC *N- H Small-scale reaction
9h H CO2CH3  Product not isolated
HOOC
5h
N
o B(OH) 2  /
-- 'H 259i N9i - H CO 2 CH 3
N 0
5i
*compounds were purified using reverse-phase preparative HPLC
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Table 5.2. High-resolution MS data for 19,20-dihydroakuammicine analogs 5a-i (analogs
with substituent at the 7-position of the indole ring).
19,20- R = Cl R = Br R = phenyl R = 4-Fphenyl
dihydro- N N N N
akuammicine N 'H N I'H' N 'HN - 'H
CI H CO2CH 3  Br H CO 2CH 3  - H CO2CH3  - H CO 2CH 3
5 5a 5b 5d F
5e
Expected 359.1526 403.1021 401.2224 419.2129
[M+H]
Observed 359.1520 403.1011 401.2228 419.2133
[M+H]
Accuracy -1.7 -2.5 +1.0 +1.0
(ppm)
MS/MS 359.2,327.1 403.1,371.1 401.2,369.2 419.2,387.2
fragments
RT (min) 2.40 2.46 2.73 2.74
19,20- R = 4-methoxy R = 4-methyl R = 4-carboxy R = furanyl
dihydro- phenyl phenyl phenyl
akuammicine N N N N
-- -H 
-- -H N %HN NH CO2 CH 3  - C2CH3 H CO2CH3  C2CH3
HOOC0
MeO Me HO5 5f 5g 5h Si
Expected 431.2329 415.2380 445.2121 391.2016
[M+H]
Observed 431.2330 415.2376 445.2123 391.2015
[M+H]
Accuracy +0.2 -1.0 +0.4 -0.3
(ppm)
MS/MS 431.2,399.2 415.2,383.2 445.2,413.2 391.2,359.2
fragments
RT (min) 2.70 2.92 2.06 2.50
RT = retention time, LC gradient 10-90% acetonitrile/water (0.1% TFA) in 5 minutes
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Figure 5.15 MS/MS analysis for 19,20-dihydroakuammicine analogs 5d-i (analogs with
substituent at the 7-position of the indole ring)
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Figure 5.16 UV spectra of 19,20-dihydroakuammicine analogs 5a-e and 5i. A. 12-
chloro-19,20-dihydroakuammicine 5a. B. 12-bromo-19,20-dihydroakuammicine 5b. C.
12-phenyl-19,20-dihydroakuammicine 5d. D. 12-(4-fluorophenyl)-19,20-
dihydroakuammicine 5e. E. 12-furanyl-19,20-dihydroakuammicine 5i.
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We next focused our attention on the chemical derivatization of alkaloid analogs with a
chlorine at the 6-position of the indole ring (Figure 5.8). Crude extracts containing 11-
chloro-19,20-dihydroakuammicine 5c, 1 1-chloroakuammicine 6c and 11-
chlorotabersonine 7c appeared to be good substrates for the Suzuki-Miyaura cross-
coupling reactions using aryl and heteroaryl boronic acid substrates (Figure 5.17-5.22).
Of the six aryl and heteroaryl boronic acids (9d-i) tested, only the electron-deficient 4-
carboxyphenylboronic acid 9h did not yield the desired analogs (Figure 5.18, 5.20 and
5.22). High-resolution mass spectrometry and tandem MS/MS were used to confirm the
identities of all alkaloid analogs (Table 5.3-5.5 and Figure 5.23-5.25).
N
CI
NH CO2 CH3
6c
N
N
H CO2CH3
6c
N
N
H 00 2CH3
6c
m/z 357 + 429
m/z 357 + 429
10 min M' HC2H ~ 5 1
+ Me B(OH)2
9g
10mz 357 + 399
+ --,B(OH)2HC0H
9d 9d 0 minm/z 
357 + 399
- 14 11 2 1 2 0 2.Y "29 020 3 00 0 0 0 0 a 0 imne(min)
Figure 5.17 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 1 1-chloroakuammicine 6c (m/z 357) with phenylboronic acid 9d (bottom), 4-
methylphenylboronic acid 9g (middle) and 4-methoxyphenylboronic acid 9f (top).
Expected products were 1 1-phenylakuammicine 6d (m/z 399), 11-(4-methylphenyl)-
akuammicine 6g (m/z 413) and 11-(4-methoxyphenyl)-akuammicine 6f (m/z 429).
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Figure 5.18 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 1 1-chloroakuammicine 6c (m/z 357) with 4-fluorophenylboronic acid 9e
(bottom), 4-carboxyphenylboronic acid 9h (middle) and furanylboronic acid 9i (top).
Expected products were 1 1-(4-fluorophenyl)-akuammicine 6e (m/z 417), 11-(4-
carboxyphenyl)-akuammicine 6h (m/z 443) and 1 1-furanyl-akuammicine 6i (m/z 389).
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Figure 5.19 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 1 1-chloro-19,20-dihydroakuammicine 5c (m/z 359) with phenylboronic acid
9d (bottom), 4-methylphenylboronic acid 9g (middle) and 4-methoxyphenylboronic acid
9f (top). Expected products were 1 1-phenyl-19,20-dihydroakuammicine 5d' (m/z 401),
1 1-(4-methylphenyl)-19,20-dihydroakuammicine 5g' (m/z 415) and 11-(4-
methoxyphenyl)-19,20-dihydroakuammicine 5f' (m/z 431).
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Figure 5.20 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 11-chloro-19,20-dihydroakuammicine 5c (m/z 359) with 4-
fluorophenylboronic acid 9e (bottom), 4-carboxyphenylboronic acid 9h (middle) and
furanylboronic acid 9i (top). Expected products were 11-(4-fluorophenyl)-19,20-
dihydroakuammicine 5e' (m/z 419), 11-(4-carboxyphenyl)- 19,20-dihydroakuammicine
5h' (mlz 445) and 1 1-furanyl-19,20-dihydroakuammicine 5i' (m/z 391).
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Figure 5.21 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 11-chlorotabersonine 7c (m/z 371) with phenylboronic acid 9d (bottom), 4-
methylphenylboronic acid 9g (middle) and 4-methoxyphenylboronic acid 9f (top).
Expected products were 11-phenyltabersonine 7d (m/z 413), 11-(4-methylphenyl)-
tabersonine 7g (m/z 427) and 1 1-(4-methoxyphenyl)-tabersonine 7f (m/z 443).
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Figure 5.22 LC-MS traces showing the progression of Suzuki-Miyaura cross-coupling
reactions of 1 1-chlorotabersonine 7c (m/z 371) with 4-fluorophenylboronic acid 9e
(bottom), 4-carboxyphenylboronic acid 9h (middle) and furanylboronic acid 9i (top).
Expected products were 11-(4-fluorophenyl)-tabersonine 7e (m/z 431), 11-(4-
carboxyphenyl)-tabersonine 7h (m/z 457) and 11-furanyl-tabersonine 7i (m/z 403).
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Table 5.3. High-resolution MS data for akuammicine analogs 6c-i (analogs with
substituent at the 6-position of the indole ring).
Akuammicine R = Cl R = phenyl R = 4-Fphenyl
N N N
CI - - H 
- * '*H-
6 H CO2CH 3  H CO 2CH3  H CO2CH3
6c 6d 6e
Expected [M+H] 357.1364 399.2067 417.1955
Observed [M+H] 357.1355 399.2062 417.1955
Accuracy (ppm) -2.5 -1.3 0.0
MS/MS 357.1,325.1 n/a* 417.2,385.1
fragments
RT (min) 2.19 2.61 2.57
Akuammicine R = 4-methoxy R = 4-methylphenyl R = furanyl
phenyl
N IN
N
Meo N "HMe N v
CO2CH3 H CO2 CH3 - H60 N
H CO2CH36f 6g 6i
Expected [M+H] 429.2173 413.2224 389.1860
Observed [M+H] 429.2191 413.2219 389.1867
Accuracy (ppm) +4.3 
-1.2 +1.8
MS/MS n/a* 413.2,381.2 389.2,357.2
fragments
RT (min) 2.55 2.79 2.37
RT = retention time, LC gradient 10-90% acetonitrile/water (0.1% TFA) in 5 minutes
* Tandem MS/MS are not available because these analogs cannot be separated from
19,20-dihydroakuammicine analogs. Since the masses of akuammicine analogs and the
corresponding 19,20-dihydroakuammicine analogs only differ by 2 units, the ions are too
close to isolate prior to fragmentation.
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Table 5.4. High-resolution MS data for 19,20-dihydroakuammicine analogs 5c, 5d'-i'
(analogs substituent at the 6-position of the indole ring).
19,20-dihydro- R = Cl R = phenyl R = 4-Fphenyl
akuammicine N
CI -NH F N
N HN H CO2 CH3
5 H CO 2CH 3  H CO 2CH 3
5c 5d' 5e'
Expected [M+H] 359.1521 401.2224 419.2129
Observed [M+H] 359.1526 401.2216 419.2138
Accuracy (ppm) +1.4 -2.0 +1.9
MS/MS fragments 359.2,327.1 n/a* 419.2,387.2
RT (min) 2.28 2.65 2.65
19,20-dihydro- R = 4-methoxy R = 4-methylphenyl R = furanyl
akuammicine phenyl N N
N ~ H 0 *
Me N NNH Co2CH: H CO2CH3
5MeO N
5f' H CO2CH3 5g' 5i'
Expected [M+H] 431.2329 415.2380 391.2016
Observed [M+H] 431.2347 415.2395 391.2053
Accuracy (ppm) +4.2 +3.6 +9.4
MS/MS fragments n/a* 415.2,383.2 n/a*
RT (min) 2.58 2.84 2.41
RT = retention time, LC gradient 10-90% acetonitrile/water (0.1% TFA) in 5 minutes
* Tandem MS/MS are not available because these analogs cannot be separated from
akuammicine analogs. Since the masses of akuammicine analogs and the corresponding
19,20-dihydroakuammicine analogs only differ by 2 units, the ions are too close to isolate
prior to fragmentation.
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Table 5.5. High-resolution MS data for tabersonine analogs 7c-i (analogs with
substituent at the 6-position of the indole ring).
Tabersonine R = Cl R = phenyl R = 4-Fphenyl
,, 
HN
NH\ NH
7 C1 N F H CO2Me
H CO 2Me H CO2Me
7c 7d 7e
Expected [M+H] 371.1521 413.2224 431.2129
Observed [M+H] 371.1514 413.2233 431.2136
Accuracy (ppm) -1.8 +2.2 +1.6
MS/MS fragments 371.1,339.1 413.2,381.2 431.2,399.2
RT (min) 2.17 2.61 2.61
Tabersonine R = 4-methoxy R = 4-methyl phenyl R = furanyl
phenyl
N.H\ NH\,H
NH
MO CO2 Me Me N NH0OM H CO 2Me
7f 7g 7i
Expected [M+H] 443.2329 427.2380 403.2016
Observed [M+H] 443.2331 427.2376 403.2019
Accuracy (ppm) +0.5 -0.9 +0.7
MS/MS fragments 443.2,411.2 427.2,395.2 403.2,371.2
RT (min) 2.55 2.79 2.36
RT = retention time, LC gradient 10-90% acetonitrile/water (0.1% TFA) in 5 minutes
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Figure 5.23 MS/MS analysis for akuammicine analogs 6c, 6e, 6g and 6i (analogs with
substituent at the 6-position of the indole ring).
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Figure 5.24 MS/MS analysis for 19,20-dihydroakuammicine analogs 5c, 5d' and 5g'
(analogs with substituent at the 6-position of the indole ring).
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Figure 5.25 MS/MS analysis for tabersonine analogs 7c-i (analogs with
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5.3 Conclusions
Analogs of natural products, or "unnatural products", sometimes exhibit improved or
altered biological activities'. Efficient access to these analogs will greatly facilitate drug
discovery screening efforts. Efforts to modify C. roseus natural products described in
previous chapters have enabled regioselective installation of a chemical handle-the
organohalogens-into the indole moiety of monoterpene indole alkaloids. Using mild
cross-coupling reactions, these halogenated analogs were successfully derivatized with
several aryl and heteroaryl functional groups, which could further improve the bioactivity
of the compounds. In short, we have applied a chemogenetic approach-installation of a
chemical handle into the alkaloids, followed by postbiosynthetic chemical
derivatizations-to produce analogs of C. roseus MIAs. Efforts to screen these new
analogs for biological activies are underway. The effectiveness of this approach should
facilitate rational modification of other classes of natural products for biological activity
screening and drug development.
5.4 Experimental Methods
5.4.1 Extraction of Alkaloids from Transformed TDC-Suppressed Hairy Roots Fed
with Tryptamine Analog Subtrates
To obtain chlorinated and brominated alkaloids, root tips (10-15) from TDC-suppressed 3
(for 7-chlorotryptamine 2a and 7-bromotryptamine 2b) and STRvm 4 (for 6-
chlorotryptamine 2c) hairy roots were subcultured in 50 mL Gamborg's B5 liquid media
(half strength basal salts, full strength vitamins, 30 g/L sucrose, pH 5.7) and grown at
26'C in the dark at 125 rpm for three weeks prior to supplementing the media with
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tryptamine analogs 2a-c (600 tM final concentration). All tryptamine analog substrates
were synthesized as previously reported'8 .After two weeks of co-cultivation, hairy roots
were ground with a mortar, pestle and 106 pm acid washed glass beads in n-butanol (10
mL/g of fresh weight hairy roots). The crude natural product mixtures were filtered
through 0.2 tm cellulose acetate membrane (VWR) and subsequently subjected to LC-
MS analysis.
These crude alkaloid mixtures were diluted 1/100 with methanol for mass spectral
analysis. Samples were ionized by ESI with a Micromass LCT Premier TOF Mass
Spectrometer. The LC was performed on Acquity Ultra Performance BEH C18, 1.7 [tm,
2.1 x 100 mm column on a gradient of 10-90% acetonitrile/water (0.1% TFA) over 5
minutes at a flow rate of 0.6 mL/min. The capillary and sample cone voltages were 1300
and 60 V, respectively. The desolvation and source temperature were 300 and 100 *C.
The cone and desolvation gas flow rates were 60 and 800 L/hour. Analysis was
performed with MassLynx 4.1.
LC-MS analysis of these extracts indicated accumulation of 12-chloro-19,20-
dihydroakuammicine 5a when 7-chlorotryptamine 2a was supplemented to the media
(Figure 5.6); 12-bromo-19,20-dihydroakuammicine 5b when 7-bromotryptamine 2b was
added to the media (Figure 5.7); and 1 1-chloro-19,20-dihydroakuammicine 5c, 11-
chloroakuammicine 6c and 1 1-chlorotabersonine 7c when 6-chlorotryptamine 2c was
supplemented to the media (Figure 5.9).
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5.4.2 General Procedure for the Small-Scale Synthesis of Arvl Alkaloid Analogs
Crude extract mixtures containing chlorinated or brominated alkaloids were obtained
through extraction as described above from 100 mg of fresh hairy roots. The solvent was
removed from the mixtures under reduced pressure and the resulting crude solid was
placed under vacuum overnight. The crude solid was redissolved in 0.7 mL degassed
anhydrous n-butanol and to this mixture was added arylboronic acid (3.0 equiv.),
Pd(OAc) 2(0.05 equiv.), SPhos (0.13 equiv.) and K3P0 4 (5.0 equiv.). The mixture was
purged with argon and then stirred at 100 'C for 10 minutes until all of the chlorinated
alkaloid starting material has been consumed as observed by LC-MS.
The reaction mixture was allowed to cool to room temperature and then diluted with n-
butanol (4 mL). The mixture was filtered through 0.2 ltm cellulose acetate membrane
(VWR) and concentrated under vacuum. This oil was then sonicated for 30 minutes in 0.1
% TFA/water (5 mL). The acidified solution was washed with hexanes (3 X 5 mL) to
remove hydrophobic compounds. A solution of NH 40H was then used to adjust the pH of
the solution to 9. The basic aqueous solution was then extracted with ethyl acetate (3 X 5
mL). The organic fractions were combined and the solvent was concentrated under
vacuum to yield brown oil. This oil was redissolved in 25% acetonitrile/water (0.1%
water) and was purified on a 10 x 20 mm Vydec reverse phase column using a gradient of
25 - 60 % acetonitrile/water (0.1% TFA) over 30 minutes. Alkaloids were monitored at
228 nm and fractions containing the alkaloid analogs of interest were combined and
concentrated under vacuum. Isolated alkaloids were analyzed by LC-MS (same
parameters as above), analytical HPLC, high resolution LC-MS and tandem MS/MS.
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5.4.2 General Procedure for the Large-Scale Synthesis of Aryl Alkaloid Analogs
Crude extract mixtures containing chlorinated were obtained through extraction as
described in section 5.4.1 from 14-23g of fresh hairy roots. To quantify the amounts of
12-chloro-19,20-dihydroakuammicine 5a in the extracts, a standard curve was
constructed by quantifying the peak areas of several concentrations (20 - 1400 nM) of
12-chloro-19,20-dihydroakuammicine 5a authentic standard using MassLynx 4.1.
The solvent was removed from the mixtures under reduced pressure and the resulting
crude solid was placed under vacuum overnight. The crude solid was redissolved in 30-
50 mL degassed anhydrous n-butanol and to this mixture was added arylboronic acid (3.0
equiv.), Pd(OAc) 2 (0.05 equiv.), SPhos (0.13 equiv.) and K3PO4 (5.0 equiv.). The mixture
was purged with argon and then stirred at 100 'C for 60 minutes until all of the
chlorinated alkaloid starting material has been consumed as observed by LC-MS.
The reaction mixture was allowed to cool to room temperature and then filtered through
0.2 [tm cellulose acetate membrane (VWR) and concentrated under vacuum. This oil was
then sonicated for 30 minutes in 0.1 % TFA/water (25 mL). The acidified solution was
washed with hexanes (3 X 25 mL) to remove hydrophobic compounds. A solution of
NH 40H was then used to adjust the pH of the solution to 9. The basic aqueous solution
was then extracted with ethyl acetate (3 X 25 mL). The organic fractions were combined
and the solvent was concentrated under vacuum to yield brown oil. This oil was
redissolved in 25% acetonitrile/water (0.1% water) and was purified on a 10 x 20 mm
Vydec reverse phase column using a gradient of 25 - 60 % acetonitrile/water (0.1% TFA)
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over 30 minutes. Alkaloids were monitored at 228 nm and fractions containing the
alkaloid analogs of interest were combined and concentrated under vacuum.
Isolated alkaloids were analyzed by LC-MS (same parameters as above), analytical
HPLC, high resolution LC-MS, tandem MS/MS, UV-vis spectroscopy, 1H NMR and 13C
NMR using a Bruker AVANCE-600 NMR spectrometer equipped with a 5mm
1H{13C,31P} cryo-probe.
12-phenyl-19,20-dihydroakuammicine 5d
N
N
H CO2CH3
1H NMR (600 MHz, CD 30D): 8 7.55 (m, 4H), 7.43 (m, 2H), 7.31 (d, J = 7.2 Hz, 1H),
7.10 (t, J= 7.8 Hz, 1H), 4.68 (s, 1H), 3.77 (m, 1H), 3.73 (s, 3H), 3.58 (m, 1H), 3.42 (m,
1H), 3.35 (m, 1H), 3.21 (m, 1H), 3.09 (m, 1H), 2.28 (dd, J = 7.8, 13.8 Hz, 1H), 2.12 (m,
1H), 2.03 (m, 2H), 0.97 (m, 2H), 0.79 (t, J = 7.8 Hz, 3H); 13C NMR (126 MHz, CD30D):
8 169.06, 168.33, 141.86, 138.84, 135.41, 130.39 (2x), 129.99, 129.02, 128.78 (2x),
123.67,120.35, 101.22,97.43, 66.40,53.51, 53.18, 52.05,46.75,41.64,40.99, 30.51,
27.25, 24.06, 11.33; ESI-MS (m/z): [M]* calcd. for C26H2N 2O 2, 401.2224; found,
401.2228.
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12-(4-fluorophenyl)-19,20-dihydroakuammicine 5e
N
N
H CO2CH3
F
'H NMR (600 MHz, CD 30D): 6 7.59 (m, 2H), 7.43 (d, J = 7.2 Hz, 1H), 7.29 (m, 3H),
7.10 (t, J = 7.2 Hz, 1H), 4.68 (s, 1H), 3.74 (s, 3H), 3.72 (m, 1H), 3.56 (m, 1H), 3.42 (m,
1H), 3.35 (m, 1H), 3.19 (m, 1H), 3.09 (m, 1H), 2.27 (dd, J= 7.8, 14.4 Hz, 1H), 2.12 (m,
1H), 2.03 (m, 2H), 0.96 (m, 2H), 0.78 (t, J = 7.8 Hz, 3H); 13C NMR (126 MHz, CD30D):
8 169.07, 168.28, 135.47, 130.83, 130.76, 129.98, 124.98, 123.71, 120.47, 117.25,
117.08, 97.64, 66.38, 53.48, 53.16, 52.08, 46.73, 41.60, 40.98, 30.49, 27.22, 24.04, 11.32
(note that quaternary carbon peaks are not observed in 13C NMR); '9F NMR (376 MHz,
CD30D): 6 116.41; ESI-MS (m/z): [M]* calcd. for C26H27N202F, 419.2129; found,
419.2133.
12-furanyl-19,20-dihydroakuammicine Si
N
--HN
- H CO 2 CH 3
'H NMR (600 MHz, CD 30D): 6 7.73 (s, 1H), 7.53 (d, J = 7.8 Hz, 1H), 7.37 (d, J= 7.2
Hz, 1H), 7.04 (t, J = 7.2 Hz, 1H), 6.83 (d, J = 3.6 Hz, 1H), 6.62 (t, J = 1.2 Hz, 1H), 4.67
(s, 1H), 3.84 (s, 3H), 3.72 (m, 1H), 3.58 (m, 1H), 3.41 (m, 1H), 3.20 (m, 2H), 3.06 (m,
1H), 2.21 (dd, J = 7.8, 14.4 Hz, 1H), 2.13 (m, 1H), 2.06 (m, 2H), 0.97 (m, 2H), 0.78 (t, J
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= 7.2 Hz, 3H); 13C NMR (126 MHz, CD30D): 8 143.75, 125.78, 123.23, 120.19, 112.88,
107.42, 97.50, 66.36, 53.21,53.02, 52.14, 46.78,41.78, 40.96, 30.52, 27.23,24.05, 11.29
(note that quaternary carbon peaks are not observed in 13C NMR); ESI-MS (m/z): [M]*
calcd. for C24H26N20 3, 391.2016; found, 391.2015.
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CHAPTER 6
CONCLUSIONS AND FUTURE DIRECTIONS
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6.1 Conclusions
Medicinal plants produce an array of clinically useful compounds that have continued to
be an inspiration for synthetic chemists'. The work discussed in the preceding chapters
demonstrates that, despite their genetic and developmental complexity, medicinal plants
are also a viable platform for synthetic biology efforts. Chapter 2 describes the successful
introduction of a biosynthetic enzyme with redesigned substrate specificity into
periwinkle, a medicinal plant that produces monoterpene indole alkaloids including the
anticancer agents, vinblastine and vincristine (Figure 6.1)2. We show that the resulting
transgenic plant cell culture produced a variety of unnatural alkaloid compounds when
co-cultured with simple, achiral, commercially available precursors that the re-engineered
enzyme was designed to accept. Regenerated C. roseus plants from transformed hairy
roots have an apparent morphology and alkaloid profiles similar to that of wild-type
plants. To the best of our knowledge, this is the first time that this type of metabolic
engineering has been accomplished in plant culture.
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Figure 6.1. Overexpression of an engineered gene in C. roseus cell culture. STR:
strictosidine synthase.
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Chapter 3 describes the introduction of a new functional group- the organohalide- into
periwinkle alkaloid biosynthesis (Figure 6.2)3. We transformed prokaryotic halogenase
enzymes into the genome of periwinkle, which lacks the biosynthetic ability to produce
halogenated compounds. These prokaryotic halogenases function in the plant cell to
generate halogenated tryptophan, which is then shuttled into alkaloid metabolism
yielding halogenated monoterpene indole alkaloids. A new functional group- an
organohalide- is thereby introduced into the complex metabolism of C. roseus, and is
incorporated in a predictable and regioselective manner onto the plant alkaloid products.
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Figure 6.2. Introduction of prokaryotic halogenases into C. roseus cell culture.
Chapter 4 describes mutasynthesis of tryptamine-derived alkaloids in periwinkle cell
culture (Figure 6.3)4. We used RNA-mediated silencing of tryptophan decarboxylase to
suppress the biosynthesis of the endogenous tryptamine substrate. Monoterpene indole
alkaloid production almost completely disappeared in transformed hairy roots.
Monoterpene indole alkaloid biosynthesis could be rescued by the addition of tryptamine
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or a number of analogs to the culture medium. Notably, the yields of a number of
unnatural alkaloids derived from an exogenous unnatural tryptamine substrate were
improved because the natural alkaloids were no longer present. To the best of our
knowledge, this is the first example of mutasynthesis in a plant system.
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Figure 6.3. Mutasynthesis of tryptamine-derived alkaloids in C. roseus cell culture.
TDC: tryptophan decaboxylase.
Chapter 5 describes post-biosynthetic diversification of monoterpene indole alkaloids
(Figure 6.4). We utilized halogenated alkaloids that have been generated via strategies
described in Chapter 2-4 in palladium-catalyzed Suzuki-Miyaura cross-coupling
reactions. Several aryl and heteroaryl analogs of monoterpene indole alkaloids were
synthesized and purified in milligram quantities. The effectiveness of this approach will
facilitate rational modification of other classes of natural products for biological activity
screening and drug development.
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Figure 6.4. Chemogenetic approaches to derivatize halogenated alkaloids.
Appendix D describes the re-engineering of Papaver somn'ferum codeine O-demethylase
(PsCODM), a 2-oxoglutarate/Fe(II)-dependent dioxygenase in morphine biosynthesis, to
exhibit higher substrate specificity towards codeine (Figure 6.5). Wild type PsCODM
can catalyze the O-demethylation of both codeine and thebaine5 . Homology model of
PsCODM based on the crystal structure of Arabidopsis thaliana anthocyanidine synthase
(AtANS) was created, and PsCODM's substrate binding site, based on this protein model,
was identified. Rational site-directed mutagenesis of the residues that form the substrate-
binding pocket yielded a mutant that maintains its demethylase activity towards codeine
but not thebaine. We envision that this PsCODM mutant will be of great use in microbial
production of morphine. Specifically, reconstitution of morphine biosynthetic pathway in
yeast using this mutant instead of the wild type enzyme will prevent accumulation of an
off-pathway intermediate oripavine, thereby increasing the yield of morphine.
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MeO
Oripavine
Figure 6.5. Re-engineering of Papaver somniferum codeine O-demethylase (PsCODM)
in morphinan alkaloid biosynthetic pathway. T60DM: thebaine 6-0-demethylase; COR:
codeinone reductase; CODM: codeine O-demethylase.
6.2 Future Directions
6.2.1 Overcoming the Bottleneck in Halogenated Alkaloid Biosynthesis in RebH/F
Hairy Root Cultures
Chapter 3 describes the successful engineering of plant cell culture to produce
halogenated alkaloids autonomously 3. We introduced halogenase enzymes into
periwinkle hairy root culture, which lacks the biosynthetic ability to produce halogenated
compounds natively. These prokaryotic halogenases function in the plant cell to generate
halogenated tryptophan, which is then incorporated into alkaloid metabolism yielding
halogenated monoterpene indole alkaloids. Normally, tryptophan does not accumulate in
either wild type or transformed hairy roots. However, we observed chlorinated
tryptophan accumulation in transformed hairy roots, suggesting that decarboxylation of
chlorinated tryptophan is a bottleneck in vivo. This is consistent with the 30-fold-lower
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catalytic efficiency of the decarboxylase enzyme (TDC) for chlorinated tryptophan in
vitro. Accumulation of chlorinated tryptophan is not only "wasteful", but may cause the
apparent slow growth morphology in the hairy roots. Thus, we are presented with a
unique metabolic engineering problem to aleviate this bottleneck in halogenated alkaloid
production. Possible solutions are illustrated in Figure 6.6. i) Overexpress C. roseus TDC
along with RebH and RebF in C. roseus hairy root cultures. Both the constitutive and
inducible promoters should be explored to yield hairy root cultures with optimal
halogenated alkaloid production capacity and with no apparent growth abnormalities. ii)
Re-engineer C. roseus TDC to have greater substrate promiscuity. Specifically, identify a
TDC mutant that can decarboxylate halogenated tryptophan analogs with higher catalytic
efficiency compared to that of the wild type enzyme. Introduction of this re-engineered
enzyme into C. roseus should yield transformed hairy root cultures that accumulate lower
levels of chlorinated tryptophan and higher levels of chlorinated alkaloids. iii) Re-
engineer halogenases to chlorinate tryptamine preferentially over native substrate
tryptophan.
i. Overexpress C. roseus TDC along with RebH and RebF in C. roseus hairy root cultures
In the first engineering effort to overcome this bottleneck, Weslee Glenn constitutively
overexpressed TDC, in addition to RebH and RebF, in C. roseus hairy roots (i, Figure
6.6). Transformed lines accumulated lower levels of 7-chlorotryptophan, suggesting that
higher expression of TDC led to the expected greater clearance of the compound (Glenn
and O'Connor, unpublished). However, for reasons that remain unclear, lower levels of
chlorinated alkaloids were observed in these transgenic lines compared to lines that had
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Figure 6.6. Strategies to overcome the bottleneck in halogenated alkaloid biosynthesis in
RebH/F hairy root cultures. TDC: tryptophan decarboxylase.
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been transformed with only RebH and RebF. Moreover, TDC/RebF/H transformed lines
grew significantly slower than RebF/H lines and stopped growing altogether after several
subcultures. Glenn and O'Connor's findings are consistent with previous studies that
observed similar growth retardation and low alkaloid levels in C. roseus cell cultures that
constitutively overexpress TDC. Therefore, instead of using constitutive promoters to
drive the expression of TDC, future engineering efforts should utilize inducible
promoters, such as the glucocorticoid- and ethanol-inducible promoters6 '7 . In addition to
enabling temporal control of gene expression, these promoters have been shown to be
dose dependent; expression level correlates with the concentration of the inducer (i.e.
glucocortisone or ethanol) in the culture media. We envision that having the ability to
control both when and how much to overexpress TDC will allow us to prevent the
wasteful buildup of chlorinated tryptophan while minimizing the detrimental effects of
TDC constitutive overexpression.
ii. Re-engineer C. roseus TDC to have greater substrate promiscuity
Another strategy to prevent the accumulation of chlorinated tryptophan is to improve the
rate of the decarboxylation step. Specifically, TDC should be re-engineered to carry out
the decarboxylation of chlorinated and brominated tryptophan with higher catalytic
efficiency (ii, Figure 6.6). While the crystal structure of C. roseus TDC has not been
determined at this time, the structures of several mammalian aromatic amino acid
decarboxylases are available. Of these, C. roseus TDC shows the highest sequence
identity (42%) to the pig kidney L-DOPA decarboxylase, which converts L-
dihydroxyphenylalanine (L-DOPA) to dopamine8 . Homology models of C. roseus TDC
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based on the structure of the pig kidney L-DOPA decarboxylase will provide structural
insights into the enzyme's substrate binding pocket. Rational re-design of TDC should be
done to yield mutants with enhanced catalytic efficiency towards chlorinated and
brominated tryptophan analogs. Introduction of this re-engineered enzyme along with
RebH and its reductase partner into C. roseus should yield transformed hairy root cultures
that accumulate lower levels of chlorinated tryptophan and higher levels of chlorinated
alkaloids.
iii. Re-engineer halogenases to chlorinate tryptamine preferentially over native substrate
tryptophan
Plant primary metabolism is an essential part of plant survival, whereas secondary
metabolites (sometimes referred to as 'specialized metabolites'), while not fully
elucidated, are implicated to be involved in plant defense9 .The modification-integration
of a halogen moiety-that we have introduced into C. roseus occurs immediately after
the proposed final step of primary metabolism. Engineering at this step may affect plant
development more strongly than modifications done later in secondary metabolism.
Ideally, we should introduce halogenase enzymes that modify tryptamine, the substrate
proposed to be at the beginning of secondary metabolism. Engineering at this step may
prevent any undesirable, detrimental effects on plant growth (iii, Figure 6.6). Therefore,
RebH should be re-engineered to chlorinate tryptamine preferentially over native
substrate tryptophan. An ongoing effort by Weslee Glenn has identified a RebH mutant
that prefers tryptamine over tryptophan at physiological concentrations of both substrates
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(Glenn and O'Connor). The re-engineered mutant should be introduced to C. roseus hairy
root culture for in vivo production of halogenated MIAs.
6.2.2 Generation of Transgenic Plant Culture Expressing 6- and 4-halogenases
The experiments described in chapter 3 demonstrate that a new functional group- an
organohalide- can be introduced into the complex metabolism of C. roseus (Figure 6.7)3.
At present, we have successfully incorporated halides in a regioselective manner onto the
plant alkaloid products at two different positions (5- and 7-positions) on the indole ring.
A halogenase enzyme that chlorinates tryptophan at the 6-position has been identified.
Like RebH and PyrH, the 6-halogenase enzyme, called Thal, is flavin-dependent and
requires a partner reductase to maintain flavin at the functional oxidation state. In vitro
studies demonstrate that Thal can also use bromide to yield 6-bromotryptophan'0 . Future
efforts should focus on the introduction of Thal, along with flavin reductase RebF and the
strictosidine synthase mutant STRvm into C. roseus to generate transformed plant culture
capable of producing chlorinated and brominated alkaloids.
Though there is speculation of their existence, at present halogenases that chlorinate
tryptophan at the 4-position have not yet been identified. Several proposed auxin
biosynthetic pathways use tryptophan as the precursor". In one proposed pathway,
tryptophan is converted to tryptamine before being further metabolized in several steps to
the auxin indole-3-acetic acid (IAA). It is mechanistically plausible that another auxin, 4-
chloroindole-3-acetic acid (the 4-chloro analog of IAA), is derived from either 4-
chlorotryptophan or 4-chlorotryptamine, suggesting that plant 4-halogenase enzymes may
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exist. Once such a halogenase is identified, it should be introduced into C. roseus to
generate transformed plant culture capable of producing chlorinated alkaloids.
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Figure 6.7. Generation of transgenic plant cultures capable of producing chlorinated and
brominated alkaloids.
6.2.3 Applying Combinatorial Biosynthesis to Other Monoterpene Indole Alkaloid
Pathways
Plants in the Apocynaceae, Loganiaceae, Rubiaceae and Nyssaceae families all produce
monoterpene indole alkaloids with dramatically diverse structures 12 . The studies
described in the preceding chapters focused primarily on C. roseus for various practical
reasons: C. roseus seedlings grow relatively quickly (1 week germination time); are
amenable to genetic transformation and hairy root-to-plant regeneration; and the
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biosynthetic pathway has been partially elucidated. From medicinal chemistry standpoint,
however, other MIA-producing plants are equally important and similarly deserving of
metabolic reprogramming/synthetic biology efforts (Figure 6.8). Camptotheca
acuminata and Ophiorrhiza pumila both produce the antitumor agent camptothecin;
Rauwolfia serpentina produces the antiarrhythmic agent ajmaline; and strychnos nux-
vomica produces the convulsant strychnine. The success of these engineering efforts
depends on how substrate specific these other MIA biosynthetic pathways are. We
envision that the introduction of re-engineered STR or prokaryotic halogenases into other
MIA producing plants will lead to production of unnatural alkaloids.
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Figure 6.8. Metabolic reprogramming of alkaloid biosynthesis in MIA-producing plant
cell cultures.
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6.2.4 Cloning of MIA Biosynthetic Genes and Elucidation of MIA Biosynthetic
Pathway
Advances in plant metabolism research have not been as dramatic as those in prokaryotic
and fungal systems. Recent decades have witnessed successful engineering of microbial
systems to produce high-value natural and unnatural compounds at industrial scale
(Chapter 1)"3-". The primary reason for the lag in plant metabolism research is the
complexity associated with cloning plant biosynthetic genes in plants. Genes of plant
biosynthetic pathways are normally unclustered, and many biosynthetic enzymes are
labile or expressed in low abundance. Therefore, the identification of enzymes is
typically more arduous in plant metabolism research. While traditional purification
strategies remain an effective strategy for identifying certain plant enzymes, modern
approaches are clearly needed to fully elucidate the monoterpene indole alkaloid
pathway-along with many other plant pathways-in a rapid timeframe. A collaborative
research endeavor among the O'Connor group and several other groups is focused on
obtaining the transcriptomic and metabolomic data for C. roseus and 13 other medicinal
plants. By correlating the transcript levels and metabolite profiles for each tissue types
(e.g. root, stem, shoot, flowers, leaves), gene-metabolite maps can be created to facilitate
the identification of genes involved in the biosynthesis of a specific metabolite. These
gene discovery efforts will enable heterologous production of natural and unnatural
alkaloids in microbial systems.
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6.2.5 Biological Activity Screening of MIA Analogs
The experiments described in the preceding chapters produced a variety of analogs of
ajmalicine, tabersonine, catharanthine, serpentine, akuammicine and
dihydroakuammicine. Many of these natural alkaloids have known biological activities.
Ajmalicine is an adrenergic receptor antagonist and is used clinically to treat high blood
pressure", '. Serpentine is a topoisomerase II inhibitoro and several serpentine analogs
have been shown to exhibit superior inhibitory activity to the natural serpentine (McCoy,
Usera and O'Connor, unpublished). Akuammicine is an opioid receptor agonist21 .
Tabersonine derivatives, Jerantinines A-G, exhibit cytotoxic activity against human KB
cells2 2 . It is imperative to screen MIA analogs for biological activity. We have submitted
several of these compounds for biological activity screening at Vanderbilt University.
Future experiments should aim to assay the remaining analogs for a broad range of
biological assays.
6.2.6 Coupling Reactions In Planta
Chapter 5 describes chemical derivatization of chlorinated and brominated alkaloids with
a variety of aryl and heteroaryl boronic acids via the palladium-catalyzed Suzuki-
Miyaura coupling reactions. Our current approach involves two separate steps: 1) obtain
halogenated analogs by genetic engineering of C. roseus either with or without precursor-
feeding and (2) modify these halogenated analogs synthetically via the Suzuki-Miyaura
coupling reactions. After one week of culture in the presence of halogenated tryptamine
substrates, the plant material is lysed and alkaloids are extracted into an organic solvent.
The crude alkaloid extracts are then used in the chemical derivatization reaction. We
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envision that the efficiency of the process will be improved if the coupling reactions can
be performed inside the plant cells.
In a recent work, Bradley and coworkers have extended the versatility of the Suzuki-
Miyaura coupling reactions by performing the reaction inside living cells23 . Palladium is
normally toxic to cells, rendering previous attempts at in vivo coupling reactions
unsuccessful. To overcome this problem, the team trapped palladium nanoparticles within
polystyrene microspheres, thereby preventing the metal catalyst from killing the cells.
The polystyrene microspheres with immobilized palladium can enter eukaryotic cells and
mediate the Suzuki-Miyaura cross-coupling reactions. Applying this strategy to plant cell
and tissue cultures will provide a direct one-step access to MIA analogs. Brominated
analogs are sufficiently activated to undergo the coupling reactions at 26'C, the
temperature at which hairy roots are normally maintained. Specifically, one week after
supplementing the culture with brominated tryptamine substrates, the polystyrene
microspheres with immobilized palladium nanoparticles will be supplemented into the
hairy root media along with the other coupling reagents. Portions of hairy roots will be
taken out from the culture at different time intervals for alkaloid assessment. The success
of this strategy depends on, among other factors, whether or not the palladium catalyst
and the other coupling reagents will be accessible to brominated alkaloids. Will
polystyrene microspheres and other coupling reagents be able to enter plant cells? If so,
will they all be localized in the organelle(s) where brominated alkaloids are accumulated?
These are not easy questions to answer, and the underlying challenges are by no means
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straightforward to overcome. Nevertheless, we envision that the success of this strategy
will find broad applications in in planta labeling and alkaloid localization studies.
6.2.7. Elucidating the Physiological Role of MIAs
Extensive efforts have led to the elucidation of physiological functions of a number of
plant-derived alkaloids, such as the pyrrolizidine and tropane alkaloids 24 . For example,
transgenic tobacco plants in which the nicotine biosynthetic pathway is genetically
silenced have been used to demonstrate the defensive role of nicotine. In contrast, while
medicinal properties of MIAs are well documented, their physiological roles remain
largely unknown. In C. roseus, MIA biosynthesis can be elicited by fungal extracts26,
suggesting that MIA biosynthesis appears to be a plant response to fungal attack.
Moreover deglycosylated strictosidine has been shown to exhibit weak anti-microbial
activity27 , suggesting that the compound may deter pathogens. However, aside from these
examples, the roles MIAs play in C. roseus are not known. Specifically, what advantage
do these compounds confer to the producing organism?
Chapter 4 describes suppression of tryptamine biosynthesis in C. roseus hairy root
cultures 4. Alkaloid production almost completely disappeared in transformed hairy roots.
The lack of tryptamine and downstream alkaloids did not appear to affect the growth or
morphology of the silenced cultures, indicating that tryptamine and downstream alkaloids
do not play an essential role in the controlled environment of plant cell culture. We
attempted to regenerate C. roseus plants from these transformed hairy roots. These
tryptamine-deficient plantlets appeared to be regenerating normally in plant media under
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sterile environment. However, once the plantlets were transferred to soil (Miracle gro),
they exhibited severe growth retardation and were unviable. Together, these experiments
suggest that while tryptamine and MIAs do not appear to play an essential role in growth
or development in C. roseus hairy root culture, they may be vital for whole plant survival
in a non-controlled environment.
Tryptamine and its precursor tryptophan may be involved in the biosynthesis of auxins,
which play an essential role in plant development". Therefore, the primary reason that
tryptamine-deficient plants are not viable in a non-controlled environment may not be
directly related to the absence of MIAs but rather the detrimental perturbation of auxin
biosynthesis associated with TDC silencing. To determine the ecological roles of MIAs,
another precursor should be targeted for suppression. Previous attempts to suppress
secologanin biosynthesis in C. roseus hairy root cultures using the chemical inhibitor
fosmidomycin had no apparent adverse effects on root growth28 . Moreover, secologanin
is produced in only a few plant species, suggesting that it does not have a general
function in plant metabolism. Simply put, suppression of secologanin biosynthesis
provides a more unambiguous route to elucidate the physiological roles of MIAs. To
accomplish this, at least one of the three known biosynthetic enzymes in secologanin
pathway (i.e. geraniol 10-hydroxylase (G1OH), loganic acid methyl transferase (LOMT)
and secologanin synthase (SLS)) will be silenced (Chapter 1). Suppression of the more
upstream enzyme-G1OH, in this case-is ideal because it will not lead to any wasteful
buildup of pathway intermediates. We envision that silencing of G1OH, just as in the case
of silencing of TDC, will completely obliterate alkaloid biosynthesis. By using the same
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procedure described in Chapter 4, G1OH-suppressed hairy roots will be generated. Mass
spectrometry and reverse transcription PCR analyses will be used to ensure suppression
of alkaloid biosynthesis. Transformed hairy roots will be used to regenerate the
corresponding transgenic plants. As a control, all regenerated plants will be compared to
a control plant that has been regenerated from wild type hairy root culture that lacks any
silencing plasmid. If G1OH-suppressed plants appear to be viable on soil, we will assess
the alkaloid content in the leaves, stems and the root tissue of these regenerated plants.
Finally, a more thorough study detailing how 'alkaloid-free' C. roseus plants interact with
pathogens from the environment will provide some of the very first data regarding the
ecological roles of MIAs.
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CHAPTER 2 - APPENDIX A
LC-MS TRACES AND NMR SPECTRA:
EVALUATION OF ALKALOID
PRODUCTION IN ENGINEERED C. ROSEUS
Part of this appendix is published as a brief communication in
Nature Chemical Biology 2009, 5, 151-153
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Figure 2A.1, A-B Chapter 2. LC-MS traces of selected alkaloid analogs formed by
feeding 5-chlorotryptamine 2a to 2-week-old pCAMV214M hairy roots (cell lines 31, 37
and 49). Formation of chlorinated analogs (A, m/z 371, 337+34; and B, m/z 387, 353+34)
upon feeding of 5-chlorotryptamine 2a to hairy roots. These analogs (m/z M+34) are
absent in pTAV214M cultures (cell lines 3) fed with 5-chlorotryptamine 2a either with or
without the glucocorticoid inducer, dexamethasone, as well as in wild-type and
pCAMWT cultures fed with 5-chlorotryptamine 2a.
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Figure 2A.1, C-D Chapter 2. LC-MS traces of selected alkaloid analogs formed by
feeding 5-chlorotryptamine 2a to 2-week-old pCAMV214M hairy roots (cell lines 31, 37
and 49). Formation of chlorinated analogs (C, m/z 385, 351+34; and D, m/z 373, 339+34)
upon feeding of 5-chlorotryptamine 2a to hairy roots. These analogs (m/z M+34) are
absent in pTAV214M cultures (cell lines 3) fed with 5-chlorotryptamine 2a either with or
without the glucocorticoid inducer, dexamethasone, as well as in wild-type and
pCAMWT cultures fed with 5-chlorotryptamine 2a.
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Figure 2A.1, E-F Chapter 2. LC-MS traces of selected alkaloid analogs formed by
feeding 5-chlorotryptamine 2a to 2-week-old pCAMV214M hairy roots (cell lines 31, 37
and 49). Formation of chlorinated analogs (E, m/z 383, 349+34; and F, m/z 389, 355+34)
upon feeding of 5-chlorotryptamine 2a to hairy roots. These analogs (m/z M+34) are
absent in pTAV214M cultures (cell lines 3) fed with 5-chlorotryptamine 2a either with or
without the glucocorticoid inducer, dexamethasone, as well as in wild-type and
pCAMWT cultures fed with 5-chlorotryptamine 2a.
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Figure 2A.2 Chapter 2. LC-MS traces of selected alkaloid analogs formed by feeding 5-
chlorotryptamine 2a to 2-week-old pCAMV214M hairy roots showing characteristic
isotopic signature of chlorine. Intensities are normalized pairwise.
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Figure 2A.3, A-B Chapter 2. LC-MS traces of selected alkaloid analogs formed by
feeding 5-bromotryptamine 2c to 2-week-old pCAMV214M hairy roots (cell lines 31, 37
and 49). Formation of brominated analogs (A, m/z 431, 353+78; and B, m/z 417, 339+78)
upon feeding of 5-bromotryptamine 2c to hairy roots. These analogs (m/z M+78) are
absent in wild-type culture fed with 5-bromotryptamine 2c.
281
4106 _ftA -- , - - - - - - -- - __ - - -- ft -__
pCAMBIAV214MA cell line 49
+ 5- bromotryptamine nwk 427
pCAMBIAV214M coll lIne 37
+5- bromotryptane n0 427
pCAMBIAV214M cell line 31
+ 5 brmorypailnen*427
Wildtype hairy root
+ 5-bromotryptamine nat 427
6.75 700 725
Time (min)
iL~N~ pCAMBIAV214M cell lIne 4+5- bromotryptamne n* 433
pCAMBIAV214M cell line 37
+ 5- bromotryptamne naz 433
Time (min)
Figure 2A.3, C-D Chapter 2. LC-MS traces of selected alkaloid analogs formed by
feeding 5-bromotryptamine 2c to 2-week-old pCAMV214M hairy roots (cell lines 31, 37
and 49). Formation of brominated analogs (C, m/z 427, 349+78; and D, m/z 433, 355+78)
upon feeding of 5-bromotryptamine 2c to hairy roots. These analogs (mlz M+78) are
absent in wild-type culture fed with 5-bromotryptamine 2c.
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Figure 2A.4 Chapter 2. LC-MS traces of selected alkaloid analogs formed by feeding 5-
bromotryptamine 2c to 2-week-old pCAMV214M hairy roots showing characteristic
isotopic signature of bromine. Intensities are normalized pairwise.
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Figure 2A.5, A-B Chapter 2. LC-MS traces of selected alkaloid analogs formed by
feeding 5-methyltryptamine 2b to 2-week-old pCAMV214M hairy roots (cell lines 31, 37
and 49). Formation of methylated analogs (A, m/z 351, 337+14; and B, m/z 367, 353+14)
upon feeding of 5-methyltryptamine 2b to hairy roots. Note that some of these analogs
(m/z M+14) are still present, though in significantly lower quantities, in wild-type culture
fed with 5-methyltryptamine 2b. Definitive assignment of the structure of these
compounds as originating from 2b depends on more detailed structural characterization.
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Figure 2A.5, C-D Chapter 2. LC-MS traces of selected alkaloid analogs formed by
feeding 5-methyltryptamine to 2-week-old pCAMV214M hairy roots (cell lines 31, 37
and 49). Formation of methylated analogs (C, m/z 365, 351+14; and D, m/z 353, 339+14)
upon feeding of 5-methyltryptamine 2b to hairy roots. Note that some of these analogs
(m/z M+14) are still present, though in significantly lower quantities, in wild-type culture
fed with 5-methyltryptamine 2b. Definitive assignment of the structure of these
compounds as originating from 2b depends on more detailed structural characterization.
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Figure 2A.5, E-F Chapter 2. LC-MS traces of selected alkaloid analogs formed by
feeding 5-methyltryptamine to 2-week-old pCAMV214M hairy roots (cell lines 31, 37
and 49). Formation of methylated analogs (E, m/z 363, 349+14; and F, m/z 369, 355+14)
upon feeding of 5-methyltryptamine 2b to hairy roots. Note that some of these analogs
(m/z M+14) are still present, though in significantly lower quantities, in wild-type culture
fed with 5-methyltryptamine 2b. Definitive assignment of the structure of these
compounds as originating from 2b depends on more detailed structural characterization.
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Figure 2A.6 Chapter 2. LC-MS traces of selected alkaloid analogs formed by feeding
either 5-chlorotryptamine or 5-methyltryptamine to 2-week-old pCAMV214M hairy
roots showing relative production levels of natural alkaloids (ajmalicine 4 and
tabersonine 5) compared to unnatural chlorinated/methylated alkaloids. Intensities are
normalized pairwise. The ratio of natural catharanthine to natural tabersonine (green
traces) changes depending on whether 2a or 2b is fed to the cultures.
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CHAPTER 3 - APPENDIX B
LC-MS TRACES, NMR SPECTRA, UV SPECTRA AND MS/MS ANALYSIS:
EVALUATION OF ALKALOID PRODUCTION IN ENGINEERED C. ROSEUS
Part of this appendix is published as a letter in
Nature 2010, 468, 461-464
293
7-chorotryoi
0 m/z 239
iti.116o i66 h 1 '. 0 .k0 4 '2b TZ V i
"RebF/H line 5 N m/z 239
RebF/H line4 m/z 239
RebF/H line 3 m/z 239
1il CM NP~IP i 0 1 * or. 2b0 2;0 240 260 2.8l RebF/H line 2rz23
RebF/H line I m/z 239
''. PRO............i7'i6 poli 240 2h0.1
r Wild type line!o m/z 239
Time (min)
7-chlorotryptophan
Al N.4 m/z 239
RebF/H line 11
m/z 239
I RebF/H line 10 
z23
P ' .11 V-1 hoN Io go 2o 2o b b1.0 I 0' JO I.t TVi "M 240 71-02b
RebF/H line 9 m/z 239
ibo 120 140 ibbit 160 2.00 2 *02' 77 12'
RebF/H line 8 mlz 239
'I'li ~ ~ ~ ~ / 239r, 7; ~z 1b 1
RebF/H line 7 m/z 239
1 11............ 2..... 2....2Ao0 2.8 2.80
Z%
S RebF/H line 6
Time (min)
m/z 239
IaO ij. bai'*" bo 2 0' =280
Figure 3B.1, A-B Chapter 3. Extracted LC-MS chromatograms showing the presence of
7-chlorotryptophan la (mlz 239) in several RebF/H hairy roots. This compound, which is
not observed in control cultures transformed with no plasmid, co-elutes with an authentic
standard of 7-chlorotryptophan la.
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Figure 3B.1, C-D Chapter 3. Extracted LC-MS chromatograms showing the presence of
7-chlorotryptophan la (mlz 239) in several RebF/H hairy roots. This compound, which is
not observed in control cultures transformed with no plasmid, co-elutes with an authentic
standard of 7-chlorotryptophan la.
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Figure 3B.1, E Chapter 3. Extracted LC-MS chromatograms showing the presence of 7-
chlorotryptophan la (m/z 239) in several RebF/H hairy roots. This compound, which is
not observed in control cultures transformed with no plasmid, co-elutes with an authentic
standard of 7-chlorotryptophan la.
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Figure 3B.2, A-B Chapter 3. Extracted LC-MS chromatograms showing the presence of
7-chlorotryptamine 2a (m/z 195) in several RebF/H hairy roots. This compound, which is
not observed in control cultures transformed with no plasmid, co-elutes with an authentic
standard of 7-chlorotryptamine 2a.
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Figure 3B.2, C-D Chapter 3. Extracted LC-MS chromatograms showing the presence of
7-chlorotryptamine 2a (mlz 195) in several RebF/H hairy roots. This compound, which is
not observed in control cultures transformed with no plasmid, co-elutes with an authentic
standard of 7-chlorotryptamine 2a.
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Figure 3B.2, E Chapter 3. Extracted LC-MS chromatograms showing the presence of 7-
chlorotryptamine 2a (m/z 195) in several RebF/H hairy roots. This compound, which is
not observed in control cultures transformed with no plasmid, co-elutes with an authentic
standard of 7-chlorotryptamine 2a.
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Figure 3B.3, A-B Chapter 3. Extracted LC-MS chromatograms showing the presence of
12-chloro-19,20-dihydroakuammicine 5a (m/z 359) in selected RebF/H hairy roots. This
compound, which is not observed in control cultures transformed with no plasmid, co-
elutes with an authentic standard of 12-chloro-19,20-dihydroakuammicine 5a.
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Figure 3B.3, C-D Chapter 3. Extracted LC-MS chromatograms showing the presence of
12-chloro-19,20-dihydroakuammicine 5a (m/z 359) in selected RebF/H hairy roots. This
compound, which is not observed in control cultures transformed with no plasmid, co-
elutes with an authentic standard of 12-chloro-19,20-dihydroakuammicine 5a.
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Figure 3B.3, E Chapter 3. Extracted LC-MS chromatograms showing the presence of 12-
chloro-19,20-dihydroakuammicine 5a (mlz 359) in selected RebF/H hairy roots. This
compound, which is not observed in control cultures transformed with no plasmid, co-
elutes with an authentic standard of 12-chloro-19,20-dihydroakuammicine 5a.
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Figure 3B.4, A-B Chapter 3. Extracted LC-MS traces showing the isotopic distribution
expected for a chlorinated compound.
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Figure 3B.4, C Chapter 3. Extracted LC-MS traces showing the isotopic distribution
expected for a chlorinated compound.
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Figure 3B.5, A-B Chapter 3. Extracted LC-MS traces showing the production of
chlorinated alkaloids along with the traces showing production of the parent natural
alkaloids from the same cultures.
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Figure 3B.5, C Chapter 3. Extracted LC-MS traces showing the production of
chlorinated alkaloids along with the traces showing production of the parent natural
alkaloids from the same cultures.
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Figure 3B.6, A-B Chapter 3. Chlorinated alkaloid production in PyrH/RebF/STRvm
hairy roots (line 7) as evidenced by LC-MS analysis of C. roseus extracts. The mutant
strictosidine synthase enzyme, STRvm, is not expressed in this line as evidenced by real
time PCR.
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Figure 3B.7, A-B Chapter 3. Chlorinated alkaloid production in RebF/H hairy roots after
1, 2, 6, 7, 11 and 13 subcultures as evidenced by LC-MS analysis of C. roseus extracts.
308
m/z 359
c~I
m/z 359
3.20
m/z 359
m/z 359
2A0 2.60 2
m/z 239
220 2.4 2.60 2.k
m/z 239
... .
m/z 239
m/z 239
.
"M W
O*M I
..
-
0 ' ' ' 'i. b d
-M ..... 3716 -
1A 07 0 20 2 2;
i 0
NaNH2
NH
U 1 -1 0 ~o~ ik %.4 "b020
after 13 subcultures
after 11 subcultures
m/z 195
m/z 195
100 1.20 140
after 7 subcultures
100 17 1O
after 6 subcultures
a 2n 1.40tues
after 2 subcultures
1.00 10 1. 40
RebF/H line 5
after 1 subculture
0 1.20 1.40
Time (min)
1.0 1.1 260 2.2 2.W 0 2.c 2k
Figure 3B.7, C Chapter 3. Chlorinated alkaloid production in RebF/H hairy roots after 1,
2,6,7, 11 and 13 subcultures as evidenced by LC-MS analysis of C. roseus extracts.
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Figure 3B.8, A-B Chapter 3. Chlorinated alkaloid production in PyrH/RebF/STRvm
hairy roots (line 1) after 2, 3 and 4 subcultures as evidenced by LC-MS analysis of C.
roseus extracts.
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Figure 3B.8, C-D Chapter 3. Chlorinated alkaloid production in PyrH/RebF/STRvm
hairy roots (line 1) after 2, 3 and 4 subcultures as evidenced by LC-MS analysis of C.
roseus extracts.
311
12-chloro-19,20- m/z 359
* a dihydroakuammicine a ccca
1 1 1.40 7.16 'ib0' ..40 .Ub 'k '. i
RebF/H line 5 m/z 359
+ 20m M KCI \
RebF/H line 5 m/z 359
+ 15 mM KC
RebF/H line 5 m/z 359
+10mM KCI
1. 1.40 1.0 1.1200 .h 140 k0 b'3.W 03.k3
RebF/H line 5 m/z 359
+ 5 mM KCI mz3
P. - 140 1. 0 V -2 bo2 0 1 ... b
RebF/H line 5
m/z 359
+ 0 mM KCI
l)lk 1'.40 i b.bd .bd. 140 2h...... ... 3.40 3
Time (min)
NH2
7-chlorotryptophan m/z 239
RebF/H line 5 m/lz 239
+ 20 mnM KCI
o.................
1b0k i.o ..... 13 2O 2 ~ '2.9" h2
1 RebF/H line 5 m/z 239
+15 mM KCl
lAI 1.. 1.6, ... 2k 240 260 2
RebF/H line 5 m/z 239
+ 10 mM KCI
1 .IAO A.16 316 166 7E 27Z 22 IWO
1 RebF/H Iline 5 
rl 3
+5mMKCI 
2RebF/H line 5
m/z 239
+0mMKC
1 1A 4 to 'i.7oo.220.240 6 12
Time (min)
Figure 3B.9, A-B Chapter 3. Levels of chlorinated alkaloid 5a and 7-chlorotryptophan
la in response to increasing KCl concentration.
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Figure 3B.9, C Chapter 3.
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Figure 3B.10 Chapter 3. Extracted LC-MS traces comparing the production of
chlorinated and brominated alkaloids in selected RebF/H hairy roots growing on solid
media that have been supplemented with KBr (0 - 20 mM).
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Figure 3B.11 Chapter 3. Accumulation of the major natural alkaloids (tabersonine 7,
catharanthine 8 and ajmalicine 6) that are produced in wild type hairy roots.
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Figure 3B.18 Chapter 3. UV spectra of chlorinated and brominated alkaloids. A. 12-
chloro-19,20-dihydroakuammicine 5a. B. 12-bromo-19,20-dihydroakuammicine 5c.
C.10-chloroajmalicine 6b. D. 15-chlorotabersonine 7b. E. 10-cholorocatharanthine 8b.
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Figure 3B.19 Chapter 3. MS/MS analysis for (A) 12-chloro-19,20-dihydroakuammicine
5a and (B) 12-bromo-19,20-dihydroakuammicine 5c. (A) 12-chloro-19,20-
dihydroakuammicine 5a is identified as the m/z = 359.2 ion showing the fragment m/z =
327.1. (B) 12-bromo-19,20-dihydroakuammicine 5c is identified as the m/z = 403.1 ion
showing the fragment m/z = 371.1.
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RE-ENGINEERING DIOXYGENASES IN MORPHINE BIOSYNTHETIC PATHWAY
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D.1 Introduction
The opium poppy (Papaver somniferum) produces an array of medicinally important
benzylisoquinoline alkaloids (BIAs) such as the analgesics codeine 10 and morphine 11
(Figure D.1)1,2. The biosynthesis of these alkaloids begins with the condensation of
dopamine 1 and 4-hydroxyphenylacetaldehyde (4HPAA) 2 to form (S)-norcoclaurine 3.
Through a series of methylation and hydroxylation steps, (S)-norcoclaurine 3 is converted
into (S)-reticuline 4, the pivotal intermediate of many BIAs in the downstream pathways.
(S)-reticuline 4 is further converted in six enzymatic steps to thebaine 5, the alkaloid
intermediate at the entry point of the morphinan alkaloid pathway.
Two biosynthetic routes have been proposed for the conversion of thebaine 5 to morphine
11 (Figure D.1) 3 . In the first route (route A, Figure D.1), thebaine 5 is demethylated at
the 6 position by thebaine 6-0-demethylase (T60DM) to form ,x-unsaturated ketone
neopinone 7, which spontaneously isomerizes to form the more stable a,1-unsaturated
ketone codeinone 8. Reduction of the carbonyl in 8 by codeinone reductase (COR) yields
codeine 10. Finally, demethylation of 10 at the 3 position by codeine O-demethylase
(CODM) leads to morphine 11. Alternatively, in the second route (route B, Figure D.1),
thebaine 5 is demethylated at the 3 position by CODM to form oripavine 6. Second
demethylation -this time at the 6 position-of 6 by T60DM leads to morphinone 9,
which is subsequently reduced by COR to form morphine 11. Morphinan alkaloids
thebaine 5, oripavine 6, codeine 10 and morphine 11 accumulate in P. somniferum
suggesting that both routes are operative in vivoi,2.
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Figure D.1 Biosynthesis of benzylisoquinoline alkaloids in Papaver somniferum.
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The entire morphinan alkaloid pathway in P. somniferum has been fully elucidated at the
genetic level' 2 . Genes encoding thebaine 6-0-demethylase (PsT60DM) and codeine 0-
demethylase (PsCODM) have recently been cloned3 . Surprisingly, they both encode for
2-oxoglutarate/Fe(II)-dependent dioxygenases. While this family of enzymes has
previously been shown to catalyze N-demethylation 4 , this is the first report of 2-
oxoglutarate/Fe(II)-dependent dioxygenases catalyzing O-demethylation. Remarkably,
PsT60DM and PsCODM exhibit high sequence similarity (73% identity at the amino
acid level) and yet they are able to carry out O-demethylation regioselectively; T60DM,
which accepts both thebaine (kcat/Km = 837 s-1M 1, Km = 20 ± 7 uM) and oripavine (kcat/Km
= 1242.6 s' M1 , Km= 15 + 3 [M) as substrates, catalyzes O-demethylation at position 6,
while CODM, which accepts both codeine (kcat/Km = 785 s- M 1 Km= 21 ± 8 uM)
and thebaine (kcat /Km = 235 s 1M, Km = 42 ± 8 uM), catalyzes O-demethylation at
position 3 (Figure D.1) 3 . From a structural standpoint, it is interesting to understand how
these two highly similar enzymes are able to carry out O-demethylation regioselectively.
Furthermore, such an understanding will help rationalize the seemingly redundant way in
which nature synthesizes morphine 11.
This appendix describes rational re-design of Papaver somniferum CODM (PsCODM) to
exhibit higher substrate specificity towards codeine 10. Homology structural model of
PsCODM based on the crystal structure of Arabidopsis thaliana anthocyanidine synthase
(AtANS) was created, and PsCODM's substrate binding site based on this protein model
was identified. Rational redesign of the substrate-binding pocket yielded a mutant that
maintains its demethylase activity towards codeine 10 but not thebaine 5. We envision
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that this PsCODM mutant will be of great use in microbial production of morphine 11.
Specifically, reconstitution of morphine biosynthetic pathway in yeast using this mutant
instead of the wild type enzyme will prevent accumulation of an off-pathway
intermediate oripavine 6, thereby improving the yield of morphine. Moreover,
introduction of the re-engineered enzyme into Papaver somniferum could yield plant
varieties with altered alkaloid profiles.
D.2 Results and Discussion
D.2.1 Construction of CODM Mutant Expression Plasmids
E. coli expression plasmids pQEDIOX1 and pQEDIOX3, which contain the open reading
frames of Papaver somnferum T60DM and CODM, respectively, were provided by Dr.
Jillian Hagel and Professor Peter Facchini (University of Calgary). Initial protein
expression screening revealed that PsT60DM mutants are expressed at very low levels.
Therefore, we chose to focus our initial re-engineering efforts on PsCODM. Since the
crystal structure of PsCODM is not available at present, we decided to build homology
models5 of PsCODM based on the crystal structure of an enzyme that has the highest
amino acid sequence similarity to PsCODM. Blast search revealed that PsCODM shows
moderate sequence similarity (32% identity at the amino acid level) to Arabidopsis
thaliana anthocyanidin synthase (AtANS), which is also a 2-oxoglutarate/Fe(Il)-
dependent dioxygenase6 . To obtain homology models of PsCODM based on the crystal
structure of AtANS, we used automated protein-homology-modeling server SWISS-
MODEL (Figure D.2) 5. From this model, the substrate and co-factor binding site was
identified. Key residues that are important for Fe(II)/2-oxoglutarate binding are
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highlighted in Figure D.3. Clustal alignment of PsCODM, PsT60DM and PsDIOX2
(another Papaver somniferum 2-oxoglutarate/Fe(II)-dependent dioxygenase whose native
substrate has not yet been identified) revealed three specific regions within the substrate
binding pockets where PsCODM and PsT60DM differ significantly at the amino acid
level: region A1-A2, region B and region Cl-C 2(Figure D.2 - D.3). We decided to convert
PsCODM to PsT60DM at these three regions using sequential site-directed mutagenesis.
In total, 16 CODM mutants were constructed (Table D.1)
Table D.1 PsCODM mutants that were constructed in this study. * indicates that the
residues in that region were mutated to those of PsT60DM
Al A2  B C1  C2  (wild type PsCODM)
1) A,* A2* B C1* C2*
2) A,* A2  B C1* C2*
3) A,* A2* B C1  C2*
4) A,* A2* B C1* C2
5) A1* A2* B C1  C2
6) A,* A2  B C, C2 *
7) A,* A2  B C1* C2
8) A1* A2  B C1  C2
9) A1  A2* B C1 * C2*
10) A, A2  B C1* C2*
11) A1  A2* B C1  C2*
12) A, A2* B CI* C2
13) A1  A2* B C1  C2
14) A, A2  B C1  C2*
15) A, A2  B C1* C2
16) A1 A2 B* C, C2
336
Figure D.2. Homology models of PsT60DM (green) and PsCODM (pink) based on the
crystal structure of AtANS. The models were created using SWISS-MODEL.
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DIOX1 MEKAKLMKLGNGMEIPSVQELAKLTLAEIPSRYVCANENLLLPMGASVINDHETIPVIDI 60
DIOX2 METAKLMKLGNGMSIPSVQELAKLTLAEIPSRYICTVENLQLPVGASVIDDHETVPVIDI 60
DIOX3 METPILIKLGNGLSIPSVQELAKLTLAEIPSRYTCTGESPLNNIGASVTDD-ETVPVIDL 59
** *.*****. ******************* *. * .**** .* **.****.
DIOX1 ENLLSPEPIIGKLELDRLHFACKEWGFFQVVNHGVDASLVDSVKSEIQGFFNLSMDEKTK 120
DIOX2 ENLISSEPVTEKLELDRLHSACKEWGFFQVVNHGVDTSLVDNVKSDIQGFFNLSMNEKIK 120
DIOX3 QNLLSPEPVVGKLELDKLHSACKEWGFFQLVNHGVDALLMDNIKSEIKGFFNLPMNEKTK 119
.**-* **. *****-** *********.******. *.* .**.*.***** *.** *
Region A
DIOX1 YEQEDGDVEGFGQGFIESEDQTLDWADIFMMFTLPLHLRKPHLFSKLPVPLRETIESYSS 180
DIOX2 YGQKDGDVEGFGQAFVASEDQTLDWADIFMILTLPLHLRKPHLFSKLPLPLRETIESYSS 180
DIOX3 YGQQDGDFEGFGQPYIESEDQRLDWTEVFSMSLPLHLRKPHLFPELPLPFRETLESYLS 179
* *-*** ***** - **** ***. .. * . .. *********** .**.*.***.*** *
DIOX1 EMKKLSMVLFNKMEKALQVQAAEIKGMSEVFIDGTQAMRMNYYPPCPQPNLAIGLTSHSD 240
DIOX2 EMKKLSMVLFEKMEKALQVQAVEIKEISEVFKDMTQVMRMNYYPPCPQPELAIGLTPHSD 240
DIOX3 KMKKLSTVVFEMLEKSLQL--VEIKGMTDLFEDGLQTMRMNYYPPCPRPELVLGLTSHSD 237
.***** *.*. .**-**. *** . . . .* * * **********.*.* .*** ***
DIOX1 FGGLTILLQINEVEGLQIKREGTWISVKPLPNAFVVNVGDILEIMTNGIYHSVDHRAVVN 300
DIOX2 FGGLTILLQLNEVEGLQIKNEGRWISVKPLPNAFVVNVGDVLEIMTNGMYRSVDHRAVVN 300
DIOX3 FSGLTILLQLNEVEGLQIRKEERWISIKPLPDAFIVNVGDILEIMTNGIYRSVEHRAVVN 297
* *******. ********. * ***. ****. ** .***** .*******. * .**.***
+ + Region B Region C
DIOX1 STNERLSIATFHDPSLESVIGPISSLITPETPALFKSGSTYGDLVEECKTRKLDGKSFLD 360
DIOX2 STKERLSIATFHDPNLESEIGPISSLITPNTPALFRSGSTYGELVEEFHSRKLDGKSFLD 360
DIOX3 STKERLSIATFHDSKLESEIGPISSLVTPETPALFKRG-RYEDILKENLSRKLDGKSFLD 356
**.********** *** *******.**.*****. * * .... * .**********
DIOX1 SMRI- 364
DIOX2 SMRM- 364
DIOX3 YMRM- 360
Figure D.3. Sequence alignment of PsDIOX1 (PsT60DM), PsDIOX2 and PsDIOX3
(PsCODM). + indicates residues that have been proposed to be important in 2-
oxoglutarate binding. 4 indicates residues that have been proposed to be important in
coordinating Fe(II).
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D.2.2 Heterologous Expression of PsCODM Mutants and In vitro Activity Assay of
PsCODM Mutants
Heterologous expression of PsCODM wild type and mutant enzymes in E. coli were
adapted from a previously reported protocol3 . Robust protein expression was observed in
most of the mutants (Figure D.4). The only mutant that had low expression level was the
A1A 2*BCC 2mutant. Mutant PsCODM enzymes were screened with substrates thebaine
10 and codeine 5 under assay conditions containing saturating concentrations of the
alkaloids (0.25 mM). Briefly, the assay was performed using a 100 [L reaction mixture
of 100 mM Tris-HCl (pH 7.4), 10% (v/v) glycerol, 14 mM 2-mercaptoethanol, 0.25 mM
alkaloid, 10 mM 2-oxoglutarate, 10 mM sodium ascorbate, 0.5 mM FeSO 4, and 1 tM
purified enzyme. The assays were incubated at 30*C and were quenched after 4 hours.
Product formation was observed using liquid chromatography-mass spectrometry (LC-
MS). LC-MS traces of representative in vitro enzymatic assays of wild type and mutant
PsCODM enzymes are shown in Figure D.5 - D.6. Endpoint assays indicated that the
majority of the mutants lost their O-demethylase activity towards both thebaine 5 and
codeine 10. Out of the total of sixteen mutants, only two (A A2 B C1* C2 and A, A2 B* C1
C2 mutants) maintained O-demethylase activity towards codeine 10 (Figure D.5).
Interestingly, while the A, A2B* C1 C2 mutant also maintained O-demethylase activity
towards thebaine 5, the A1 A2 B C,* C2 mutant can no longer O-demethylate thebaine 5
(Figure D.6).
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Figure D.4. SDS-PAGE of purified wild type and
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Figure D.5. LC-MS traces of an in vitro enzymatic assay of wild type and mutant
PsCODM enzymes (1 [M final enzyme concentration) with 0.25 mM codeine 10 in Tris
buffer (100 mM Tris-HCl, 10% (v/v) glycerol, 14 mM 2-mercaptoethanol, pH 7.4)
containing 10 mM 2-oxoglutarate, 10 mM sodium ascorbate and 0.5 mM FeSO 4.Reactions were performed at 30*C for 4 hours. m/z 286 corresponds to morphine 11. LC-
MS spectra are normalized to the same y-axis scale.
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Figure D.6. LC-MS traces of an in vitro enzymatic assay of wild type and mutant
PsCODM enzymes (1 [LM final enzyme concentration) with 0.25 mM thebaine 5 in Tris
buffer (100 mM Tris-HCl, 10% (v/v) glycerol, 14 mM 2-mercaptoethanol, pH 7.4)
containing 10 mM 2-oxoglutarate, 10 mM sodium ascorbate and 0.5 mM FeSO4.
Reactions were performed at 30*C for 4 hours. m/z 298 corresponds to oripavine 6. LC-
MS spectra are normalized to the same y-axis scale.
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Competitive assay conditions with saturating concentration (0.25 mM) of both thebaine 5
and codeine 10 were also used to screen PsCODM mutants (Figure D.7). Formation of
morphine 11 and oripavine 6 at 4:1 ratio was observed when wild type PsCODM was
used. Similarly, the A1 A2 B* C1 C2 mutant yielded both morphine 11 and oripavine 6 at
approximately 4:1 ratio, though at lower concentrations compared to the wild type
enzyme. Finally, the A1 A2B CI* C2 mutant produced only morphine 11, indicating that it
is selective towards codeine 10.
In addition to screening with natural alkaloid substrates thebaine 5 and codeine 10, we
also screened PsCODM mutants with the synthetic morphinan alkaloid analog
hydrocodone (dihydrocodeinone) 12 (Figure D.8). Hydrocodone 12 can be derived from
codeine 10 by oxidizing the hydroxyl group at the 6-position and reducing the adjacent
alkene. Not surprisingly, at saturating concentration (0.25 mM) of 12, PsCODM mutants
exhibited similar O-demethylase activity between hydrocodone 12 and codeine 10. Out of
the total of sixteen mutants, only two (A, A2 B CI* C2and A1 A2 B* C1 C2mutants) formed
the product hydromorphone (dihydromorphinone) 13.
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Figure D.7. LC-MS traces of an in vitro enzymatic assay of wild type and mutant
PsCODM enzymes (1 [M final enzyme concentration) with 0.25 mM thebaine 5 and
0.25 mM codeine 10 in Tris buffer (100 mM Tris-HCl, 10% (v/v) glycerol, 14 mM
2-mercaptoethanol, pH 7.4) containing 10 mM 2-oxoglutarate, 10 mM sodium ascorbate
and 0.5 mM FeSO4. Reactions were performed at 30*C for 4 hours. m/z 286 corresponds
to morphine 11; m/z 298 corresponds to oripavine 6. LC-MS spectra are normalized to
the same y-axis scale.
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/'0 CODM
NMeH
O
Hydrocodone 12(dihydrocodeinone)
Hydromorphone 13
(dihydromorphinone)
A1 A2 B* C1 C2
A1 A2 B C1* C2*
A1 A2 B C1* C2
A1* A2* B C1 C2
A1* A2 B C1 C2
Figure D.8. LC-MS traces of an in vitro enzymatic assay of wild type and mutant
PsCODM enzymes (1 ILM final enzyme concentration) with 0.25 mM hydrocodone 12 in
Tris buffer (100 mM Tris-HCl, 10% (v/v) glycerol, 14 mM 2-mercaptoethanol, pH 7.4)
containing 10 mM 2-oxoglutarate, 10 mM sodium ascorbate and 0.5 mM FeSO4.
Reactions were performed at 30*C for 4 hours. m/z 286 corresponds to hydromorphone
13. LC-MS spectra are normalized to the same y-axis scale.
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D.3 Conclusions
Papaver somniferum codeine O-demethylase (PsCODM), a 2-oxoglutarate/Fe(II)-
dependent dioxygenase in morphine biosynthesis, was re-engineered to exhibit higher
substrate specificity towards codeine 10. Rational site-directed mutagenesis of the
residues that form the substrate-binding pocket, as determined by a homology structural
model, yielded a mutant (A, A2B Ci* C2) that maintained its demethylase activity
towards codeine 10 but not thebaine 5. Reconstitution of morphine biosynthetic pathway
in yeast using this PsCODM mutant instead of the wild type enzyme will improve the
yield of morphine by preventing the accumulation of an off-pathway intermediate
oripavine 6. Moreover, we envision that the simultaneous suppression of wild type
PsCODM and overexpression of this mutant enzyme in P. somniferum will yield plant
varieties with improved morphine production.
D.4 Experimental Methods
D.4.1 Construction of CODM Mutant Expression Plasmids
pQEDIOX1 (pQET60DM) and pQEDIOX3 (pQECODM), which contain the open
reading frames of PsT60DM and PsCODM, respectively, were provided by Professor
Peter Facchini and Dr. Jillian Hagel (University of Calgary). To obtain the sixteen
CODM mutants (Table D.1), site-directed mutagenesis (SDM) was performed using
Stratagene QuikChange Site-Directed Mutagenesis kit. SDM primers are summarized in
Table D.2. The PsCODM mutant constructs were sequenced to verify their identities and
were subsequently transformed into E. coli strain SG13009 (Qiagen) via electroporation
using standard protocols.
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Plasmid Template used in SDM Primers used in SDM
pQECODM A,* A, B C, C2  pQECODM A1 A2 B C1 C2  Forward: 5'-ggaccaaagacttgattgggctgatgtgtttagcatgttaagtc-3'
Reverse: 5'-gacttaacatgctaaacacatcagcccaatcaagtctttggtcc-3'
Then perform the second round of SDM with the following primers
Forward: 5'-ccaaagacttgattgggctgatatatttagcatgttaagtcttcctc-3'
Reverse: 5'-gaggaagacttaacatgctaaatatatcagcccaatcaagtctttgg-3'
pQECODM A,* A2* B C1 C pQECODM A,* A2 B C1 C2  Forward: 5'-aaagacttgattgggctgatatatttatgatgttaagtcttcctctccatt-3'
Reverse: 5'-aatggagaggaagacttaacatcataaatatatcagcccaatcaagtcttt-3'
Then perform the second round of SDM with the following primers
Forward: 5'-cttgattgggctgatatatttatgatgttcactcttcctctccatttaagga-3'
Reverse: 5'-tccttaaatggagaggaagagtgaacatcataaatatatcagcccaatcaag-3'
pQECODM A, A2* B C1 C, pQECODM A, A2 B C1 C2 Forward: 5'-caaagacttgattggactgaagtgtttatgatgttcactcttcctctccatttaaggaagcc-3'
Reverse: 5'-ggcttccttaaatggagaggaagagtgaacatcataaacacttcagtccaatcaagtctttg-3'
pQECODM A1 A2 B* C1 C2  pQECODM A1 A2 B C1 C2  Forward: 5'-gacacctgctttgttcaaaagtggatctacatatgaggatattttgaagg-3'
Reverse: 5'-ccttcaaaatatcctcatatgtagatccacttttgaacaaagcaggtgtc-3'
pQECODM A, A2 B C1* C2  pQECODM A, A2 B C1 C2  Forward: 5'-tttgttcaaaagaggtaggtatggggatcttttgaaggaaaatctttcaagg-3'
Reverse: 5'-ccttgaaagattttccttcaaaagatccccatacctacctcttttgaacaaa-3'
Then perform the second round of SDM with the following primers
Forward: 5'-caaaagaggtaggtatggggatcttgtggaggaaaatctttcaagga-3'
Reverse: 5'-tccttgaaagattttcctccacaagatccccatacctacctcttttg-3'
pQECODM A1 A2 B Ci* C2* pQECODM A, A2 B C1 * C2  Forward: 5'-gtatggggatcttgtggaggaatgtctttcaaggaagcttga-3'
Reverse: 5'-tcaagcttccttgaaagacattcctccacaagatccccatac-3'
Then perform the second round of SDM with the following primers
Forward: 5'-agaggtaggtatggggatcttgtggaggaatgtaagacgaggaagcttgatggaaa-3'
Reverse: 5'-tttccatcaagcttcctcgtcttacattcctccacaagatccccatacctacctct-3'
pQECODM A, A2 B C1 C2* pQECODM A1 A2 B C1 C2  Forward: 5'-gacacctgctttgttcaaaagaggtaggtatgaggatattttgaa
ggaatgtaagacgaggaagcttgatggaaaatcatttct-3'
Reverse: 5'-agaaatgattttccatcaagcttcctcgtcttacattccttcaa
aatatcctcatacctacctcttttgaacaaagcaggtgtc-3'
pQECODM A,* A2 BC1* C2* pQECODM A1 A2 B C1* C2* Forward: 5'-ggaccaaagacttgattgggctgatgtgtttagcatgttaagtc-3'
Reverse: 5'-gacttaacatgctaaacacatcagcccaatcaagtctttggtcc-3'
Then perform the second round of SDM with the following primers
Forward: 5'-ccaaagacttgattgggctgatatatttagcatgttaagtcttcctc-3'
Reverse: 5'-gaggaagacttaacatgctaaatatatcagcccaatcaagtctttgg-3'
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Plasmid Template used in SDM Primers used in SDM
pQECODM A,*A 2* BCI*C 2 * pQECODM A,* A2 BC,* C* Forward: 5'-aaagacttgattgggctgatatatttatgatgttaagtcttectctccatt-3'
Reverse: 5 '-aatggagaggaagacttaacatcataaatatatcagcccaatcaagtcttt-3'
Then perform the second round of SDM with the following primers
Forward: 5'-cttgattgggctgatatatttatgatgttcactcttcctctecatttaagga-3'
Reverse: 5'-tecttaaatggagaggaagagtgaacatcataaatatatcagcccaatcaag-3'
pQECODM A* A 2* B C1 C, pQECODM A A2 B C*C 2  Forward: 5'-caaagacttgattggactgaagtgtttatgatgttcactcttcctctccatttaaggaagcc-3
Reverse: 5'-ggcttccttaaatggagaggaagagtgaacatcataaaeacttcagtccaatcaagtctttg-3
pQECODM A,* A2 B C1 C2  pQECODM A2* A* B C, C Forward: 5'-gacacctgctttgttcaaaagaggtaggtatgaggatattttgaa
ggaatgtaagacgaggaagettgatggaaaatcatttet-3'
Reverse: 5'-agaaatgattttccatcaagcttcctcgtettacattccttcaa
________________________aatatcctcatacctacctcttttgaacaaagcaggtgtc-3'
pQECODM A1 A2* B Ci C2 * pQECODM A, A,* B C1 C, Forward: 5'-gacaectgctttgtteaaaagaggtaggtatgaggatattttgaa
ggaatgtaagacgaggaagcttgatggaaaatcatttct-3'
Reverse: 5'-agaaatgattttccatcaagcttcctcgtcttacattccttcaa
_______________________aatatccteatacctacctcttttgaacaaagcaggtgtc-3'
pQECODM A,* A2* BC*C 2 * pQECODM A,* A,* B C1 C2  Forward: 5'-gacacctgctttgttaaaagaggtaggtatgaggatattttgaa
ggaatgtaagacgaggaagcttgatggaaaatcatttct-3'
Reverse: 5'-agaaatgattttccatcaagcttcctcgtcttacattccttcaa
aatatcctcatacctacctcttttgaacaaagcaggtgtc-3'
pQECODM A1 A,* B C1 *C,* pQECODM A* A2 B C* C* Forward: 5'-caaagattgattggactgaagtgtttatgatgttcactttcetctccatttaaggaagcc-3'
Reverse: 5'-ggcttccttaaatggagaggaagagtgaacatcataaacacttcagtccaatcaagtctttg-3'
pQECODM A1 * A,* BCL* C, pQECODM A* A2 * B C1 C2  Forward: 5-tttgttcaaaagaggtaggtatggggatcttttgaaggaaaatctttcaagg-3'
Reverse: 5'-ccttgaaagattttccttcaaaagatccatacctacctcttttgaacaaa-3'
Then perform the second round of SDM with the following primers
Forward: 5'-caaaagaggtaggtatggggatcttgtggaggaaaatctttcaagga-3'
Reverse: 5'-tccttgaaagattttcctccaaagatccccatacctacctcttttg-3'
pQECODM A,* A, B Cj* C, pQECODM A,* A, B C CG Forward: 5'-tttgttcaaaagaggtaggtatggggatcttttgaaggaaaatctttcaagg-3a
Reverse: 5'-ccttgaaagattttccttcaaaagatccccatacctacctcttttgaacaaa-3 a
Then perform the second round of SDM with the following primers
Forward: 5'-caaaagaggtaggtatggggatcttgtggaggaaaatctttcaagga-3
Reverse: 5'-tccttgaaagattttcctccacaagatccccatacctacctcttttg-3'
D.4.2 Heterologous Expression of PsCODM Mutants
A single transformed E. coli colony was inoculated in 10 mL LB media supplemented
with kanamycin (0.05 g/L) and ampicillin (0.1 g/L) and incubated overnight at 37 'C with
shaking at 225 rpm. An aliquot of the overnight culture (8 mL) was then used to inoculate
800 mL LB media supplemented with kanamycin (0.05 g/L) and ampicillin (0.1 g/L) and
incubated at 37 *C with shaking at 225 rpm until an OD60 of 0.6 was reached. Cells were
induced for overexpression by the addition of isopropyl -D-galactopyranoside (IPTG,
final concentration 0.3 mM) and the culture was allowed to continue growth for 24 hrs at
6 'C. Cells were harvested by centrifugation and lysed by sonication. The hexa-histidine-
tagged CODM mutants were purified using Talon colbalt affinity column (Clontech)
using manufacturer's protocols. Eluted enzyme was subsequently buffer-exchanged into
Tris buffer (100 mM Tris-HCl pH 7.4, 10% (v/v) glycerol and 14 mM
2-mercaptoethanol) and immediately assayed for activity. This enzyme was not stable
upon extended storage.
D.4.3 In Vitro Activity Assay of PsCODM Mutants
The conditions for the in vitro activity assay were adapted from a previously reported
protocol 3. Briefly, the assay for 2-oxoglutarate/Fe(II)-dependent dioxygenase activity was
performed using a 100 kL reaction mixture of 100 mM Tris-HCl (pH 7.4), 10% (v/v)
glycerol, 14 mM 2-mercaptoethanol, 0.25 mM alkaloid(s), 10 mM 2-oxoglutarate, 10
mM sodium ascorbate, 0.5 mM FeSO 4, and 1 tM purified enzyme. Assays were carried
out for 4 hours at 30*C. Aliquots (25 gL) were quenched in 1 mL methanol, containing
yohimbine (500 nM) as an internal standard. The samples were centrifuged in a
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microcentrifuge (13,000 rpm, 5 min) to remove particulates and then analyzed by LC-
MS. Samples were ionized by ESI with a Micromass LCT Premier TOF Mass
Spectrometer. The LC was performed on an Acquity Ultra Performance BEH C18, 1.7
tm, 2.1 x 100 mm column on a gradient of 10-90% acetonitrile/water (0.1% formic acid)
over 5 minutes at a flow rate of 0.6 mL/min. The appearance of morphine 11, oripavine 6
and hydromorphone 13 was monitored by peak integration and normalized to the internal
standard. All chemicals were obtained from a commercial source (Sigma Aldrich).
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